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Since the introduction of antibiotics into clinical use for the treatment of bacterial infections, 
resistance has repeatedly emerged and current levels of resistance represent a significant threat 
to patient outcomes in both healthcare and community settings. Collectively, the main drivers 
of antibiotic resistance emergence and spread are mobile genetic elements, such as insertion 
sequences, transposons, and plasmids, the latter of which can confer resistance to multiple 
antimicrobial agents. These multiresistance plasmids exist at low copy-numbers and generally 
contain a toolkit of maintenance mechanism, such as Type Ib plasmid partitioning systems, 
which ensure plasmid copies are stably maintained during cell division, even in the absence of 
selection pressure for the phenotypes that they confer. 
 
 
Type Ib plasmid partitioning systems have been well studied in association with select plasmids 
from Gram-negative organisms. In the context of Gram-positive organisms, particularly 
staphylococcal and enterococcal plasmids, the functionality of such systems has been studied 
to a much lesser extent. In general, Type Ib partitioning systems encode an ATPase motor 
protein and a DNA-binding protein, referred to as ParA and ParB, respectively. ParA drives 
plasmid segregation via dynamic movement, while ParB interacts with ParA and binds to a 
plasmid centromere-like site (parS); this binding facilitates both transcriptional regulation of 
the par operon and plasmid segregation via interaction with dynamic ParA molecules. As little 
is known about how these components function in Gram-positive bacteria, particularly coccoid 
shaped cells, the putative Type Ib systems identified on the staphylococcal and enterococcal 
resistance plasmids p107A and pJEG029, respectively, have been investigated in this study. 
In this regard, data presented in this thesis provides an important mechanistic overview of how 
Type Ib partitioning systems function in coccoid organisms and confirms their similarity with 
well-studied systems. Specifically, functional studies, combined with site-directed 
xii  
mutagenesis, have confirmed the requirement of both ParA and ParB for plasmid stability. 
Additionally, DNA-binding studies and reporter assays have also confirmed that ParB binds to 
predicted parS sites and regulates transcription of the par operon. Interestingly, in the case of 
the pJEG029 system, the ParB protein also regulates the repA gene, and this is the first report 
of such regulation where the replication gene is located in a separate operon. Furthermore, 
cytological studies using the staphylococcal system have for the first time revealed that ParA 
displays dynamic movement within coccoid cells in association with the bacterial nucleoid, 
which is consistent with the current model for Type I partitioning systems; note that ParB also 
appears to enhance this movement. 
 
 
Collectively, the results presented in this thesis address a serious knowledge gap and provide a 
detailed mechanistic understanding of staphylococcal and enterococcal Type Ib plasmid 
partitioning systems. Ultimately, this and future studies will help provide opportunities for the 
development of targeted interventions aimed at disrupting resistance plasmid carriage and 






1.1 Clinical relevance of staphylococci and enterococci 
Staphylococci and enterococci are characterised as Gram-positive, opportunistic pathogenic 
bacteria that appear as grape-like clusters (staphylococci) or short chains (enterococci) of cocci 
under microscopic observation. These bacteria are typically 0.5 – 1.5 µm in diameter and are 
facultative anaerobes that naturally form part of the normal flora of skin and mucous 
membranes (staphylococci), or the gastrointestinal tract (enterococci) of animals and humans 
(Harris et al., 2002). 
 
 
In terms of staphylococci, production of the coagulase enzyme is a primary differentiator 
between the pathogenic species Staphylococcus aureus and less harmful coagulase-negative 
staphylococci (CNS) such as Staphylococcus epidermidis. Strains of S. aureus are typically 
golden yellow in appearance and have a butyrous consistency when grown on solid media 
(Kiser et al., 2011). Importantly, S. aureus isolates, more commonly known as ‘Golden Staph’, 
are a major cause of hospital-acquired infections worldwide and are an increasing cause of 
infections in the wider community. These community-associated strains are more sensitive to 
antibiotics but appear to display increased virulence (Calfee, 2017). 
 
 
For enterococci, a positive pyruvate test differentiates between the most commonly isolated 
species Enterococcus faecalis from Enterococcus faecium (Kiser et al., 2011). Vancomycin- 
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resistant enterococci (VRE) represent an increasing burden in Australian healthcare settings. 
While less pathogenic than methicillin-resistant S. aureus (MRSA), enterococci are 
problematic due to their intransigence to antimicrobial therapy. VRE clinical isolates, which 
are mostly E. faecium, have a variety of intrinsic and acquired mechanisms of antibiotic 
resistance. In the case of vancomycin, high-level resistance emerged in North America and 
Europe in the late 1980s due to acquisition of the vanA determinant, which encodes inducible 
resistance to all known glycopeptides and is an integrated part of Tn1546. This transposon and 




In Australia, vancomycin resistance was largely mediated by a chromosomally encoded vanB 
determinant, which does not encode expanded glycopeptide resistance (i.e., isolates remain 
teicoplanin susceptible), and was common amongst clinical E. faecium isolates where 36.5% 
of all E. faecium bacteraemia isolates displayed such resistance (Coombs et al., 2014). 
However, it is now apparent that vanA-positive E. faecium isolates are emerging in Australian 
hospitals (Lee et al., 2020), and this represents significant clinical concern due to expanded 
glycopeptide resistance (i.e., teicoplanin resistance) (Santajit and Indrawattana, 2016) and 
increased potential for the transfer of high-level vancomycin resistance to MRSA isolates, the 
latter of which is driven by transmissible vanA resistance plasmids. 
 
 
In the broader context of healthcare associated infections, S. aureus and E. faecium belong to 
a group of microorganisms that are collectively referred to as the ‘ESKAPE’ pathogens 
(Enterococcus faecium, Staphylococcus aureus, Klebsiella pneumoniae, Acinetobacter 
baumannii, Pseudomonas aeruginosa, and Enterobacter species). The ESKAPE acronym aptly 
describes  this  group of  pathogens  as  they are  extremely adept  at  ‘escaping’ the  action of 
antimicrobial agents and thus contribute significantly to the increase and transfer of antimicrobial 
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resistance (Ma et al., 2020, Pendleton et al., 2013). 
1.2 Emergence and mechanisms of drug resistance development 
Antibiotics, namely penicillin, were therapeutically introduced as the main effective treatment 
against bacterial infections, particularly staphylococcal infections in the 1940s. Initially, the 
majority of S. aureus isolates were found to be susceptible to penicillin, however, by 1950 
approximately half of the strains isolated were resistant (Livermore, 2000). This was due to the 
production of a β-lactamase enzyme encoded by a gene (blaZ) located on a plasmid carried by 
the bacteria (Foster, 2017). β-lactamases hydrolyse the β-lactam ring of penicillin, preventing 
the drug from successfully binding to its target, penicillin-binding-proteins (PBPs), which are 
essential proteins required for cell wall synthesis (Reygaert, 2009). 
 
 
Alternate antibiotics were developed shortly after the increase in penicillin resistance became 
prevalent. These included streptomycin, chloramphenicol, tetracycline and macrolides such as 
erythromycin (Livermore, 2000). Further development of resistance to these antimicrobials led 
to the establishment of semi-synthetic antibiotics, including oxacillin and methicillin, which 
were developed to combat penicillin resistance (Lyon and Skurray, 1987). Initially, methicillin 
was effective against the vast majority of S. aureus strains, however methicillin-resistant S. 
aureus (MRSA) isolates soon emerged, causing hospital-acquired infections worldwide 
(Hiramatsu et al., 2001). Community-acquired MRSA infections have also been on the rise 
since the mid-1990s and the causative strains appear to be more pathogenic than those 
associated with hospital-acquired infections (Cooke and Brown, 2010). 
 
 
In MRSA, the genetic component that gives rise to methicillin resistance is the mecA gene, 
which is located on the mobile element known as the staphylococcal chromosome cassette mec 
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(SCCmec) (Jansen et al., 2006). The mecA gene encodes a PBP called PBP2a, which facilitates 
methicillin resistance due to its low binding affinity for β-lactam antibiotics (Katayama et al., 
2005, Rice, 2010). As these antibiotics cannot bind to PBP2a, normal cell wall synthesis is able 
to proceed uninterrupted (Malachowa and DeLeo, 2010). 
 
 
At present, glycopeptide antibiotics such as vancomycin or teicoplanin are currently the drugs 
of choice for treating MRSA infections (John, 2020). Although vancomycin is effective against 
MRSA infections, antibiotic selective pressure has led to the emergence of vancomycin-
intermediate and vancomycin-resistant S. aureus (VISA and VRSA, respectively) (John, 2020). 
VRSA strains are uncommon and are proposed to arise due to the exchange of genetic material 
(i.e., transposons/plasmids) between bacteria (Appelbaum, 2007). In comparison, the 
acquisition of vancomycin resistance by enterococci is more common, where different 
resistance types have been identified on different transposons. In general, there are six types of 
vancomycin resistance determinants/gene clusters that have been characterised to date; the two 
main types are vanA and vanB, with vanA being the most prevalent (Courvalin, 2006). The 
vanA and vanB gene clusters are located on transposons Tn1546 and Tn1547, respectively, 
which are carried by transferable plasmids in enterococcal isolates (Werner et al., 2011, 
Courvalin, 2006), as described above. Studies have shown that the structure of the vanA gene 
cluster in enterococci vary in diverse geographic areas due to point mutations, deletions and 
insertions of insertion sequence (IS) elements, which result in Tn1546-like structures (Werner 
et al., 2011). 
 
 
The rise of multiresistant staphylococcal (MRSA) and enterococcal (VRE) strains, which is 
largely driven by mobile elements, continues to challenge the utility of existing antibiotics. For 
example, the transfer of high-level vancomycin resistance was demonstrated as an interspecies 
transfer of Tn1546 and Tn1546-like structures (encoding the vanA gene cluster) from a VRE 
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isolate to a conjugative multiresistance plasmid in an MRSA isolate. Moreover, conjugative 
transfer of the van element to a MRSA strain in vitro confirmed the concern for vancomycin 
resistance transmission, where subsequent vancomycin-resistant S. aureus (VRSA) strains 
have since been reported (Cong et al., 2020). 
1.3 Genetics of antibiotic resistance 
Although antibiotic resistance can arise due to chromosomal mutations, the main driver of 
multiresistance is the acquisition of pre-existing resistance determinants (often from 
environmental bacteria; Lacey, 1984, Patel, 2003) through horizontal gene transfer (HGT), 
which is the transfer of DNA between donor and recipient bacterial cells. HGT is facilitated by 
mobile genetic elements such as insertion sequence (IS) elements, transposons (Tn) and 
plasmids (Aminov, 2009, Firth and Skurray, 1998). Transposons and IS elements encode a 
transposase enzyme, which allows them to move from one site to another within (or between) 
DNA molecules (Bauman and Machunis-Masuoka, 2009). Thus, HGT plays an essential role 
in the maintenance, increase and expanse of antibiotic resistance in bacteria, with both 
staphylococci and enterococci being prime examples (Firth and Skurray, 1998, Patel, 2003, 
Appelbaum, 2007). It is important to note that resistance determinants largely evolved prior to 
the use of antibiotics in hospitals, in order for bacteria to adapt to various environmental 
pressures, such as antibiotics produced by bacterial competitors (Aminov, 2009). 
1.4 Plasmids 
Plasmids are typically double-stranded circular DNA molecules that undergo autonomous 
replication within a bacterial cell (Lodish, 2008). These extrachromosomal DNA elements 
occur naturally in bacteria and often confer advantageous phenotypes on host cells, such as 
antibiotic resistance and increased virulence (Bahl et al., 2009, Giedraitiene et al., 2011). 
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Determinants associated with such phenotypes are often inserted into plasmids via transposons 
and IS elements. Transfer of a plasmid from one bacterium to another is facilitated via the 
processes of transformation, conjugation and transduction (Firth et al., 2018). 
1.5 Staphylococcal plasmids 
Staphylococcal plasmids are pivotal in the acquisition, maintenance and dissemination of 
antibiotic resistance. These plasmids were first recognised in the 1960s, and clinical S. aureus 
strains were commonly found to contain one or more resistance plasmids (Novick, 1989). 
Subsequently, staphylococcal plasmids have been somewhat loosely grouped into four classes 
– small rolling-circle replicating plasmids, pSK639 family plasmids, multiresistance plasmids 
and conjugative multiresistance plasmids (Lozano et al., 2012). However, the pSK639 family 
has been recently found to categorise with multiresistance plasmids (Partridge et al., 2018). 
The classification of staphylococcal plasmids has been based on a traditional typing system 
where plasmids were named after the genes they carried or the phenotype they presented. 
Recently, a new replicon typing system has been developed for Gram-positive bacteria where 
the homology of replication genes is utilised (Partridge et al., 2018), however the traditional 
naming system is referred to in this thesis. 
1.5.1 Small rolling-circle plasmids 
The family of small rolling-circle (RC) replicating plasmids was first identified in strains of S. 
aureus, however different Gram-positive bacteria have subsequently been shown to also carry 
these small multicopy plasmids (Ruiz-Maso et al., 2015). RC plasmids replicate using an 
asymmetric rolling-circle mechanism and obtain high-copy numbers (15 - 50 copies) in a cell; 
their small size (1 - 5 kb) typically allows them to often only carry a single resistance 
determinant (Khan, 1997, Novick, 1989). This class of plasmids is further categorised into four 
families and are described based on conserved domains in the replication region (Partridge et 
al., 2018). Some RC plasmids display highly similar DNA segments, even between different 
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bacterial genera, such that they appear to be composed of discrete functional cassettes which 
encode proteins involved in replication and antibiotic resistance (Novick, 1989). Cassette 
exchange is thought to be promoted by the RC replication mechanism coupled with regions of 
sequence similarity. The RSA/pre mobilisation system on some RC plasmids is also thought to 
mediate the exchange of these cassettes between RC plasmids of different families. For 
example, the staphylococcal plasmid pT181 has a mobilisation system that shows similarity to 
a relaxase/oriT system on the streptococcal plasmid pMV158 (Partridge et al., 2018). 
1.5.2 Multiresistance plasmids 
Multiresistance plasmids have been identified in clinical S. aureus isolates since the 1960s and 
carry multiple antimicrobial resistance determinants, hence their name (Firth et al., 2000). 
These plasmids are 15 - 40 kb in size and replicate at low-copy numbers in the cell utilising a 
theta-mode replication system (Berg et al., 1998, Firth et al., 2000). Most of these plasmids 
using this mode of replication encode a highly conserved replication initiator protein, RepA, 
from the RepA_N family (PF06970) (Shearer et al., 2011). The rep genes encoding this domain 
have also been present on staphylococcal conjugative multiresistance plasmids such as pSK41 
(Section 1.5.4) (Firth et al., 2000), as well as plasmids from other bacterial genera, such as 
pAD1 from E. faecalis (Weaver et al., 2009). The pSK639 family of plasmids have been 
grouped into the class of multiresistance plasmids based on size and mode of replication. This 
plasmid family can also be differentiated from RC plasmids due to their ability to carry IS 
elements, such as IS257. In the case of pSK818, the tetracycline resistance determinant was 
acquired via the IS257-mediated integration of the RC plasmid pT181 (Leelaporn et al., 1996). 
Additionally, staphylococcal multiresistance plasmids can be further split into two main 
groups: the β-lactamase/heavy metal resistance plasmids and the pSK1 family plasmids. 
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β-lactamase/heavy metal resistance plasmids were first identified in staphylococcal isolates in 
the late 1960s. The resistance gene blaZ, which encodes a β-lactamase, is located on the 
transposon Tn552 and transferred from the chromosome of an S. aureus isolate to a heavy 
metal-resistance plasmid (Rowland and Dyke, 1990). The Tn552 transposon confers resistance 
to antibiotics such as penicillin and other β-lactams (e.g., cephalosporins) (Rowland and Dyke, 
1990), while another transposon associated with the multiresistance plasmid family (Tn551), 
confers resistance to aminoglycosides (Firth et al., 2000). 
 
 
The pSK1 family plasmids were initially isolated from clinical S. aureus strains in Australia 
during the 1980s. The qacA gene, which encodes resistance to antiseptics and disinfectants, is 
ubiquitously carried by this plasmid family (Tennent et al., 1989). This family of plasmids 
variously carries Tn4001 and the Tn552-like β-lactamase transposon Tn4002, or the composite 
structure referred to as Tn4003, which confer resistance to aminoglycosides and trimethoprim, 
respectively (Jensen et al., 2010). In addition, the RepA homolog that falls into the cluster of 
the pSK1 plasmid family is also prevalent in multiresistance plasmids within the 
Staphylococcus genus other than S. aureus (Weaver et al., 2009). 
1.5.3 Conjugative multiresistance plasmids 
The conjugative multiresistance plasmids are the largest staphylococcal plasmids in size (30 - 
60 kb) and utilise a theta-mode replication system. pSK41 was initially the prototype for this 
family of plasmids, which can facilitate their own cell-cell transfer via the process of 
conjugation, encoded by the tra and oriT regions (Berg et al., 1989). Similar to staphylococcal 
multiresistance plasmids (Section 1.5.3), pSK41-like plasmids encode a RepA-N replication 
initiation system facilitating theta-mode replication (Liu et al., 2013, Shearer et al., 2011). A 
striking feature of pSK41-like plasmids is the presence of multiple copies of IS257, which have 
mediated the insertion of different resistance determinants, sometimes in the form of co-
integrated smaller plasmids. For example, pSK41 contains genes encoding resistance to 
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bleomycin and aminoglycosides via the IS257-mediated integration of the RC plasmid pUB110 
(Berg et al., 1998). Furthermore, resistance to gentamicin that emerged in the mid-1970s, which 
is mediated by Tn4001 derivatives of IS257, was initially identified on pSK41-type plasmids 
(Partridge et al., 2018). Other resistances encoded by pSK41 family plasmids include 
trimethoprim (Leelaporn et al., 1996), antiseptics and disinfectants (Tennent et al., 1989), 
mupirocin (Diep et al., 2006) and vancomycin (Weigel et al., 2003). 
 
 
In addition to the pSK41 family, two other families of staphylococcal conjugative plasmids 
have been recently identified, represented by the prototype plasmids pWBG749 and pWBG4, 
both of which are distinct from pSK41 family plasmids in terms of the conjugation gene clusters 
that they carry (Ramsay et al., 2016). The pWBG749 plasmid was identified in a community-
associated MRSA isolate in Australia and is not associated with antimicrobial resistance genes, 
however, genes encoding resistance to penicillin, aminoglycosides and vancomycin have been 
identified on other plasmid family members (Partridge et al., 2018, Rossi et al., 2014, O'Brien 
et al., 2015). The pWBG4 plasmid encodes resistance to aminoglycosides, macrolides, 
lincosamides and spectinomycin, with related plasmids also conferring trimethoprim and 
linezolid resistance (Partridge et al., 2018, Ramsay et al., 2016). Moreover, pWBG749 family 
plasmids have demonstrated mobilisation of non-conjugative plasmids using a newly described 
relaxase-in trans mechanism, where oriT mimic sequences found on plasmids that lack 
mobilisation genes closely resemble the pWBG749 oriT sequence (Partridge et al., 2018, 
Ramsay et al., 2016, O'Brien et al., 2015). 
1.6 Enterococcal plasmids 
Enterococci that are resistant to multiple antimicrobials can develop further resistance to 
antibiotics through the acquisition of genes present on conjugative/mobilisable plasmids. In 
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this regard, enterococcal plasmids have been conventionally grouped into four main classes – 
RC, Rep_3, Incompatibility plasmids (Inc18) and RepA_N plasmids (Arredondo-Alonso et al., 
2020). 
1.6.1 Small rolling-circle plasmids 
Although RC plasmids were originally described in S. aureus, they are a ubiquitous family of 
plasmids across Gram-positive bacteria. In enterococci, they have been characterised based on 
the replication initiator proteins encoding the Rep_trans, Rep_1 or Rep_2 conserved domains 
(Clewell et al., 2014, Partridge et al., 2018). Examples of plasmids identified that contain these 
conserved domains are the pT181-family, the pMV158 family and pUB110 family, 
respectively (Clewell et al., 2014). As RC plasmids do not need to recruit specific host proteins 
to initiate replication, it affords them the ability to replicate in a broad range of bacterial hosts. 
1.6.2 Rep_3 plasmids 
Several plasmids in both E. faecalis and E. faecium belong to the Rep_3 family, however, these 
plasmids have not been widely studied in these species (Clewell et al., 2014). Replication 
initiator proteins containing the conserved Rep_3 domain are ubiquitous in well-studied 
enterobacterial plasmids and could potentially provide a model for study of such plasmids in 
enterococci. In any case, of these enterococcal plasmids, the replicon of pCIZ2 is the best 
described (Criado et al., 2008). Analysis of this plasmid revealed that direct repeats located 
upstream of the initiator gene (repE) function as an origin of replication. Furthermore, gel 
analysis confirmed that it utilises a theta mode of replication, rather than a rolling circle 
mechanism. In addition, transformation efficiencies were tested with several species and 
revealed a narrow host range for pCIZ2; note that other enterococcal plasmids within the Rep_3 
family have a similar genetic organisation of direct repeats upstream of the replication initiation 
gene (Criado et al., 2008, Clewell et al., 2014). 
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1.6.3 Incompatibility plasmids 
Incompatibility (Inc) plasmids are a large family of plasmids with a broad host range that 
include enterococcal and streptococcal conjugative plasmids (Zhu et al., 2010). In general, 
plasmids are classified as incompatible if they fail to co-reside in the same cell, that is, the 
introduction of a second plasmid (of the same group) disrupts the inheritance of the first 
plasmid (Hegstad et al., 2010, Novick, 1987). Inc18 plasmids generally range in size from 25 
- 50 kb and in enterococci typically confer resistance to macrolides but can also encode 
resistance to other antibiotics, such as lincosamides and vancomycin. With respect to 
vancomycin resistance, a characterised vanA plasmid from an E. faecalis isolate was reported 
to be first identified as an Inc-18 plasmid, being conjugative and not pheromone-responsive 
(Flannagan et al., 2003). Additionally, Inc-18 plasmids can also be transferred between 
multiple bacterial genera, such as streptococci, lactococci, staphylococci and enterococci (Zhu 
et al., 2010), and two well-characterised examples are pIP501 and pAMβ1. 
 
 
Of note, pMG1-like plasmids are related to those of the Inc18 family and since being identified 
in an E. faecium clinical isolate from Japan, identification of the plasmid became more frequent 
from clinical isolates in hospitals in the United States (Tomita et al., 2002). Analysis of a unique 
pMG1-like plasmid (known as pHTβ) via sequence homology revealed the plasmid showed no 
similarities with broad host range plasmids and pheromone-responsive plasmids (Ike et al., 
1998, Tomita et al., 2003). The pHTβ plasmid is a vancomycin resistance plasmid, encoding a 
VanA-type determinant on a Tn1546-like transposon, and is likely the progenitor to the 
derivatives pHTα and pHTγ (Tomita et al., 2003). pMG1-like plasmids have been shown to be 
widely distributed amongst vancomycin-resistant E. faecium clinical isolates, and the Tn1546-
like transposon along with other mobile genetic elements, have contributed to the spread of 
vancomycin resistance (Partridge et al., 2018). In this regard, pMG1-like plasmids have a 
conjugative transfer system that differs from other known conjugative plasmids found in 
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enterococci (Tomita et al., 2002). 
1.6.4 RepA_N plasmids 
The RepA_N family consists of plasmids that are broadly distributed in Gram-positive bacteria 
and is comprised of E. faecalis pheromone-responsive plasmids, E. faecium pRUM-like 
plasmids and the so-called megaplasmids. Although they are broadly distributed, they are 
restricted to their native hosts and not much is known about how replication is regulated 
(Hegstad et al., 2010, Partridge et al., 2018). 
 
 
Pheromone-responsive plasmids encode a signal-sensing system that functions by sensing 
peptide pheromones secreted by plasmid-free recipients that ultimately induce plasmid transfer 
via conjugation (Weaver et al., 2009). Shortly after the pheromone response was first described 
and published, the replicon of E. faecalis plasmid pAD1 was identified and characterised 
(Weaver et al., 2009). In this regard, a fragment of DNA consisting of three genes within the 
pAD1 replicon was identified; these encoded the proteins named RepA, RepB and RepC 
(Weaver et al., 1993). Based on sequence homology, RepA resembled a replication initiator 
protein and transpositional insertion mutations within the gene resulted in replication 
inhibition, suggesting that the protein is essential for plasmid function (Weaver et al., 1993, 
Francia et al., 2004). In comparison, repB and repC were described to most likely represent a 
partition system; insertion mutations within these genes affected copy number and plasmid 
stability (Francia et al., 2004). In this regard, repB and repC encode proteins that are both 
homologous and functionality related to ParA and ParB proteins, respectively, from Type Ib 
partitioning systems (Weaver et al., 2009). 
 
 
The pRUM-like plasmids also consist of elements that are similar to that described for pAD1 
(in terms of replication), as well as elements that potentially resemble those contributing to 
plasmid segregational stability i.e., partitioning, multimer resolution and toxin-antitoxin 
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systems (Grady and Hayes, 2003). The PCR-based plasmid typing system for enterococci has 
shown that many hospital-adapted strains contain pRUM-related replicons. This is suggestive 
that pRUM-like plasmids play a significant role in facilitating adaptation to hospital settings 
(Hegstad et al., 2010). As such, pRUM-like plasmids can confer resistance to multiple 
determinants, and in the case of pS177, these plasmids are responsible for the transfer of 
vancomycin (vanA) resistance on a Tn1546-like transposon to MRSA (described in Section 
1.2) (Partridge et al., 2018). 
 
 
Megaplasmids (>100 kb) have been described in enterococci, although they seem to be 
confined to E. faecium (Freitas et al., 2010). Many of these megaplasmids harbour multiple 
virulence factors and antibiotic resistance genes, enhancing colonisation and therefore making 
E. faecium more capable of causing infections (Gomez et al., 2011). Genetic determinants that 
assist in the increasing number of enterococcal infections include genes encoding the 
enterococcal surface protein (esp) and a putative hyaluronidase (hylEfm) (Rice et al., 2003). 
Studies have indicated that the acquisition of hylEfm-containing plasmids, such as megaplasmid 
pLG1, is linked with increased colonisation and virulence factors (Arias et al., 2009). These 
types of megaplasmids can also confer vancomycin resistance via the vanA gene cluster 
(Gomez et al., 2011). In this regard, hospitals in different countries have identified an increase 
in the number of E. faecium isolates carrying the hylEfm gene, suggesting that horizontal gene 
transfer plays a significant role, in conjunction with the heavy use of antibiotics, in the spread 
of these plasmids (Freitas et al., 2010, Gomez et al., 2011). 
1.7 Plasmid maintenance systems 
Plasmids that undergo replication resulting in high copy-numbers, in particular RC plasmids, 
are readily able to segregate binomially without the assistance of a maintenance system. This 
is primarily due to the fact that daughter cells are highly likely to receive at least one copy of 
the  plasmid  as  a  result  of  passive  diffusion  (i.e.,  random  chance).  In comparison, 
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multiresistance and conjugative multiresistance plasmids are substantially larger in size and 
exist at low copy-numbers. Therefore, daughter cells are less likely to receive a plasmid copy 
via passive diffusion. As such, low copy number plasmids need to encode maintenance systems 
in order to maintain their presence within a growing population of cells, in the absence of 
selection (Firth et al., 2000, Berg et al., 1998). They can contain one or more of these 
mechanisms to assist in maintaining their own level of stability (Sengupta and Austin, 2011). 
Such mechanisms include multimer resolution systems, post-segregational killing (PSK) 
systems and active plasmid partitioning systems. 
1.7.1 Multimer resolution systems 
Multimer resolution systems are involved in the resolution of plasmid multimers, which result 
as a by-product of replication and homologous recombination. Plasmid multimers are 
associated with both low and high-copy number plasmids, such as the F, P1 and R1 plasmids 
in Escherichia coli, and ultimately reduce the number of plasmids that can be segregated into 
daughter cells (Pogliano et al., 2001, Weitao et al., 2000, Nordstrom and Austin, 1989). As 
such, plasmids often encode multimer resolution systems and various studies have shown that 
they increase plasmid segregational stability via the resolution of plasmid multimers (LeBard 
et al., 2008). For example, pSK41 family plasmids carry the resolvase gene res, which in 
combination with an active plasmid partitioning system, ensures that daughter cells receive 
individual plasmid copies (LeBard et al., 2008). 
1.7.2 Post-segregational killing systems 
Post-segregational killing (PSK) systems also contribute to the maintenance of plasmids in cells 
by selectively killing and thus preventing the proliferation of plasmid-free cells (Gerdes et al., 
1997). These systems rely on a toxin-antitoxin (TA) interaction, where an unstable antitoxin 
inhibits the action of the toxin in the cell. At present, there are three distinctly characterised TA 
systems and three newly discovered PSK systems that have been observed in bacteria (Harms 
et al., 2018, Unterholzner et al., 2013, Page and Peti, 2016). Type I and III systems are similar 
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in which they both encode an antisense RNA antitoxin, however the mode of interaction is 
different (Unterholzner et al., 2013). A characterised example for type I TA systems is the 
hok/sok system by E. coli resistance plasmid R1, which maintains R1 in a growing population 
of cells by eliminating those that become plasmid-free (Gerdes et al., 1986). Type II systems 
are the best studied, where they encode a protein antitoxin that binds directly to the toxin protein 
for inhibition; the antitoxin neutralises the toxin, resulting in no damage to plasmid-containing 
cells (Unterholzner et al., 2013). One of the many examples for type II TA systems are the CcdA 
and CcdB proteins in E. coli encoded on the F plasmid which are responsible for cell killing by 
specifically targeting DNA gyrase (Bernard and Couturier, 1992, Jensen and Gerdes, 1995). 
Type III systems are exemplified by the toxI/toxN TA module, which functions as a protein-
RNA mechanism and is the first described of its type (Fineran et al., 2009). This system was 
identified on a plasmid from an Erwinia carotovora isolate and is recognised to abort phage 
infection via altruistic cell death, as well as contributing to plasmid maintenance, in several 




The three recently identified TA systems (types IV – VI) differ from the previous types where 
the antitoxin gene encodes a low-molecular-weight protein (Page and Peti, 2016). In the Type 
IV system, there is no interaction between toxin and antitoxin, but instead interaction with 
cytoskeletal proteins MreB and FtsZ, inhibits polymerisation (Unterholzner et al., 2013). The 
type V system involves the antitoxin protein cleaving the mRNA of the toxin and thus 
preventing translation and expression of the toxin (Harms et al., 2018). The type VI TA system 
is composed of a toxin that inhibits the DNA replication elongation complex and other clamp-
binding proteins, whereby the antitoxin adaptor protein neutralises the toxicity of the toxin 
(Page and Peti, 2016).  
For enterococci, a type I system (termed par) has been described for the E. faecalis plasmid 
16  
pAD1, which was the first characterised in Gram-positive bacteria (Clewell et al., 2014). The 
TA mechanism of par seems to share some similarities with the hok/sok system found in Gram- 
negative bacteria (Hayes, 2003). In addition, a novel type II TA cassette (axe-txe) has been 
described for the E. faecium plasmid pRUM, which has also been shown to be functional in a 
variety of evolutionarily divergent bacterial hosts (Grady and Hayes, 2003). 
1.7.3 Active plasmid partitioning 
Active plasmid partitioning systems are a key mechanism utilised by plasmids with low copy 
numbers in order to maintain their retention in a growing population of cells, in the absence of 
phenotypic selection; it is important to note that such plasmids can also encode multimer 
resolution and PSK systems as well (Ebersbach and Gerdes, 2005). In general, most plasmid 
partitioning (par) loci identified on staphylococcal and enterococcal plasmids comprise three 
components that are vital for active segregation. They consist of a centromere-like site and two 
genes that encode a motor protein (NTPase), and a DNA-binding protein that binds to DNA 
tandem repeats in the centromere-like site (Schumacher, 2008). There are generally three 
characterised types of partitioning systems (Types I-III), which are differentiated based on the 
distinct type of NTPase utilised (Schumacher, 2008). Prototypes of the partitioning system 
types with genetic arrangements are shown in Figure 1.1. 
 
 
The mechanism of plasmid segregation differs between the three types of plasmid partitioning 
systems (Sections 1.8.1-1.8.3), although the function of all three components required are 
typically similar.  In general, the DNA-binding proteins bind to the tandem repeats of  the 
centromere, and upon further binding and recruitment of additional proteins, a nucleoprotein 
complex is formed and is often referred to as the segrosome (Schumacher et al., 2007). The 
pairing of two plasmid molecules via this complex has been observed in the case of some 
partitioning systems and is proposed to be an initial (and essential) step in the partitioning 
process (Jensen et al., 1998). 
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Figure 1.1 Genetic Organisation of Partitioning System Prototypes 
Representatives of active plasmid partitioning systems: Type Ia (plasmids P1 and F), Type Ib 
(plasmids pTAR, pTP228 and pAD1 [enterococcal prototype]), Type II (plasmid R1), and Type 
III (plasmid pBtoxis) prototype systems are shown. Genes encoding NTPase proteins and 
centromere-binding proteins are represented by orange and blue solid arrows, respectively. 
Centromere-like sites are shown as green solid boxes and promoters are represented by bent 
arrows. This figure was adapted from (Guynet and de la Cruz, 2011, Ebersbach and Gerdes, 
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At present, three types of NTPase motor proteins have been identified in active plasmid 
partitioning systems: Walker-type ATPases (Type I), actin-like ATPases (Type II) and tubulin- 
like GTPases (Type III) (Salje, 2010, Baxter and Funnell, 2014). The type of motor protein 
generally determines the mechanism of plasmid segregation (described in Sections 1.8.1- 
1.8.3). In all cases, the motor protein interacts with the segrosome and drives separation of 
plasmid copies. A fourth novel partitioning system, consisting of only one trans- acting protein 
(neither an ATPase or GTPase) as well as a cis-acting centromere-like site has been identified 
(Simpson et al., 2003). This arrangement differs from the three characterised types and the 
proposed mechanism of plasmid segregation is still unknown (Salje, 2010). In most cases, 
autoregulation of the various par operons is achieved via binding of the DNA-binding protein 
to the upstream centromere-like site in Types Ib, II, and III systems (Guynet and de la Cruz, 
2011). In the case of Type Ia systems, the motor protein regulates transcription via binding to 
the promoter region via a DNA-binding domain. Further details on the mechanisms of active 
plasmid partitioning systems Types I-III are described below in Section 1.8. 
 
 
1.8 Active plasmid partitioning systems 
 
1.8.1 Type I active plasmid partitioning systems 
Type I partitioning systems represent the most common partitioning mechanism associated 
with bacterial plasmids. The gene encoding the Walker-type ATPase protein (parA) in Type I 
partitioning systems is typically located directly upstream of the gene encoding the centromere- 
binding protein (parB; Figure 1.1). In addition, Type I par systems are further split into two 
subtypes, Type Ia and Type Ib. The main differences between these two subtypes are the 
location of the centromere-like site (Type Ia, downstream of the par operon; Type Ib, upstream 
of the par operon), and the type of DNA-binding domain that the centromere-binding proteins 
possess (i.e., either helix-turn-helix or ribbon-helix-helix) (Ebersbach and Gerdes, 2005, Huang 
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et al., 2011). 
 
 
Type Ia systems have been extensively studied using two distinct prototypes: sopABC of the F 
plasmid and parABS of the P1 plasmid (Figure 1.1). In the F plasmid, SopB binds to the 
centromere-like site via a helix-turn-helix (HTH) domain (Ebersbach and Gerdes, 2005). While 
SopB is able to polymerise by itself, studies have shown that interaction with the nucleoprotein 
complex accelerates SopA polymer formation (Schumacher, 2008). In addition, and unlike 
other partitioning systems (Types Ib, II and III), the SopA motor protein also regulates 
transcription of the par operon. 
 
 
The Type Ia system of the P1 plasmid is also similar with respect to the arrangement on the F 
plasmid. This P1 prophage plasmid is reliant on active partitioning in order to achieve true 
segregation (Davey and Funnell, 1994). It has been shown that an excess of either ParA or ParB 
(or both) leads to plasmid instability (Davey and Funnell, 1994, Davis et al., 1996, Davis et al., 
1992). Furthermore, in vivo studies of fluorescently labelled Par proteins (via fluorescent 
protein fusions) have shown that P1 plasmids move apart to become evenly distributed along 
the length of a cell (Sengupta et al., 2010). This process is mediated by nucleoid associated 
dynamic ParA gradients, where earlier studies suggested the type of movement was from ParA 
filaments that move plasmids via a pulling or oscillating mechanism (Vecchiarelli et al., 2010). 
Recent research is now favouring a diffusion-ratchet model for Type I plasmid partitioning 
systems, where the nucleoid is used as a scaffold for the movement of bound plasmid DNA 
along a gradient of nucleoid-bound ParA-ATP molecules. This pattern is modulated by ParB 
as it promotes ATP hydrolysis and ParA movement, resulting in plasmid movement within the 
cell (Vecchiarelli et al., 2013).  
 
The mechanistic roles of the Type Ib par components have been well studied in association 
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with select plasmids, although the Type Ib partitioning mechanism is not fully understood (Yin 
et al., 2006). A large number of plasmids from Gram-negative bacteria have been identified as 
containing Type Ib systems, such as pTP228 and pTAR (Yin et al., 2006) (Figure 1.1). Both 
pTP228 and pTAR plasmids contain identical elements but have been assigned different names. 
In the case of pTP228, its centromere-like site, ATPase motor protein and DNA-binding protein 
are referred to as parH, ParF and ParG, respectively. The ParG protein binds to the centromere- 
like site (parH) upstream of the parF gene, and electrophoretic mobility shift assays were used 
to elucidate this binding (Golovanov et al., 2003). ParG contains a RHH domain, which is 
primarily used in DNA binding and closely resembles the transcriptional repressor family 
Arc/MetJ (Carmelo et al., 2005). Specifically, the dimeric RHH domain β-sheets of ParG 
mediate interaction with the parH centromere-like site, and this is an essential interaction for 
successful plasmid segregation (Golovanov et al., 2003). In addition, ParG interaction with 
ParF enhances polymerisation of ParF, although ATP is also required (Zampini et al., 2009). In 
the case of pTAR, these elements are referred to as parS, ParA and ParB in the same respect 
– these names are more commonly used in association with Type Ib par systems. Observations 
similar to those described above for the pTP228 ParG protein, have also been made with respect 
to the ParB proteins of the pTAR Type Ib system (Kalnin et al., 2000, Machon et al., 2007). 
As described previously, the type of DNA-binding protein for Type I plasmid partitioning 
systems differ between the two subtypes Ia and Ib. In most cases, these proteins are referred to 
as ParB and represent dimeric DNA-binding proteins that contain a known DNA binding motif: 
a helix-turn-helix (HTH) motif or a six-stranded β-sheet coiled-coil (RHH) motif. HTH DNA 
motifs are commonly found in Type Ia partition system ParB proteins, which consist of an N- 
terminal NTPase binding domain, a central HTH domain and a C-terminal domain that 
facilitates dimer formation (Schumacher, 2012). The N-terminal domain interacts with the 
ATPase and mediates oligomerisation at and around its par site resulting in ParB spreading 
(Baxter and Funnell, 2014). This mechanism of spreading (away from the par site) is still 
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unclear, although it has been shown for both the SopB and ParB proteins of the F and P1 
plasmids, respectively (Kim and Wang, 1999, Rodionov et al., 1999). 
 
 
RHH proteins are common among Type Ib plasmid partitioning systems. They are also 
prevalent in Type II systems, however, the organisation of the DNA-binding proteins differ in 
the position of the domains that interact with DNA and the ParA ATPase; Type II RHH proteins 
interact with DNA via the N-terminal domain and the ATPase via the C-terminal domain 
(Baxter and Funnell, 2014). As mentioned previously, plasmid pTP228 possesses a RHH motif 
in the DNA-binding protein, ParG. The specific interaction of ParG with its respective DNA 
binding sites (parH), is similar to that of the transcriptional repressors from the Arc/MetJ 
family, in that the RHH dimeric structure inserts the β-sheet into the major groove of parH 
DNA (Golovanov et al., 2003). 
 
 
Studying cellular localisation of Type I ParA proteins (in vivo) has been largely facilitated using 
fluorescent protein fusions. Various studies of the Type Ib systems described above have also 
shown that plasmids are evenly distributed along the length of a cell via nucleoid associated 
ParA proteins (Ringgaard et al., 2009). In this regard, there are currently several models for 
ParA driven segregation, however initially there were only two main models. The first model 
proposed a pulling mechanism mediated by dynamic ParA filaments (or bundles thereof) to 
either poles of the cell, either around or through the nucleoid (Ebersbach and Gerdes, 2004). The 
second model described a diffusion-ratchet mechanism (or ‘brownian-ratchet’) which involves 
the nucleoid being used as a scaffold and ATP hydrolysis driving a gradient of ParA-ATP 
molecules for ParB-bound plasmid DNA movement (Figure 1.2A) (Vecchiarelli et al., 2010, 
Vecchiarelli et al., 2013). 
 
 
Whilst the second model still seems to be favoured, variations of this have emerged. For 
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example, the ‘DNA-relay model’ proposes that the elasticity of the chromosome allows ParB- 
bound plasmid DNA to move in the direction where the concentration of ParA is present on 
the chromosome (Lim et al., 2014). This particular model was proposed after the models 
described above failed to fit the mechanism of ParA segregation and movement of the ParB- 
DNA complex (Lim et al., 2014). 
 
 
Furthermore, in (Le Gall et al., 2016) described a strategy of combining whole-chromosome 
labelling with 3D super-resolution imaging to confirm the partition complex and ParA co- 
localise to high-density regions of the chromosome. This study suggests chromosomal DNA 
plays a pivotal role by enriching its association with ParA-ATP and ParB-bound plasmid DNA. 
In this regard, the methodology utilised revealed that ParA specifically localises within the 
volume of the nucleoid (Le Gall et al., 2016), and this is consistent with reports on ParA 
volumetric localisation in other models (Ringgaard et al., 2009). 
 
 
Consistent with this observation, a more recent study described a 3D meshwork model 
(McLeod et al., 2017). Using the parFG system from plasmid pTP228 to investigate the ParA 
partition complex, this study revealed that ParF is observed as a diffuse structure. Specifically, 
using 3D-SIM super resolution microscopy, the structure of ParF was observed to branch out 
into the nucleoid and create a 3D meshwork. This meshwork is proposed to act as a ‘venus 
flytrap’, whereby ParG-bound plasmid DNA complexes are readily ‘captured’ by ParF. 
McLeod (et al., 2017) stated that investigations of ParA segregation of plasmid pB171 eluded 
to the same mechanism, that is the protein forms structures within the nucleoid, and not just on 
the surface (Ietswaart et al., 2014). It is interesting to note that the study by McLeod (et al., 
2017) was prepared at the time Le Gall (et al., 2016) published their proposed mechanism of 
volumetric ParA localisation through the nucleoid. 
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Figure 1.2 Plasmid segregation mechanisms of active plasmid partitioning systems 
Models of plasmid segregation for Types I, II and III active plasmid partitioning systems. 
 
A. Diffusion-ratchet model for Type I active plasmid partitioning. ParB dimerises and loads 
onto the plasmid as ParA-ATP binds non-specifically to nucleoid DNA. The ParB-plasmid 
DNA complex interacts with ParA-ATP and further enhances ATP hydrolysis, resulting in 
dissociation of ParA-ADP from the nucleoid. The ParB-plasmid DNA complex then re-binds 
with ParA-ATP that is bound to the nucleoid, where this interaction results in the plasmid 
moving along the ParA-ATP gradient towards the cell poles and higher concentrations of ParA- 
ATP. As ParA-ADP dissociates from the nucleoid, the plasmid is released from the complex 
and segregated into the newly formed daughter cell. 
B. Insertional polymerisation model for Type II active plasmid partitioning. Following the 
formation of the ParR-plasmid DNA complex, ParM-ATP filaments are recruited and formed 
at the complex. As ParM-ATP is further recruited to the filament ends, the ParR-plasmid DNA 
complex is pushed to either end of the cell, resulting in plasmid segregation. ParM-ATP is 
hydrolysed to ParM-ADP and the filaments destabilise, releasing the plasmid copies in 
daughter cells. 
C. Treadmilling model for Type III active plasmid partitioning. TubZ filaments are formed and 
use a ‘treadmilling’ method, where polymerisation and depolymerisation occurs in opposite 
directions. TubR-plasmid DNA complexes that are bound to these TubZ-GTP filaments are 
pulled along the filament until it reaches the cell pole. The plasmid is released or unloaded and 
the TubZ reverses its direction to repeat the process towards the opposite cell pole. 
Bacterial cells are represented by black rounded-rectangles and nucleoid DNA is shown in 
yellow. Red arrows indicate movement of the plasmid complex within the cell, while solid 
black  arrows  represent  the  recruitment  of  NTP  and  dashed  black  arrows  represent  the 
depolymerisation of NDP. Figure was adapted and modified from (Guynet and de la Cruz, 


























































In relation to enterococcal plasmids, pheromone-responsive plasmid pAD1 has been described 
to contain a plasmid segregation cassette, corresponding to the Type I partitioning arrangement, 
particularly to subtype Ib (Clewell, 2007). The genetic organisation of the pAD1 partition 
system consists of a similarly sized ParA homolog, RepB, and a centromere-binding protein 
RepC, which has been shown to bind specifically in vitro and recruit RepB proteins to form the 
nucleoprotein complex (Figure 1.1) (Clewell et al., 2014). An E. faecium plasmid, pGENT, has 
also been described to show homology with Type Ib ParA proteins, however the centromere 




1.8.2 Type II active plasmid partitioning systems 
Type II active plasmid partitioning systems are similar to Type Ib systems (Section 1.8.1), in 
that the centromere-like site and par promoter are located upstream of the genes that encode 
the motor protein and centromere-binding protein. Moreover, the centromere-binding protein 
contains a ribbon-helix-helix (RHH) domain that mediates binding to the centromere-like site 
(Gerdes et al., 2010). 
 
 
The R1 plasmid from E. coli represents the best studied of the Type II partitioning systems 
(Figure 1.1). The R1 par operon is comprised of parM and parR, which encode the actin-like 
motor protein and centromere-binding protein, respectively. These genes are located 
downstream of the centromere-like site (parC) and the par promoter (Ppar) (Garner et al., 2007). 
parC contains five 11 bp repeats located both upstream and downstream of the promoter; a 
consensus sequence is formed from these repeats and is likely to be directly involved in ParR- 
DNA binding (Dam and Gerdes, 1994). In regards to ParM, it has no role in parC binding or 
transcriptional regulation of the par operon (Jensen et al., 1994), however it does polymerise 
via its ATPase activity (Bork et al., 1992). Furthermore, ParM filaments alter continuously, 
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demonstrating both polymerisation and depolymerisation when ParR and parC are absent, and 
thus displays dynamic instability (Garner et al., 2004). Studies have proposed that the 
instability of these filaments is fundamental for plasmid partitioning (Gerdes et al., 2010). 
 
 
More stable polymerisation of ParM filaments requires interaction with the ParR/parC complex 
between paired plasmids, followed by the extension of filaments rapidly pushing the plasmids 
to opposite ends of the cell (Moller-Jensen et al., 2002). The force of the separation causes the 
ParM filaments to depolymerise and ParM molecules to disassociate, ensuring further 
segregation of plasmids (Popp et al., 2008). Studies have shown that via site-directed 
mutagenesis, the D170A and D170E mutations located within the ParM ATPase domain lead 
to a decrease in polymerisation activity and hence a fall in stable plasmid partitioning (Jensen 
and Gerdes, 1997). Accordingly, this provides definitive evidence that ParM polymerisation is 
required for active plasmid segregation, which has led to the development of an insertional 
polymerisation model that is now proposed for all Type II partitioning systems (Figure 1.2B). 
ParR-plasmid DNA complexes form the starting point for ParM filament formation. As ParM- 
ATP is recruited onto the filament ends, the plasmid complexes are pushed to either end of the 
cell; hydrolysis of ParM-ATP to ParM-ADP within the filaments leads to destabilisation, 
resulting in plasmid copies in separate daughter cells (Moller-Jensen et al., 2003). Such systems 
include the one encoded by the S. aureus conjugative multiresistance plasmid pSK41 




1.8.3 Type III active plasmid partitioning systems 
In recent times, the Type III par system has been identified in association with two Bacillus 
plasmids: pBtoxis from B. thuringiensis and pXO1 from B. anthracis. This partitioning system 
differs in comparison to the Type I and II par systems with respect to the type of motor protein 
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it encodes (i.e., GTPase) and its location, which is directly downstream of the centromere- 
binding protein instead of upstream (Figure 1.1) (Larsen et al., 2007). 
 
 
The pBtoxis partitioning loci consists of four 12 bp direct DNA repeats that comprise the 
centromere-like site; the operon is regulated by binding of TubR to this site via a RHH domain 
(Tang et al., 2007, Larsen et al., 2007). Polymer formation is proposed to be similar to that 
represented by the Type II ParM insertional polymerisation model, although for Type III par 
systems a treadmilling mechanism is utilised for the formation of TubZ filaments (Figure 1.2C) 
(Larsen et al., 2007). TubR-plasmid DNA complexes attached to the ends of the TubZ 
filaments are pulled using a treadmilling or ‘tramming’ method; once the TubR-plasmid 
complex reaches the cell pole, the plasmid is released or ‘knocked off’ and the TubZ filament 
reverses direction to repeat the process towards the opposite cell pole (Ni et al., 2010). The 
mechanism of interaction between both the TubR and TubZ proteins is not known, however, it 
is suggested that such interaction is not required for polymerisation to occur (Ni et al., 2010). 
1.8.4 Novel plasmid partitioning systems 
In addition to the three types of classic plasmid partitioning systems described above, there are 
other more novel segregation systems that have been identified – par from plasmid pSK1 and 
stbABC from plasmid R388 (Guynet and de la Cruz, 2011). 
 
 
The novel plasmid partitioning system on pSK1 is the only known system that encodes a single 
protein called Par (Simpson et al., 2003, Schumacher, 2008). The par system is widely 
associated with staphylococcal multiresistance plasmids and has also been associated with 
plasmids from various Gram-positive bacteria (Schumacher, 2008). There is only minor 
similarity between this system and the other partitioning systems. Although Par possesses a 
coiled-coil domain rather than NTPase activity, it does bind to a centromere-like site via a HTH 
domain that is required for both transcriptional regulation (of the single par gene) and 
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partitioning function (Simpson et al., 2003). 
 
 
The par locus of the pSK1 plasmid represents the prototypical system and it is divergently 
transcribed from the replication initiation gene rep. It has been shown that the pSK1 par gene 
is independently required to maintain plasmid stability (Firth et al., 2000). Nevertheless, until 
the specific mechanism of how it achieves this is understood, the assignment of a novel active 
partitioning system is somewhat appropriate. 
 
 
The stbABC locus has been described for the E. coli plasmid R388, however it does not encode 
a typical partitioning system. Guynet (et al., 2011) reported that only one gene (stbA) of this 
locus is required for plasmid stability and encodes a DNA-binding protein that interacts with a 
specific cis-acting site. This protein (StbA) does not possess any NTPase activity and therefore 
relies on host cell machinery to drive partitioning (Guynet et al., 2011). In this regard, a ‘pilot- 
fish’ mechanism for segregation was proposed where plasmids are paired to the host nucleoid 
via StbA and segregate passively in association with replicated chromosomes as part of the cell 




1.9 Type Ib active plasmid partitioning systems 
 
1.9.1 Staphylococcal multiresistance plasmid p107A 
A large-scale plasmid-sequencing project revealed that some staphylococcal resistance 
plasmids associated with clinical MRSA and CNS isolates encode a putative Type Ib plasmid 
partitioning system (Shearer et al., 2011). These Type Ib systems undoubtedly contribute to 
the prevalence and spread of resistance plasmids amongst Gram-negative organisms, however, 
they have been studied to a much lesser extent in Gram-positive organisms (Golovanov et al., 
2003), and in relation to staphylococcal plasmids, this system hasn’t been studied at all. 
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As expected, and consistent with other partitioning systems, staphylococcal Type Ib par 
systems consist of a centromere-like cis-acting site (parS) and putative parA and parB genes 
(Figure 1.3). The latter encodes a RHH DNA-binding protein (ParB) that binds to the parS site, 
facilitating both transcriptional regulation (of the par operon) and plasmid segregation via 
interaction with dynamic ParA molecules. 
 
Initially, it was assumed that the cellular localisation of the Type Ib partitioning system found 
associated with staphylococcal plasmids might involve filament formation (albeit in 
association with the nucleoid) similar to that of Type II systems. However, in light of current 
research, the models described (for Type Ib systems) now involve a similar mechanism to Type 




1.9.2 Enterococcal multiresistance plasmid pJEG029 
The genome of an Australian VRE clinical isolate was recently sequenced and subsequent 
analysis revealed that the isolate contained several plasmids, one of which was named pJEG029 
(Jensen, unpublished data). This plasmid has the same replication and partitioning gene 
sequence and structure as the enterococcal multiresistance plasmids pRUM and pS177 
(collectively referred to as pRUM-like resistance plasmids; Section 1.6.4). The biology of these 
clinically important enterococcal RepA_N plasmids has not been studied in detail. 
 
 
Enterococcal Type Ib par systems consist of the same three elements as that of the 
staphylococcal Type Ib systems: a centromere-like site (parS) and two downstream par genes 
(parA and parB). This genetic arrangement is consistent amongst Type I systems in enterococci 
(Clewell et al., 2014). However, in the pJEG029 system, a second parS site (parS2) is located 
downstream of the par operon across the putative promoter for the replication initiation gene 
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repA (Figure 1.4). In this regard, these parS sites likely mediate transcriptional regulation (via 
ParB binding) of both repA and the par operon. 
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Figure 1.3. Schematic diagram of the p107A par region 
The parA (orange arrow) and parB (blue arrow) genes encode an ATPase motor protein (ParA) 
and a DNA-binding protein (ParB), respectively. The parS site (solid green box) which is 
located upstream of the Par proteins, contains a large array of direct sequence repeats to which 
ParB binds to facilitate partitioning and regulate par operon transcription. The short arrows 




















Figure 1.4. Schematic diagram of the pJEG029 par-rep region 
The parA (orange arrow), parB (blue arrow) and repA (red arrow) genes encode an ATPase 
motor protein (ParA), a DNA-binding protein (ParB) and a replication initiation protein 
(RepA), respectively. Centromere-like sites (clustered green arrow heads) have been identified 
both upstream and downstream of the par genes (parS and parS2, respectively). Double-ended 
arrows denote direct/inverted repeats (12 bp; atattataatat consensus) and the -10 and -35 regions 
of the putative Ppar and Prep promoters are boxed. The repeats in parS and parS2 are likely to 







































































1.10 Scope of thesis 
As described above, genome sequencing studies of Gram-positive bacteria have revealed 
putative Type Ib partitioning systems located on the staphylococcal and enterococcal plasmids 
p107A (Shearer et al., 2011) and pJEG029 (Jensen, unpublished data), respectively. 
As such, in order to address a serious gap in our knowledge, the main focus of this study was 
to yield detailed understanding of these systems, as they contribute to the prevalence and spread 
of resistance plasmids that have played and continue to play a pivotal role in the emergence 
and expression of antimicrobial resistance in staphylococci and enterococci. Elucidating the 
mechanistic roles of the putative p107A and pJEG029 Type Ib Par proteins may ultimately 
provide opportunities for the development of targeted interventions aimed at disrupting 
partitioning processes in these pathogenic organisms, which could promote resistance plasmid 
loss within healthcare facility environments. 
The overall objective was to generate an increased mechanistic understanding of Gram-positive 
Type Ib partitioning systems that are associated with resistance plasmids from important 
hospital pathogens. The specific aims of this study were to: 
- Determine the mechanistic role of the par system components for both staphylococcal 
and enterococcal Type Ib systems; 
- Investigate the regulation of the par operon for both systems, and; 
 






MATERIALS AND METHODS 
 
2.1 Bacterial strains, plasmids and growth conditions 
 
The microbial strains used throughout this study are described in Table 2.1. Plasmids used and 
constructed in this study are described in Table 2.2. Growth media for the bacterial cells are 
listed in Table 2.3. All growth media, solutions and laboratory consumables were sterilised by 
autoclaving at 121°C for 20 min. Solutions containing heat labile substances were sterilised by 
filtration using a 0.22 µm pore size Minisart syringe-driven filter unit (Sartorius). Stock 
antibiotic solutions were prepared and filter sterilised - where necessary, antibiotics were added 
to growth media at final concentrations listed in Table 2.4. 
 
 
Bacterial growth on solid media was prepared by inoculating bacteriological agar containing 
the appropriate antibiotic when needed and incubating the plates at 37°C (or unless otherwise 
specified) for approximately 16 - 20 h. Stationary phase bacterial cultures were prepared by 
inoculating 10 mL liquid medium with a single bacterial colony and incubated at 37°C in a 
MaxQ 6000 incubator shaker (Thermo Scientific), with agitation at 250 rpm under aerobic 
conditions. When required, optical density of cell cultures was measured at 600 nm (OD600nm) 
using a SpectraMax M2 Multi-mode Microplate Reader (Molecular Devices). 
 
 
For long-term storage of bacterial strains, stationary phase cultures were supplemented with a 
final concentration of 20% (v/v) glycerol and stored at -80°C. 
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Table 2.1 Microbial strains 
 




dam-/dcm- ara-14 leuB6 fhuA31 lacY1 tsx78 
gInV44 gaIK2 gaIT22 mcrA dcm-6 
hisG4 rfbD1 R(zgb210::Tn10) TetS 
endA1 rspL136 (StrR) dam 13::Tn9 
(CamR) xyIA-5 mtI-1 mcrB1 hsdR2 
New England BioLabs 
(Ipswich USA) 
NEB5α F' proA+B+ lacIq (ΔlacZ)M15 zzf::Tn10 
(TetR)/fhuA2Δ(argF-lacZ)U169 (Φ80 
Δ(lacZ)M15) glnV44 gyrA96 (NalR) 
recA1 relA1 endA1 thi-1 hsdR17 
New England BioLabs 
(Ipswich USA) 
DH5α supE44 ΔlacU169 (Φ80lacZΔM15) 







JH2-2 Clinical isolate harbouring defective 
ɸFL1C prophage. rif, fus 














RN4220 Restrictionless derivative of NCTC 
8325-4 
(Kreiswirth et al., 1983) 
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Table 2.2 Plasmids 
 
Plasmid Description Resistancea Reference 
 
E. coli plasmids 
   
pACYC184 E. coli cloning vector plasmid 
containing p15A ori; 4.2 kb 





pACYC184 carrying a 1.7 kb 
BamHI/SalI fragment containing 
the p107A Type Ib par region to 
disrupt the tetracycline resistance 





pLAU44 pUC18 carrying an ~9 kb fragment 
containing an array of 120 copies of 
the 19-bp Tn10 tetO binding site 
separated by 10-bp random spacer 
sequence, flanking either side of a 
gentamicin resistance gene; 11.7 kb 
ApR, GmR (Lau et al., 
2003) 
pQE30 E. coli expression vector containing 
IPTG-inducible T5 promoter and 





E. coli repressor plasmid carrying 









E. coli expression plasmid 
containing IPTG-inducible tac 
promoter, lac operator, and lacIQ 







pJEG029 pRUM-like resistance plasmid from 







Table 2.2 Plasmids (continued) 
 












E. coli-S. aureus shuttle plasmids 
pLOW-GFP E. coli-S. aureus shuttle plasmid 
containing IPTG-inducible Pspac 
promoter and lacI for controlled 
expression of gfp fusions in S. 
aureus; 7.9 kb 
ApR E. coli; 
EmR  S. aureus 
(Liew et al., 
2011) 
pSK4833 pWE180 carrying a 1.4 kb 
BamHI/HindIII fragment 
containing pSK1 rep and the par- 
rep intergenic region; 6.1 kb 
ApR E. coli; 
EmR  S. aureus 
(Firth et al., 
2000) 
pSK5483 pRB394 containing pSK1 replicon 
and promoterless chloramphenicol 
resistance gene (cat); 7.0 kb 
ApR E. coli; 
NmR  S. aureus 
(Kwong et al., 
2004) 
pSK7700 E. coli-S. aureus shuttle plasmid 
that allows protein expression via 
the cadmium inducible Pcad 
promoter, pSK41 rep; 7.2 kb 
ApR  E. coli; 
TcR  S. aureus 
(Ni et al., 
2009) 
pSK9142 E. coli-S. aureus shuttle plasmid 
containing IPTG-inducible Pspac 
promoter and carrying a 0.7 kb 
SalI/BamHI fragment containing 
Tn10 tetR; 8.3 kb 
ApR E. coli; 
NmR  S. aureus 
(Chan, 2017) 
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Table 2.2 Plasmids (continued) 
 






pSK4833 carrying a 1.9 kb 
BamHI/KpnI fragment containing 
the p107A Type Ib par region; 7.8 
kb 
 
ApR E. coli; 




pJEG005 pJEG001 site-directed mutant; 
p107A parA non-synonymous 
mutation AAA43-45ACC 
(K15T); 7.8 kb 
ApR E. coli; 
EmR  S. aureus 
This study 
pJEG006 pJEG001 site-directed mutant; 
p107A parB frameshift mutation 
(nt158); 7.8 kb 
ApR E. coli; 
EmR  S. aureus 
This study 
pJEG015 pLOW-GFP carrying a 1.5 kb 
ClaI/SwaI fragment containing 
tetA(K) and replacing ermC; 8.0 
kb 
ApR E. coli; 




pJEG016 pLOW-GFP carrying a 0.8 kb 
SalI/BamHI fragment containing 
p107A parA to create a C- 
terminal ParA-GFP fusion 
protein; 8.7 kb 
ApR E. coli; 
EmR  S. aureus 
This study 
pJEG017 pJEG016 with ermC replaced by 
tetA(K); 8.8 kb 
ApR E. coli; 
TcR  S. aureus 
This study 
pJEG024 pJEG015 carrying a 0.2 kb 
SalI/BamHI fragment containing 
p107A parB to create a C- 
terminal ParB-GFP fusion protein; 
8.2 kb 
ApR E. coli; 







Table 2.2 Plasmids (continued) 
 






pSK5483 carrying a 0.6 kb 
BamHI/HindIII fragment 
containing the p107A Ppar-cls 
region; 7.6 kb 
 
 
ApR E. coli; 




pJEG031 pJEG015 carrying a 0.2 kb 
SalI/BamHI fragment containing 
the p107A parB gene; 8.9 kb 
ApR E. coli; 
TcR  S. aureus 
This study 
pJEG034 pJEG015 carrying a 0.3 kb 
SalI/BamHI fragment containing 
the pJEG029 parB gene; 8.3 kb 
ApR E. coli; 
TcR  S. aureus 
This study 
pJEG035 pSK5483 carrying a 0.1 kb 
BamHI/HindIII fragment 
containing the pJEG029 Ppar-cls 
region; 6.2 kb 
ApR E. coli; 
NmR  S. aureus 
This study 
pJEG036 pSK5483 carrying a 0.1 kb 
BamHI/HindIII fragment 
containing the pJEG029 Prep-cls 
region; 6.2 kb 
ApR E. coli; 
NmR  S. aureus 
This study 
pJEG037 pJEG001 carrying a 2.2 kb KasI 
fragment containing Tn10 tetO 
array; 10 kb 
ApR E. coli; 
EmR  S. aureus 
This study 
E. coli-E. faecalis shuttle plasmids 
pAM401 E. coli-E. faecalis shuttle vector 
with pACYC184 and pIP501 
replicons; 10.4 kb 
CmR; TcR E. 
coli; 
CmR  E. faecium 




Table 2.2 Plasmids (continued) 
 




pAM401 carrying a 1.3 kb 
BamHI/SalI fragment containing 
the pJEG029 Type Ib par region to 
disrupt the tetracycline resistance 
gene; 11.7 kb 
 
CmR E. coli; 
CmR  E. faecium 
 
This study 
pJEG033 pAM401 carrying a 1.3 kb 
BamHI/SalI fragment containing 
the pJEG029 Type Ib par-Prep 
intergenic region to disrupt the 
tetracycline resistance gene; 11.8 
kb 
CmR E. coli; 
CmR  E. faecium 
This study 
pJEG040 Enterococcal plasmid with Tn1546 
variant; 37.6 kb 
VmR, EmR (van Hal et 
al., 2017) 
E. coli overexpression plasmids 
pJEG018 pTTQ18-RGSH6 carrying a 0.2 kb 
EcoRI/PstI fragment containing 
p107A parB to create a C-terminal 
His-tag fusion protein; 4.8 kb 
ApR This study 
pJEG019 pQE30 carrying 0.3 kb 
BamHI/KpnI fragment containing 
p107A parB to create a N-terminal 
His-tag fusion protein; 3.7 kb 
ApR This study 
pJEG039 pTTQ18-RGSH6 carrying a 0.3 kb 
EcoRI/PstI fragment containing 
pJEG029 parB to create a C- 
terminal His-tag fusion protein; 4.9 
kb 
ApR This study 
 
 
aApR, ampicillin resistance; CdR, cadmium resistance; CmR, chloramphenicol resistance; EmR, 
erythromycin resistance; GmR, gentamicin resistance; KmR, kanamycin resistance; NmR, 
neomycin resistance; TcR, tetracycline resistance; VmR, vancomycin resistance 
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Table 2.3 Microbial growth media 
 




1% (w/v) casein hydrolysate 
2.5% (w/v) yeast extract 
0.1% (w/v) K2HPO4 
0.5% (w/v) glucose 
2.5% (w/v) NaCl 
pH 7.5 
 
(Schenk and Laddaga, 
1992) 
Brain heart infusion 
(BHI) 
3.7% (w/v) BHI 
1.5% (w/v) agar (for solid media) 
Oxoid 
Luria-Bertani (LB) 1% (w/v) NaCl 
1% (w/v) tryptone 
0.5% (w/v) yeast extract 
1.2% (w/v) agar (for solid media) 
(Willetts and Finnegan, 
1970) 
NYE 1% (w/v) casein hydrolysate 
0.5% (w/v) NaCl 
0.5% (w/v) yeast extract 
1.2% (w/v) agar (for solid media) 
(Schenk and Laddaga, 
1992) 
SOC 2% (w/v) tryptone 
0.5% (w/v) yeast extract 
10 mM sodium chloride 
2.5 mM potassium chloride 
10 mM magnesium chloride 
10 mM magnesium sulfate 
20 mM glucose 
Invitrogen 
Tryptic soy 1.7% (w/v) peptone 
0.3% (w/v) soy peptone 
13.9 mM glucose 
14.3 mM di-potassium bis 
orthophosphate 
85.5 mM NaCl 
(MacFaddin, 1985) 
Recovery BHI 3.7% (w/v) BHI 
500 mM sucrose 
(Monk et al., 2012) 
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Table 2.4 Concentrations of antimicrobial compounds 
 










Chloramphenicol Cm 25 (E. coli); 10 (S. aureus) 
Erythromycin Em 10 
Kanamycin Km 15 
Neomycin Nm 10 




2.2 Reagents, solutions and oligonucleotides 
 
The composition of all reagents and solutions used in this study are presented in Table 2.5. 
Oligonucleotide sequences used in the study were manufactured by Sigma-Aldrich Pty Ltd 
(Castle Hill, NSW, Australia) and are listed in Table 2.6. Oligonucleotides were provided in 
lyophilised form and reconstituted with sterile Milli-Q water to a final stock concentration of 
100 µm - working stock solutions were prepared to a final concentration of 10 µm. Stock 
solutions of oligonucleotides were stored at -20°C. 
2.3 DNA manipulations 
 
2.3.1 Isolation of plasmid DNA 
 
Plasmid DNA was isolated from stationary phase cultures using the ISOLATE II Plasmid Mini 
Kit (Bioline), according to the manufacturer’s instructions. For the isolation of plasmid DNA 
from S. aureus, cell cultures were lysed with 0.4 mg/mL lysostaphin (Sigma-Aldrich) in 
resuspension buffer at 37°C for 30 min followed by plasmid isolation as described above. For 
the isolation of plasmid DNA from E. faecalis and E. faecium, cell cultures were lysed with 
100 mg/mL lysozyme (Astral Scientific) in resuspension buffer at 37°C for 45 min followed 
by plasmid isolation as described above. Extracted plasmid DNA was quantified (Section 2.3.6) 
and stored at 4°C or -20°C in sterile Milli-Q water. 
2.3.2 Agarose gel electrophoresis 
 
Agarose gels (1 - 1.5% w/v) were prepared in 0.5x TBE buffer (Table 2.5). DNA samples were 
mixed with 6x Gel Loading Dye (New England BioLabs) prior to loading. Samples were 
electrophoresed alongside a Hyperladder 1kb DNA ladder (Bioline) size marker in a Subcell 
GT Electrophoresis Tank supplied from a PowerPac Basic (Bio-Rad) at 200 V in 0.5x TBE 
buffer (Table 2.5) for 30 - 50 min, or unless otherwise specified. Agarose gels were stained in 
ethidium bromide (1 mg/L) for approximately 30 - 45 min and visualised by UV 
50  
transillumination at 302 nm using the GelDoc-It TS Imaging System (UVP). 
2.3.3 Polymerase chain reaction 
 
Amplification of DNA fragments was achieved by polymerase chain reaction (PCR) using 
template DNA and appropriate oligonucleotide primer pairs. PCR reactions were performed in 
a total volume of 50 µL using MyTaq DNA polymerase (Bioline), according to the 
manufacturer’s instructions. PCR amplification was carried out in a C1000 Thermal Cycler 
(Bio-Rad), where reactions contained 5 - 30 ng of template DNA and 20 µM of each forward 
and reverse primer in 2x MyTaq Mix (Bioline). Amplification was achieved with an initial 
denaturation step of 95°C for 1 min, followed by 34 cycles of the following conditions: 
denaturation at 95°C for 15 s, annealing at 55 - 65°C for 30 s, and extension at 72°C for 30 
s/kb. A final extension was carried out at 72°C for 5 min. For PCR screening of transformants, 
selected colonies were resuspended in 20 µL Milli-Q water, 2 µL of which was used as template 
DNA for PCR reactions as described above. PCRs were held in the thermal cycler at 12°C and 
processed immediately or stored at 4°C until required. 
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Anode Running Buffer (10x) 
 
200 mM Tris 
pH 8.9 
Blocking Buffer 3% (w/v) BSA 
1x TBS Buffer 
Buffer 1 50 mM Tris-Cl (pH 7.0) 
300 mM NaCl 
CAT assay Buffer 100 mM Tris-Cl (pH 7.8) 
0.1 mM acetyl-CoA 
1 mM 5,5’-dithio-bis[2-nitrobenzoic acid] 
Coomassie Brilliant Blue Stain 30% (v/v) methanol 
10% (v/v) glacial acetic acid 
0.125% (w/v) Coomassie Brilliant Blue R- 
250 
Cathode Running Buffer (10x) 100 mM Tris 
100 mM Tricine 
0.1% (w/v) SDS 
Destain Solution 30% (v/v) methanol 
10% (v/v) glacial acetic acid 
Electroporation Buffer 3.7% (w/v) BHI 
500 mM sucrose 
Elution Buffer 300 mM imidazole 
50 mM Tris-Cl (pH 7.0) 











10 mM Tris-Cl (pH 7.5) 
10 mM MgCl2 
100 mM NaCl 
0.2 mM DTT 
10% (v/v) glycerol 
Gel Buffer (3x) 3 M Tris-Cl 
0.3% (w/v) SDS 
pH 8.45 
IPTG (isopropyl-β-D-thio-galactoside) Final concentration, 0.1 M in 5 mL dH2O 
PBS 137 mM NaCl 
2.7 mM KCl 
10 mM Na2HPO4 
2 mM KH2PO4 
SDS-PAGE loading buffer (5x) 300 mM Tris-Cl (pH 6.8) 
10% (w/v) SDS 
50% (v/v) glycerol 
25% 2-mecaptoethanol 
5g/L bromophenol blue 
SDS-PAGE resolving gel mixture 15% (w/v) acrylamide (29:1) 
glycerol 
0.3% (v/v) gel buffer 3x 
0.1% (w/v) APS 
0.09% (v/v) TEMED 
 
SDS-PAGE stacking gel mixture 
 
4% (w/v) acrylamide (29:1) 
glycerol 
0.25% (v/v) gel buffer 3x 
0.01% (w/v) APS 
0.001% (v/v) TEMED 
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Secondary Binding Buffer 
 
10% (w/v) skim milk powder 
1x TBS Buffer 
Solution A 25% (v/v) 1x TBS Buffer 
30% (v/v) H2O2 
Solution B 100% methanol 
15 mg chloronapthol 
TBE Buffer (5x) 54 g Tris 
27.5 g Boric acid 
20 mL 0.5 M EDTA (pH 8.0) 
TBS Buffer (1x) 10 mM Tris 
150 mM NaCl 
pH 7.5 
TBS-Tween Buffer 0.1% (v/v) Tween 20 
1x TBS Buffer 
Wash Buffer 1 20 mM imidazole 
50 mM Tris-Cl (pH 7.0) 
300 mM NaCl 
Wash Buffer 2 50 mM imidazole 
50 mM Tris-Cl (pH 7.0) 
300 mM NaCl 
Western Transfer Buffer 25 mM Tris 
150 mM glycine 
20% (w/v) methanol 
WL Buffer 25 mM Tris-Cl (pH 7.8) 
10 mM EDTA (pH 8.0) 
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5’ – GATTTTGGATCCTTTCTATAAGATGTTGTTG – 3’ 
GM2 5’ – GTAGGTACCTTATCACATTAAACACGGAGTATC – 3’ 
GM3 5’ – CAAAGGAGGAGTAGGTACCACTACTGTATCAAC – 3’ 
GM4 5’ – GTTGATACAGTAGTGGTACCTACTCCTCCTTTG – 3’ 
GM5 5’ – GATAATCAAAAAAAGGTTGATCAGATGGCATTAGATAAAG – 3’ 
GM6 5’ – CTTTATCTAATGCCATCTGATCAACCTTTTTTTGATTATC – 3’ 
GM7 5’ – TTAGAGTCGACAGTTTATCACATTAAACAC – 3’ 
GM8 5’ – TGAGGATCCCTTTATATCCGAACCGATATATATC – 3’ 
GM9 5’ – GAAGATAGTCGACTTATCAGCTTTG – 3’ 
GM10 5’ – GGTTTAAGCTCATGTCGACTATATC – 3’ 
GM11 5’ – CAGTAGCCAATCAAAACGGTGGAGTTTCTAAAAC – 3’ 
GM12 5’ – GTTTTAGAAACTCCACCGTTTTGATTGGCTACTG – 3’ 
GM13 5’ – GAAATAAAAATAAAAAGAGCTCAAACCAAAAGAAGTAG – 3’ 
GM14 5’ – CTACTTCTTTTGGTTTGAGCTCTTTTTATTTTTATTTC – 3’ 
GM15 5’ – TCATAGGATCCGGATTTTTAGATGATATA – 3’ 
GM16 5’ – GTAGGTACCTTATCACATTAAACACGGAGTATC – 3’ 
GM17 5’ – CGGAATTCGGCAGGATTTTTAGATGATA – 3’ 
GM18 5’ – CTTCTGCAGAATTATTTTTCTCTAAAAACTC – 3’ 
GM19 5’ – CAAAAACAAATCACATGTAACATGTAACAT – 3’ 
GM20 5’ – CTTGTTACATGTAACAAGTTACGAATGTAT – 3’ 
GM21 5’ – GATTTTGGATCCTTTCTATAAGATGTTGTTG – 3’ 
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5’ – GAAATTACCAAAGCTTATAACTGACATACATTACAC – 3’ 
GM23 5’ – GTTAGTCGACATATATAAAGAATTAGTAGAAAG – 3’ 
GM24 5’ – CACGGATCCTCATGAACAC – 3’ 
GM25 5’ – CGGAATTCGGCAGAAGATAATC – 3’ 
GM26 5’ – CTTGTCGACTTTTATTTTGTTTCTTTGCT – 3’ 
GM27 5’ – AAAACAAAATAATCACACAATATTACAATATAATG – 3’ 
GM28 5’ – AATATCCCCCATTCATCTTATATTATAATATAATT – 3’ 
GM29 5’ – CTGATAAGTCGCTTATCTTCATATTGTAATA – 3’ 
GM30 5’ – CTCATGGTAACTATATCACGATATTACAATA – 3’ 
GM31 5’ – TGAGGATCCCTTTATATCCGAACCGATATATATC – 3’ 
GM32 5’ – TATAAGCTTCATTAAAATATCCCCCATTC – 3’ 
GM33 5’ – AGCGGATCCACAAAATAAAATTTAATTTACATTC – 3’ 
GM34 5’ – CCAAAGCTTGGTTTAAGCTCATGGTAAC – 3’ 
GM35 5’ – AAGTCGACAAGAAGTTGGTGATTTTGATGGCAGAAG – 3’ 
GM36 5’ – ATAGGATCCTATTATGATATCGTGATATTGAATG – 3’ 
GM37 5’ – GATTGTCGACATAGACATTATAACCTAAGGAGTGT – 3’ 
GM38 5’ – TTAGGATCCATCCTTCTATTAATTCTATTCTTTCT – 3’ 
GM39 5’ – GTTAGTCGACATATATAAAGAATTAGTAGAAAG – 3’ 
GM40 5’ – ATTAGGATCCATAATTATTTTTCTCTAAAAAC – 3’ 
GM41 5’ – GGCGCCGAAGAGACTGGTAGAAA – 3’ 
GM42 5’ – GGCGCCGTTTTACAACGTCGTGA – 3’ 
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2.3.4 Site-directed mutagenesis 
 
Site-directed mutagenesis (SDM) of plasmid DNA was performed using complimentary 
mutagenic primers (Table 2.6); silent restriction sites were introduced when possible to 
facilitate the screening of potential mutants. Each SDM reaction was performed in a total 
volume of 50 µL using Velocity DNA Polymerase (Bioline) according to the manufacturer’s 
instructions. Each reaction was supplemented with 100 ng of plasmid DNA, 2 µL of MgCl2 
and 2 µL of DMSO. PCR mutagenesis reactions was performed in a C1000 Thermal Cycler 
(Bio-Rad) with an initial denaturation step of 98°C for 3 min, followed by 20 cycles of the 
following conditions: denaturation at 98°C for 1 min, annealing at 60 - 70°C for 1 min, and 
extension at 72°C for 1 min/kb. A final extension was carried out at 72°C for 10 min before 
the reactions were held at 4°C. 
 
 
Following PCR, the reactions were incubated with 0.8 U/µL of DpnI restriction endonuclease 
(New England BioLabs) at 37°C for 2 h to specifically digest the methylated wild-type plasmid 
DNA, leaving the newly-synthesised mutant DNA undigested. After restriction digestion, DpnI 
was heat inactivated at 80°C for 20 min before reactions were transformed into chemically- 
competent E. coli DH5α cells (Section 2.4.2). 
2.3.5 DNA purification 
 
DNA fragments were purified either from agarose gels, or directly from reactions using the 
ISOLATE II PCR and Gel Kit (Bioline), according to the manufacturer’s instructions. For the 
extraction and confirmation of DNA, fragments were visualised by UV transillumination at 
302 nm using the GelDoc-It TS Imaging System (UVP). The desired gel bands were excised 
with a scalpel before proceeding with DNA purification. 
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2.3.6 Quantification of DNA 
 
The concentration of DNA samples was measured using a Nanodrop 2000c Spectrophotometer 
(Thermo Scientific) with Nanodrop operating software (NanoDrop Technologies, Version 1.5). 
2.3.7 Restriction endonuclease digestion 
 
Restriction endonuclease digestion of DNA was performed according to the manufacturer’s 
instructions (New England Biolabs). Each reaction contained 500 ng – 1 µg of DNA or PCR 
product and 0.4 - 0.6 U/µL of restriction endonuclease in 1x restriction buffer (New England 
Biolabs), made up to a total volume of 50 µL. Restriction endonuclease digestions were 
incubated at 37°C for a minimum of 1 h and then either heat-inactivated according to the 
manufacturer’s instructions, or subjected to DNA purification (Section 2.3.5). 
2.3.8 Dephosphorylation of DNA ends 
Dephosphorylation of DNA ends was performed by using Antarctic Phosphatase (AnP; New 
England Biolabs). DNA ends were treated with 0.24 U/µL of AnP in 1x Antarctic Phosphatase 
Reaction Buffer (New England Biolabs) and incubated at 37°C for 1 h. AnP was heat- 
inactivated at 65°C for 10 min following dephosphorylation. 
2.3.9 DNA Ligation 
 
DNA ligation reactions were performed in a total volume of 20 µL using a vector:insert ratio 
1:3 or 1:6. Each reaction contained 50 - 100 ng of digested (Section 2.3.7) and purified (Section 
2.3.5) vector DNA and the appropriate amount of digested and purified insert DNA. Ligation 
reactions were incubated at 25°C for 1 h, followed by 16°C overnight with 1 Weiss unit T4 
DNA ligase (20 U/µL, New England Biolabs) in 1x T4 DNA Ligase Buffer (New England 
Biolabs). Ligation reactions were either placed on ice for immediate downstream applications 
or stored at 4°C until further required. 
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2.3.10 DNA sequencing 
 
Automated sequencing of DNA was performed by Macrogen Inc. (Seoul, Korea), according to 
the company’s specifications. Reactions comprised approximately 2 µg of purified plasmid 
DNA (Section 2.3.1) in a total volume of 20 µL with sterile Milli-Q water, and supplied with 
10 µM of oligonucleotide primer. Nucleotide sequences were analysed using CLC Main 
Workbench software (CLC bio, Version 6.8.1). 
2.4 Bacterial transformation procedures 
 
2.4.1 Preparation of chemically-competent E. coli cells 
 
Stationary phase E. coli DH5α cells were inoculated 1:50 in fresh LB-broth (Table 2.3) and 
incubated at 37°C with agitation at 250 rpm until mid-exponential phase (OD600nm 
approximately 0.5). Cells were harvested by centrifugation (4,500 rpm / 8 min / 4°C; Heraeus 
Multifuge X3R, Thermo Scientific) and the cell pellet was washed with 0.5 volumes of ice- 
cold 0.1 M MgCl2 (4,500 rpm / 8 min / 4°C). Cell pellets were resuspended in 0.1 volumes of 
ice-cold 0.1 M CaCl2 and incubated on ice for 1 h. Cell suspensions were supplemented with 
sterile glycerol at a final concentration of 16% (v/v) and stored in 100 µL aliquots at -80°C. 
2.4.2 Transformation of chemically-competent E. coli cells with plasmid DNA 
 
A 100 µL aliquot of chemically competent E. coli DH5α cells (Section 2.4.1) was thawed and 
incubated on ice for 30 min with 10 µL of DNA ligation reaction or 100 – 300 ng of plasmid 
DNA. The mixtures were heat-shocked at 42°C for 2 min and then returned to ice for a further 
10 min for cell recovery. Heat-shocked cells were recovered in 750 µL of SOC medium (Table 
2.3) at 37°C with agitation (250 rpm) for 1.5 h. Transformed cells were spread in 100 µL 
aliquots on to LB-agar plates containing the appropriate antibiotic. Spread plates were 
incubated at 37°C overnight. 
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2.4.3 Preparation of electrocompetent S. aureus cells 
 
Electrocompetent S. aureus cells were prepared as previously described (Schenk and Laddaga, 
1992). S. aureus RN4220 cells were grown overnight to stationary phase in LB broth (Table 
2.3) at 37°C with agitation (220 rpm). Overnight cultures were diluted 1:25 in B2 broth (Table 
2.3) and grown at 37°C with agitation until cells reached mid-exponential phase (OD600nm ~ 
0.4). Cells were harvested by centrifugation (4,800 rpm / 8 min / RT; Heraeus Multifuge X3R, 
Thermo Scientific) and then washed three times in 0.8 volumes of sterile Milli-Q water. Cells 
were then washed with 0.2 volumes of 10% glycerol (v/v), resuspended in 0.1 volumes of 10% 
glycerol (v/v), and incubated for 15 min at room temperature before a final centrifugation step 
(as described above). Pelleted cells were resuspended in 0.03 volumes of 10% glycerol (v/v) 
and stored in 65 µL aliquots at -80°C. 
2.4.4 Electroporation of electrocompetent S. aureus cells with plasmid DNA 
Electroporation of electrocompetent S. aureus RN4220 cells was performed as previously 
described (Schenk and Laddaga, 1992). A 65 µl aliquot of electrocompetent S. aureus cells 
(Section 2.4.3) was thawed and mixed with 1 µg of plasmid DNA. The DNA/cell mixture was 
transferred to a 0.1 cm gap disposable cuvette (BioRad) and a single pulse was applied at 25 
µF / 1.3 kV / 100Ω using a GenePulser Xcell with PC Module (BioRad). Electroporated cells 
were recovered in 390 µL of B2 broth (Table 2.3) at 37°C with agitation at 250 rpm for 1 h. 
Cells were then spread in 100 µL aliquots on to NYE plates containing the appropriate 
antibiotic. Spread plates were incubated at 37°C overnight. 
2.4.5 Preparation of electrocompetent and E. faecium cells 
 
Stationary phase E. faecium TX1330 cells were diluted in BHI-broth (Table 2.3) to an OD600nm 
of 0.5 in 25 mL before incubation on ice for 10 min. Cells were harvested by centrifugation 
(5,000 xg / 8 min / 4°C; Heraeus Multifuge X3R, Thermo Scientific) and washed first with 0.8 
volumes of ice-cold sterile Milli-Q water, followed by 0.4 volumes (5,000 xg / 8 min / 4°C). 
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Cells were further washed with 0.2 volumes of 10% glycerol (v/v), followed by two repeated 
washes with 0.08 volumes and 0.04 volumes (5,000 xg / 8 min / 4°C). Cells were stored in 50 
µL aliquots at -80°C. 
 
2.4.6 Electroporation of electrocompetent E. faecium cells with plasmid DNA 
 
A 50 µL aliquot of electrocompetent E. faecium TX1330 cells (Section 2.4.5) was thawed at 
room temperature and harvested by centrifugation (11,000 xg / 5 min / RT; Heraeus Pico 21 
Centrifuge, Thermo Scientific). Cells were resuspended in 50 µL of electroporation buffer 
(Table 2.5) and mixed with 1 µg of plasmid DNA. The DNA/cell mixture was transferred to a 
0.1 cm gap disposable cuvette (BioRad) and a single pulse was applied (25 µF / 2.1 kV / 200 
Ω) using a GenePulser Xcell with PC Module (BioRad). Electroporated cells were recovered 
in 750 µL of recovery BHI-broth (Table 2.3) at 37°C with agitation at 250 rpm for 1 h. Cells 
were then spread in 100 µL aliquots on to BHI-agar plates containing the appropriate antibiotic. 
Spread plates were incubated at 37°C overnight. 
2.5 Protein manipulations 
 
2.5.1 Protein overproduction 
 
pQE30-based E. coli expression constructs (Table 2.2) were used to transform chemically- 
competent DH5α cells (Table 2.1; Section 2.4.2) containing the repressor plasmid, pREP4 
(Table 2.2). Single colonies of these transformants along with pTTQ18-RGSH-based E. coli 
expression plasmids (Table 2.2) were used to inoculate 10 mL of LB-broth (Table 2.3) 
containing the appropriate antibiotic selection, and cultures were grown at 37°C with agitation 
at 250 rpm overnight. Overnight cultures were diluted 1:50 in 10 mL of selective LB-broth 
(Table 2.3) for small-scale overproduction, or in 500 mL for large-scale overproduction. 
Cultures were grown at 37°C with agitation at 250 rpm until mid-exponential phase (OD600nm 
approximately  0.6),  at  which  point  production  of  ParB  was  induced  by  the  addition of 
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isopropyl-β-D-thio-galactoside (IPTG) to a final concentration of 1 mM. Induced cultures were 
incubated at 37°C with agitation at 250 rpm for 3 h. Following overproduction, 2 mL of small- 
scale cultures had OD values measured and cells were harvested (5,000 xg / 5 min / RT; 
Heraeus Multifuge X3R, Thermo Scientific), before pellets were stored at -80°C. Cells from 
large-scale protein overproduction cultures were harvested (2,504 xg / 10 min / RT; Beckman 
JA-14 rotor), before being stored at -20°C until required. 
2.5.2 Protein purification 
 
Harvested cell pellets from large-scale protein overproduction cultures (Section 2.5.1) were 
processed according to the conditions of the BugBuster Protein Extraction Reagent User 
Protocol TB245 Rev. F 1108 (Novagen). Briefly, the BugBuster reagent was prepared to a 1x 
working solution in Buffer 1 (Table 2.5), where cell pellets were resuspended in a total volume 
of 20 mL - recommended by the protocol depending on the weight of the pellet. Lysozyme was 
added to the cell suspension at a final concentration of 1 mg/mL, and the mixture was incubated 
at room temperature for 1 h with gentle rotation on a suspension rotary mixer (Ratek 
Instruments). Lysed cells were transferred to appropriate tubes and lysates were cleared for 
centrifugation (15,000 rpm / 30 min / 4°C; Beckman JA-20 rotor). The cell pellet was 
resuspended in 20 mL of Buffer 1 and stored as the membrane fraction, while the supernatant 
was mixed with 2 mL of a 50% slurry of Ni2+-NTA resin (Thermo Fisher Scientific) that had 
been pre-washed with Buffer 1 (Table 2.5) and recovered by centrifugation (6,000 rpm / 1 min 
/ RT; Heraeus Multifuge X3R, Thermo Scientific). Soluble fractions were incubated with the 
resin overnight at 4°C with gentle rotation on a suspension rotary mixer (Ratek Instruments). 
The resin was recovered by centrifugation (6,000 rpm / 1 min / 4°C; Heraeus Multifuge X3R, 
Thermo Scientific) with supernatant stored as flow-through fraction. The resin was washed 
with 10 mL of Wash buffer 1 (Table 2.5) at 4°C with gentle rotation for 1 h, followed by a 
wash with 10 mL of Wash buffer 2 (Table 2.5) at 4°C with gentle rotation for 1 h. Supernatants 
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after centrifugation (6,000 rpm / 1 min / 4°C; Heraeus Multifuge X3R, Thermo Scientific) were 
collected during the washes and stored as wash 1 and 2 fractions, respectively. After 
centrifugation to pellet the resin, proteins were eluted twice with 1.5 mL of Elution buffer 
(Table 2.5) at 4°C with gentle rotation for 1 h, and elutions stored separately. 
2.5.3 Protein buffer exchange 
 
Protein buffer exchange was performed on proteins purified from a large-scale overproduction 
in order to replace the Elution buffer with a compatible buffer for downstream experiments. 
ParB proteins were exchanged into EMSA buffer (Table 2.5) using PD-10 Sephadex™ G-25 M 
Columns (GE Healthcare), as outlined by the manufacturer. Columns were equilibrated with 
25 mL of EMSA buffer, before the purified protein solution was passed through and eluted 
with EMSA buffer in 1 mL aliquots. The concentration of re-buffered purified ParB protein 
was determined as described in Section 2.5.5, and fractions were stored at -20°C until required. 
2.5.4 Preparation of protein lysates for CAT assays 
 
The preparation of stationary phase S. aureus cells was performed as described by Kwong et 
al. (2004). Cells were harvested in 3 mL aliquots from a 10 mL overnight culture of selected 
strains of S. aureus by centrifugation (4,500 rpm / 5 min / RT; Heraeus Multifuge X3R, Thermo 
Scientific) before washing once with 300 µL cold WL buffer (Table 2.5). Cell pellets were 
resuspended in 300 µL cold WL buffer containing 0.1 mg/mL lysostaphin (Sigma) and 
incubated at 37°C for 30 min. Samples were cooled on ice for 10 min before being sonicated 
using Q55 sonicator (Qsonica) at an amplitude of 55 for 2 x 5 s bursts. The cell debris was 
pelleted by centrifugation (13,000 rpm / 20 min / 4°C; Heraeus Pico 21, Thermo Scientific) 
and the supernatant was transferred to new pre-chilled tubes. The concentration of cellular 
lysates was determined as described in Section 2.5.5 and stored at -20°C until required for 
chloramphenicol acetyl transferase assays (Section 2.8). 
63  
2.5.5 Protein quantification 
 
The concentration of protein samples was determined in a 96-well microplate using the 
Pierce™ BCA Protein Assay Kit (Thermo Scientific), as described by the manufacturer with 
modifications. The microplate procedure was performed using 10 µL of sample mixed with 
100 µL of BCA working reagent (Thermo Scientific); Bovine serum albumin (BSA, Amresco) 
was used to produce a standard curve and was diluted in either EMSA buffer or WL buffer 
(Table 2.5) to give final concentrations between 0 – 2,000 µg/mL. Samples were incubated at 
37°C for 30 min and the absorbance of each standard and sample was then measured at a 
wavelength of 562 nm on a SpectraMax M2 Microplate Reader (Molecular Devices). 
Concentrations were determined using the SoftMax Pro 5.4.1 software. 
2.5.6 Preparation of whole cell lysates for SDS-PAGE 
 
Harvested cell pellets from small-scale protein overproduction cultures (Section 2.5.1) were 
prepared for sodium dodecyl-sulphate polyacrylamide gel electrophoresis (SDS-PAGE; 
Section 2.5.7) by the addition of 1x SDS-PAGE loading buffer (Table 2.5). The volume added 
was based on the normalisation of optical density (OD) of each culture, as shown below. 
 
OD 





The resuspended samples were vortexed and heated at 95°C to further lyse cells and reduce 
viscosity prior to loading onto SDS-PAGE gels for protein separation. 
2.5.7 Sodium dodecyl-sulphate polyacrylamide gel electrophoresis (SDS-PAGE) 
Separation of proteins by SDS-PAGE was performed on protein lysates using the Mini- 
PROTEAN Tetra cell (Bio-Rad), assembled according to the manufacturer’s instructions. Glass 
plates were secured in a casting frame on a casting stand before a 15% (w/v) SDS-PAGE 
resolving gel mixture (Table 2.5) was poured between the plates to approximately 1 cm below the 
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bottom of the wells. The resolving gel was overlaid with Milli-Q water to facilitate polymerisation and 
obtain a level gel interface (approximately 30 - 45 min). After the gel had polymerised, the Milli-Q 
water was removed and the 4% (w/v) SDS-PAGE stacking gel mixture (Table 2.5) was poured on top 
of the resolving gel with the appropriate well comb inserted. After polymerisation, the gel was secured 
into the electrode assembly and placed into the gel tank with the Cathode running buffer (Table 2.5) 
poured into the assembly, and Anode running buffer (Table 2.5) poured into the tank to the indicated 
level for electrophoresis to occur. The comb was removed before the wells were flushed with the 
Cathode running buffer in preparation for sample loading. 
 
 
Prior to loading, protein samples were heated in 1x SDS-PAGE loading buffer (Table 2.5) at 
95°C for 5 min, unless prepared from whole cell lysates (Section 2.5.6). Lysed samples were 
loaded into the wells of the stacking gel and electrophoresed with a Precision Plus Protein 
Standard (Bio-Rad) at 30 V for 40 min, followed by 60 V for 2 h. 
2.5.8 Coomassie Blue Staining of SDS-PAGE Gels 
 
SDS-PAGE gels were stained in Coomassie Brilliant Blue stain (Table 2.5) for 30 min and 
rinsed in Destain solution (Table 2.5) until the gel background became clear. Staining and 
destaining of SDS-PAGE gels were performed with agitation using a Rocking Platform (Speed 
4.5; Ratek Instruments). Stained gels were imaged via the GelDocIt TS Imaging System (UVP) 
under white light. 
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2.6 Western blotting 
 
2.6.1 Protein transfer 
 
SDS-PAGE gels with separated proteins (Section 2.5.7) were removed from the precast 
moulds/glass plates and transferred onto a 0.45 µm BioTrace™ polyvinylidene difluoride 
(PVDF) membrane (Pall Life Sciences) by the wet transfer method (Towbin et al., 1979). The 
transfer was performed in a Mini Trans-Blot Cell (Bio-Rad) and was carried out according to 
the manufacturer’s instructions. Briefly, the membrane was activated with methanol prior to 
the transfer and was assembled with the gel in a gel-membrane sandwich immersed in Western 
Transfer buffer (Table 2.5). The gel and membrane were pressed together between two pieces 
of filter paper, followed by a foam pad on either side and fastened by a gel holder cassette (Bio- 
Rad). The gel-membrane sandwich cassette was inserted into the trans-blot cell tank and the 
western transfer was run in Western Transfer buffer (Table 2.5) at 100 V for 1 h. 
2.6.2 Production of anti-peptide antibodies for ParB protein 
 
Polyclonal antibodies were generated against two separate ParB peptide sequences (derived 
from p107A and pJEG040; Table 2.2) in two individual rabbits by Mimotopes Pty Ltd 













2.6.3 Immunological detection of proteins 
 
For the detection of proteins via Western blotting, all buffer washes and incubations were 
performed at room temperature using a Rocking Platform (Speed 4.5; Ratek Instruments). 
The PVDF membrane with the transferred proteins (Section 2.6.1) was activated with methanol 
and then washed twice with 1x TBS buffer (Table 2.5) for 10 min. The membrane was 
incubated in Blocking buffer (Table 2.5) for 1 h to prevent non-specific binding of antibodies 
to the membrane, and then washed twice in TBS-Tween buffer (Table 2.5) for 10 min each 
followed by a single wash in 1x TBS buffer for 10 min. The membrane was incubated with a 
1:1000 dilution of affinity-purified ParB peptide antibody (Section 2.6.2) in Blocking buffer 
(Table 2.5) for 1 h before washing twice in TBS-Tween buffer for 10 min each. A single wash 
with 1x TBS buffer was applied to the membrane before it was incubated with a secondary 
Goat Anti-rabbit IgG (H+L)-HRP conjugate (Bio-Rad; 1:1000 dilution) in Secondary Binding 
buffer (Table 2.5) for 1 h. The membrane was washed again twice with TBS-Tween buffer and 
once with 1x TBS buffer (10 min washes) before incubation with either chromogenic or 
enhanced chemiluminescence (ECL) detection solutions. 
 
 
The chromogenic detection Solutions A and B (Table 2.5) were prepared prior to detection, 
combined and immediately poured over the membrane. The membrane was incubated in the 
combined solution until the protein bands were visible, at which point the membrane was rinsed 
with Milli-Q water to stop the chromogenic reaction. All buffer washes and staining were 
performed at room temperature under agitation (Platform Rocker, Bioline). The membrane was 
pat-dried between filter paper and images were taken using the GelDocIt TS Imaging System 
(UVP) under white light. 
67  
ECL detection was performed using Western Lightning Plus-ECL Substrate (PerkinElmer 
Inc.). Detection of the ParB protein was performed by mixing equal volumes of Western 
Lightning Enhanced Luminol Reagent Plus (PerkinElmer) and Western Lightning Oxidizing 
Reagent Plus (PerkinElmer) before pouring over the membrane. The membrane was incubated 
with the prepared solution for 2 min in minimal to no light, and then imaged using 
chemiluminescence via the Odyssey Fc Imaging System (LI-COR Biosciences) with Image 
Studio™ acquisition software (LI-COR Biosciences). 
2.7 Plasmid segregational stability assays 
 
Strains containing the plasmid to be assayed were grown overnight in LB-broth (Table 2.3) 
with the appropriate antibiotic selection (Table 2.4). Stationary phase cultures were diluted 10- 
1 in fresh selective media and sub-cultured at 37°C with agitation (250 rpm) for 4 h. This 
constituted Day 0 of the assay. The culture was serially diluted (10-1 – 10-6) in 0.9% (w/v) NaCl, 
with viable counts performed on non-selective solid media. 10 µL of the 10-1 dilution was used 
to inoculate 10 mL of fresh LB-broth without antibiotic selection and cells were grown 
overnight at 37°C with agitation (250 rpm). The number of generations per day was calculated 
using the formula log(Δcfu/mL) / log(2), where Δcfu/mL is the difference in cfu/mL between 
the end and start of subculture. In addition, 100 µL of the 10-4 – 10-6 dilutions were spread onto 
non-selective LB-agar plates and incubated overnight at 37°C for viable plate counts. A total 
of 100 colonies from the plate counts were patched onto both selective and non-selective LB- 
agar plates and incubated at 37°C overnight to observe plasmid retention. The percentage of 
patches from the 100 colonies that had grown on both plates after overnight incubation, 
represents an approximate percentage of the population of cells that were able to retain the 
plasmid containing the Type Ib partitioning system in the absence of antibiotic selection. The 
subcultures, dilutions, plate counts and patch plates were repeated daily until the percentage of 
the cells harbouring the empty vector plasmid decreased to zero. Plasmid DNA was isolated 
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from selected colonies (Section 2.3.1) and visualised by agarose gel electrophoresis (Section 
2.3.2) to confirm the presence or absence of the assayed plasmid. 
2.8 Chloramphenicol acetyl transferase (CAT) reporter gene assays 
 
The activity of the enzyme chloramphenicol acetyl transferase (CAT) was assayed as described 
by Kwong et al. (2004). 10 µL of cellular lysate (Section 2.5.4) was added to 186 µL of CAT 
assay buffer (Table 2.5) in a microplate. Samples were equilibrated to 37°C for 2 min before 4 
µL of 5 mM chloramphenicol was added to start the reaction. Reactions were carried out at 
37°C and the absorbances were measured at a wavelength of 415 nm at 39 s intervals for 4.5 
min using a SpectraMax M2 Microplate Reader (Molecular Devices). If CAT activity was too 
high and data points were not linear, lysates were diluted before the assay was repeated. CAT 




2.9 Electrophoretic mobility shift assays (EMSAs) 
 
Gel shift assays were performed as previously described by Guan (2006), with the following 
modifications. 50 ng of a DNA fragment was incubated with varying amounts of re-buffered 
purified protein (Section 2.5.3), along with 2 µg competitor DNA and EMSA buffer (Table 
2.5) in a total volume of 20 µL. Reactions were incubated at room temperature for 30 min to 
allow for protein-DNA binding prior to loading. 
 
 
Gel mobility shift reaction mixtures were analysed by high ionic strength PAGE. A 5% (w/v) 
acrylamide gel (29:1 acrylamide:N,N’-methylene-bis-acrylamide) in 0.5x TBE buffer (Table 
2.5) was polymerised after the addition of 0.1% (w/v) APS and 0.1% (v/v) TEMED. The gel 
mixture was immediately poured between glass plates and assembled into a Mini-PROTEAN 
Tetra cell (Bio-Rad). After polymerisation, the gel was pre-run for 20 min using PowerPac 
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Basic (Bio-Rad) at 100 V in 0.5x TBE buffer (Table 2.5). Samples were loaded into the lanes, 
in addition to 6x Gel Loading Dye (New England BioLabs) in a spare lane as a guide for the 
progression of the electrophoresed samples. The electrophoresis was stopped when the dye 
front reached the end of the gel. The gel was then stained in 1 µg/mL ethidium bromide (EtBr) 
for 30 min and destained in ROH2O for 10 min. Gels were imaged by UV transillumination at 
302 nm using the GelDoc-It TS Imaging System (UVP). 
2.10 Microscopy 
 
S. aureus cells harbouring the relevant plasmids were grown overnight in 10 mL of selective 
LB-broth (Table 2.3) at 37°C with agitation at 250 rpm. Overnight cultures were used to 
inoculate fresh selective LB-broth (1:10 dilution), where cells were grown mid-exponentially 
(approximately 3 h) under the conditions described above. Incubation of cultures was continued 
for 2 h with the addition of 1 mM IPTG (Table 2.5) to induce protein expression. Live-cell 
microscopy was performed essentially as previously described (Liew et al., 2011) with 
modifications. Briefly, cells were harvested from 750 µL of induced sub-culture by 
centrifugation (12,000 xg / 2 min / RT; Heraeus Pico 21 Centrifuge, Thermo Scientific) and 
washed with 500 µL PBS (Table 2.5). For nucleoid staining, cells were resuspended in 500 µL 
PBS with 2 µg/mL DAPI (Invitrogen) and incubated in the dark for 15 min at room temperature. 
Cells were pelleted (12,000 xg / 2 min / RT; Heraeus Pico 21 Centrifuge, Thermo Scientific), 
and washed 1 - 2 times with 250 µL PBS. Cells were resuspended in 30 µL PBS, where 3 µL 
of the cell suspension was mounted onto a 2% (w/v) agarose pad within a 65 µL Gene Frame 
(Thermo Fisher Scientific) assembled onto a slide. 
 
 
Phase contrast and fluorescence microscopy was performed using a Zeiss fluorescence 
microscope (Axio Imager Z1) equipped with a 100x phase contrast objective and an AxioCam 
MRm cooled charge-coupled  device  (CCD)  camera  controlled  using  Zen  software (Blue 
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Edition, 2012; Carl Zeiss Microscopy). Cells were visualised using GFP and DAPI 
fluorescence (filter sets 44 and 49, respectively; Carl Zeiss). Image analysis and processing 
was performed using Zen 2.3 software (Blue Edition, 2011; Carl Zeiss Microscopy). 
Confocal microscopy for time-lapse and fluorescence recovery after photobleaching (FRAP) 
imaging was performed using a Zeiss LSM 800 confocal microscope (Axio Imager Z2) 
equipped with a 63x objective, an Airyscan super-resolution module and an AxioCam 506 
digital camera with Colibri LED light source, controlled using Zen 2.6 software (Blue Edition, 
2018; Carl Zeiss Microscopy). Cells were visualised using DAPI and FITC fluorescence (405 
nm and 488 nm diode laser lines, respectively; Carl Zeiss). Image analysis and processing was 






FUNCTIONALITY OF TYPE Ib PLASMID 




While Type Ib plasmid partitioning systems have been identified via sequence analysis on both 
staphylococcal and enterococcal plasmids (such as p107A and pJEG029, respectively) (Shearer 
et al., 2011, Jensen, unpublished data), the functionality of such systems has not been 
extensively explored in these organisms. To date, most knowledge we have in this regard has 
been obtained from studying select plasmids from Gram-negative organisms (Yin et al., 2006). 
As such, this chapter details the generation of plasmid constructs to assess the contribution of 
the p107A and pJEG029 putative Type Ib par components to plasmid stability in S. aureus and 
E. faecium hosts, respectively. Additionally, as E. coli cells are rod-shaped and larger in size 
compared to cocci, functionality of the p107A putative Type Ib system was also assessed to 
determine if E. coli could be used as a host for future localisation studies. 
3.2 Functional analysis of the putative staphylococcal p107A Type Ib 
partitioning system 
The ability of the putative p107A Type Ib partitioning system (abbreviated herein to p107Apar) 
to increase segregational stability of a staphylococcal mini-replicon plasmid in S. aureus 
RN4220 cells was determined. The individual requirement of both the parA and parB genes 
for partitioning function was also confirmed via the generation of mutant derivatives. 
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3.2.1 Construction of staphylococcal plasmids containing p107Apar 
PCR amplification of p107Apar (~ 1.5 kb) was performed using primers GM1 and GM2 
(Section 2.3.3) (Table 2.6), which contain BamHI and KpnI restriction sites, respectively. The 
amplicon was purified (Section 2.3.5) and then digested with BamHI and KpnI (Section 2.3.7), 
before being purified again and ligated (Section 2.3.9) with the similarly digested E. coli-S. 
aureus shuttle vector pSK4833 (Firth et al., 2000) (Table 2.2). The ligations were used to 
transform E. coli NEB5α cells to ampicillin resistance (Section 2.4.2), and selected 
transformants were initially screened by PCR using the same primers (Section 2.3.3). Plasmid 
DNA was subsequently isolated from positive clones and presence of the insert confirmed by 
restriction digestion with BamHI and KpnI (Section 2.3.7). A single recombinant plasmid was 




In order to distinguish the contribution of individual parA and parB genes with respect to 
partitioning function, site-directed mutagenesis (SDM) using pJEG001 as template DNA was 
performed to generate mutant derivatives of each gene (Section 2.3.4). Primers GM3 and GM4 
(Table 2.6) were used to introduce a missense mutation at codon 15 of the parA gene, in order 
to avoid potential polarity effects on parB expression, resulting in an amino acid substitution 
of lysine to threonine (AAA43-45ACC  K15T). The encoded protein was predicted to exhibit 
significantly lower levels of functional activity than wild type since K15 corresponds to a 
highly conserved residue within the ATPase active site of deviant Walker ATPases (Barilla et 
al., 2005); note that a silent KpnI restriction site was incorporated into each of the primers to 
facilitate screening of potential plasmid mutants. For SDM of the parB gene, primers GM5 and 
GM6 (Table 2.6) were used to introduce a frameshift mutation at codon 53 to ensure functional 
disruption (AGT157-159AT  S53fsX57) and in this case a silent BclI restriction site was 
incorporated to facilitate mutant screening. 
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Post PCR amplification (using these primer sets) and DpnI digestion, the mutagenesis reactions 
for both parA and parB were used to transform E. coli NEB5α cells to ampicillin resistance, 
where plasmid DNA was isolated from selected transformants as described above. Isolated 
plasmids for both SDM reactions were confirmed by restriction endonuclease digestion using 
the respective silent restriction enzymes; KpnI for parA (GGTAAA  GGTACC) and BclI for 
parB (TGAGTCA  TGATCA). Both mutations were verified by DNA sequencing (Section 
2.3.10) and the mutant plasmids subsequently named pJEG005 (encodes ParA-K15T) and 
pJEG006 (ParB-S53fsX57) (Table 2.2; Figure 3.1B). Prior to determining the effect of 
p107Apar and the parA/B mutant derivatives on plasmid segregational stability, all constructs 
were individually introduced into S. aureus RN4220 cells by electroporation (Section 2.4.4). 
3.2.2 Segregational stability of plasmid pJEG001 and mutant derivatives in S. aureus 
The ability of p107Apar to increase the segregational stability of the shuttle vector pSK4833 
(Table 2.2) in the absence of antibiotic selective pressure was examined in S. aureus using 
pJEG001 and mutant derivative plasmids pJEG005 and pJEG006 (Section 3.2.1). Plasmid 
segregational stability assays were performed using these plasmids (Section 2.7) and the results 
are presented in Figure 3.2. The assays were performed in triplicate and revealed that after 30 
generations of serial subculture, in the absence of antibiotic selection, approximately 55% of 
the bacterial population retained pJEG001 (+ p107Apar), whereas pSK4833 (- p107Apar) was 
completely lost from the population after 30 generations. The assays also revealed that the ParA 
(K15A) and ParB (S53fsX57) mutations negatively affected the stability of plasmids pJEG005 
and pJEG006, respectively, as they were completely lost after 20 generations (Figure 3.2). In 
combination, these results support the prediction that p107Apar represents a functioning Type 
Ib partitioning system that increases plasmid segregational stability in staphylococcal cells. 
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Figure 3.1: Schematic diagram of staphylococcal plasmids containing p107Apar 
A schematic representation of how plasmids pJEG001, pJEG005 and pJEG006 were 
constructed. A. A BamHI/KpnI fragment containing p107Apar was cloned into the multi- 
cloning site (MCS) of the similarly digested shuttle vector pSK4833 to create plasmid 
pJEG001. B. pJEG001 was used as the template for site-directed mutagenesis of the par genes. 
A non-synonymous mutation was introduced into parA (AAA43-45ACC  K15T) generating 
pJEG005 and a frameshift mutation was introduced into parB (AGT157-159AT  S53fsX57) 
generating pJEG006. Abbreviations: bla, ampicillin resistance gene; parS, centromere-like site; 
ermC, erythromycin resistance gene; MCS, multi-cloning site; pSK1 ori, pSK1 origin of 
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Figure 3.2: Stability of plasmids containing p107Apar in S. aureus 
Plasmid segregational stability of pJEG001 and mutant derivatives in S. aureus RN4220. The 
retention of plasmids pSK4833 (empty vector control) (♦), pJEG001 (p107Apar) (■), pJEG005 
(parA-K15T) (▲) and pJEG006 (parB-S53fsX57) (×) in S. aureus RN4220 cells was 
determined as described in Section 2.7. Data was normalised to 100% plasmid retention at 
generation 0. Percentage of cells retaining the plasmid was measured at 0, 12, 22 and 32 
generations. The averages of three independent assays are shown. Error bars represent standard 



































3.3 Functionality of p107Apar in the heterologous host E. coli 
 
3.3.1 Construction of an E. coli plasmid containing p107Apar 
PCR amplification of p107Apar (~ 1.5 kb) was performed using primers GM1 and GM7 
Section 2.3.3) (Table 2.6), which contain BamHI and SalI restriction sites, respectively. The 
amplicon was purified (Section 2.3.5) and then digested with BamHI and SalI (Section 2.3.7), 
before being purified again and ligated (Section 2.3.9) with similarly digested E. coli vector 
pACYC184 (Chang and Cohen, 1978) (Table 2.2), resulting in disruption of the tetracycline 
resistance gene. The ligations were used to transform E. coli NEB5α cells to chloramphenicol 
resistance (Section 2.4.2) and select transformants were initially screened by PCR using the 
same primers (Section 2.3.3). Plasmid DNA was subsequently isolated from positive clones 
(Section 2.3.1), which were confirmed by restriction digestion with BamHI and SalI (Section 
2.3.7) and agarose gel electrophoresis (Section 2.3.2). Recombinant plasmids were sequenced 
(Section 2.3.10) using primers GM1 and GM7 and a resultant construct (with the correct insert) 
was named pJEG014 (Table 2.2; Figure 3.3). 
3.3.2 Segregational stability of plasmid pJEG014 in E. coli 
The ability of p107Apar to increase the segregational stability of pACYC184 (Table 2.2), in 
the absence of antibiotic selective pressure, was examined in E. coli using pJEG014 (Section 
3.3.1). Plasmid segregational stability assays were performed using these plasmids (Section 
2.7) and the results are presented in Figure 3.4. While no repeat assays were performed due to 
time constraints it is clear that after 30 generations, in the absence of antibiotic selection, 100% 
of the bacterial population retained pJEG014 (+ p107Apar), whereas pACYC184 (- p107Apar) 
was completely lost from the population. These results indicate that p107Apar functions 
independently of native host cell machinery and that E. coli could be used as a heterologous 
host for cell imaging protein localisation studies (see Chapter 5). 
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Figure 3.3: Schematic diagram of an E. coli plasmid containing p107Apar 
A schematic representation of how pJEG014 was constructed. A BamHI/SalI fragment 
containing the p107Apar was cloned into the similarly digested vector pACYC184 to create 
plasmid pJEG014. Note that the cloned fragment disrupted the tetracycline resistance gene 
(TcR). Abbreviations: parS, centromere-like site; cat, chloramphenicol resistance gene; p15A 
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Figure 3.4: Stability of a plasmid containing p107Apar in E. coli 
Segregational stability of pJEG014 in E. coli. The retention of plasmids pACYC184 (empty 
vector control) (♦) and pJEG014 (parIb) (■) in E. coli NEB5α cells was determined as 
described in Section 2.7. Data was normalised to 100% plasmid retention at generation 0. 
Percentage of cells retaining the plasmid was measured at 0, 9, 20, 31 and 40 generations. 
































































3.4 Functional analysis of the putative enterococcal pJEG029 Type Ib 
partitioning system 
The pJEG029 putative Type Ib partitioning system (abbreviated herein to pJEG029par) was 
recently identified on a multiresistance plasmid from an Australian vancomycin-resistant 
enterococcal (VRE) clinical isolate (Jensen, unpublished data). Similar to p107Apar, this 
system contains arrays of direct/inverted repeats located upstream of the putative parA and 
parB genes, which likely encode a deviant Walker ATPase motor protein and a ribbon-helix- 
helix DNA binding protein, respectively. Interestingly, and different to p107Apar (and all other 
known Type Ib partitioning systems), arrays of the same direct/inverted repeats are also located 
downstream of pJEG029par. In this case, the repeats are located across the predicted promoter 
for the pJEG029 repA gene (Figure 1.4), indicating that ParB may mediate transcriptional 
regulation of both plasmid partitioning and replication (explored in chapter 4). In any case, the 
ability of pJEG029par to increase segregational stability of an enterococcal mini-replicon 
plasmid in E. faecium TX1330 cells was initially determined and the contribution (if any) of the 
downstream repeats was also explored. 
3.4.1 Construction of enterococcal plasmids containing pJEG029par 
PCR amplification of pJEG029par (~ 2.7 kb) was performed using primers GM8 and GM9 
(Section 2.3.3) (Table 2.6), which contain BamHI and SalI restriction sites, respectively. The 
amplicon was purified (Section 2.3.5) and then digested with BamHI and SalI (Section 2.3.7), 
before being purified again and ligated (Section 2.3.9) with the similarly digested E. coli-E. 
faecium shuttle vector pAM401 (Table 2.2) (Wirth et al., 1986). The ligations were used to 
transform E. coli DH5α cells to chloramphenicol resistance (Section 2.4.2), and selected 
transformants were initially screened by PCR using the same primers (Section 2.3.3). Plasmid 
DNA was subsequently isolated from positive clones and presence of the insert confirmed by 
restriction digestion with BamHI and SalI (Section 2.3.7). A single recombinant plasmid was 





To determine the functional significance if any of the downstream repeats (located across the 
predicted repA promoter region of pJEG029), herein designated as parS2, a fragment 
containing both pJEG029par and parS2 was PCR amplified using primers GM8 and GM10, 
which contain BamHI and SalI restriction sites, respectively. These primers were used to 
facilitate cloning into pAM401 and subsequent screening of transformants as described above. 
Plasmid DNA was again isolated from positive clones and presence of the insert confirmed by 
restriction digestion. A single recombinant plasmid was sequenced (Section 2.3.10) using 
primers GM8 and GM10 and named pJEG033 (Table 2.2; Figure 3.5). 
 
 
In order to distinguish the contribution of individual parA and parB genes with respect to 
partitioning function, primers were designed for SDM using pJEG032 as template DNA. As in 
Section 3.2.1, primers GM11 and GM12 (Table 2.6) were designed to introduce a missense 
mutation at codon 16 of the parA gene, resulting in an amino acid substitution of lysine to 
asparagine (AAA46-48AAC  K16N). Similarly, for SDM of the parB gene, primers GM13 
and GM14 (Table 2.6) were designed to introduce a frameshift mutation at codon 22 (TAC67- 
69TC  Y23fsX27) to ensure functional disruption and a silent SacI restriction site was also 
incorporated to facilitate mutant screening (GAACTAC  GAGCTC). However, despite 
obtaining potential mutants for both genes after SDM PCR, DpnI digestion and transformation 
of E. coli DH5α cells, insufficient time was available for screening and subsequent sequencing 
of any positive clones. Therefore, only plasmids pAM401 (empty vector), pJEG032 and 
pJEG033 were individually introduced into E. faecium TX1330 cells by electroporation 
(Section 2.4.6), in order to determine the effect of pJEG029par on plasmid segregational 
stability. 
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Figure 3.5: Schematic diagram of enterococcal plasmids containing pJEG029par 
A schematic representation of how plasmids pJEG032 and pJEG033 were constructed. 
BamHI/SalI fragments containing pJEG029par or pJEG029par + parS2 were cloned into the 
multi-cloning site (MCS) of the similarly digested shuttle vector pAM401 to create plasmids 
pJEG032 (I) and pJEG033 (II), respectively. Abbreviations: cat, chloramphenicol resistance 
gene; parS, centromere-like site; cop, copy control region; MCS, multi-cloning site; ori, origin 
of replication; tet, tetracycline resistance gene; rep region, replication region. Plasmid 
constructs are not to scale. 
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3.4.2 Segregational stability of plasmids pJEG032 and pJEG033 in E. faecium 
The ability of pJEG029par to increase the segregational stability of the shuttle vector pAM401 
(Table 2.2) in the absence of antibiotic selective pressure was examined in E. faecium using 
pJEG032 and pJEG033 (Section 3.4.1). Plasmid segregational stability assays were performed 
using these plasmids (Section 2.7) and the results are presented in Figure 3.6. The assays were 
performed in triplicate and revealed that after 50 generations of serial subculture, in the absence 
of antibiotic selection, approximately 80% and 50% of the bacterial cell populations retained 
pJEG032 (+pJEG029par) and pJEG033 (+ pJEG029par + parS2), respectively. In comparison, 
pAM401 (- pJEG029par) retention had decreased to approximately 10% at the completion of 
the assay. Therefore, these results support the prediction that pJEG029par represents a 
functioning Type Ib partitioning system that increases plasmid segregational stability in 
enterococcal cells. Furthermore, in the case of pJEG033, the inclusion of the downstream 
repeats (parS2) appeared to negatively impact stability function in comparison to pJEG032 
(Figure 3.6), indicating that these repeats may more exclusively play a role in the regulation of 
repA transcription through ParB binding. 
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Figure 3.6: Stability of plasmids containing pJEG029par in E. faecium 
Plasmid segregational stability of pJEG032 and pJEG033 in E. faecium. The retention of 
plasmids pAM401 (empty vector control) (♦), pJEG032 (pJEG029par) (■) and pJEG033 
(pJEG029par + parS2) (▲) in E. faecium TX1330 cells was determined as described in Section 
2.7. Data was normalised to 100% plasmid retention at generation 0. Percentage of cells 
retaining the plasmid was measured at 0, 8, 18, 28, 38, 48 and 58 generations. The averages of 































































3.5 Summary and Discussion 
The objective of this chapter was to establish, for the first time, the functional significance of 
putative Type Ib plasmid partitioning systems (and their components) identified in Gram- 
positive coccoid organisms. Based on research that largely utilised Gram-negative rod-shaped 
bacteria, related systems have been shown to enhance plasmid segregational stability via an 
active partitioning mechanism driven by ATP hydrolysis; these systems are comprised of two 
genes that encode a deviant Walker ATPase protein and a RHH DNA-binding protein which 
binds to an upstream centromere-like site comprised of DNA repeats (parS). Therefore, the 
putative Type Ib partitioning systems from the staphylococcal and enterococcal plasmids 
p107A and pJEG029, respectively, were cloned into mini-replicon shuttle vectors in order to 
assess partition function in their native hosts. Additionally, the staphylococcal system 
(p107Apar) was also cloned into an E. coli vector to assess its functionality in a heterologous 
host. 
3.5.1 p107Apar functionality in S. aureus and E. coli 
The stability assay results shown in Figure 3.2 demonstrated that p107Apar (via pJEG001) is 
likely a functioning Type Ib partitioning system, as it increased the segregational stability of 
the shuttle vector pSK4833 in the absence of antibiotic selective pressure. Additionally, these 
results also confirmed the individual functional requirement of the parA and parB genes via 
the mutant derivative plasmids pJEG005 and pJEG006, respectively, which were lost from cell 
populations at a similar rate to pSK4833 (Figure 3.2). In the case of pJEG005, an amino acid 
substitution was incorporated into the ATPase active site of the encoded ParA protein 
(ParAK15T); this site is predicted to drive/enhance ATP hydrolysis and polymerisation upon 
interaction with the ParB-parS complex (Vecchiarelli et al., 2013). The targeted lysine residue 
K15 corresponds to a highly conserved residue within the ATPase active site of deviant Walker 
ATPases and the ParAK15T mutant protein was expected to exhibit significantly lower levels 
of functional activity. In the case of pJEG006, a frameshift mutation was incorporated that 
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resulted in a C-terminal truncation of the encoded ParB protein (ParBS53fsX57); the C- 
terminal end of ParB is predicted to mediate DNA-binding via a RHH DNA-binding motif and 
thus be essential for partition function. 
 
 
In addition to the above, the stability assay result shown in Figure 3.4 also demonstrates that 
p107Apar (via pJEG014) can increase the segregational stability of plasmids in a heterologous 
host, such as E. coli. Although further replicates are required to confirm this result, this implies 
that p107Apar functions independently of other host cell machinery. Furthermore, as studying 
cellular processes in S. aureus is complicated by the small size (1 μm diameter), spherical shape 
and alternating planes of division of this organism, this result also indicates that E. coli could 
be used to more readily study the cellular localisation patterns of Par-GFP fusion proteins using 
fluorescence microscopy techniques. 
3.5.2 pJEG029par functionality in E. faecium 
Similar to above, the stability assay results shown in Figure 3.6 demonstrated that pJEG029par 
(via pJEG032) is likely a functioning Type Ib partitioning system, as it increased the 
segregational stability of the shuttle vector pAM401 in the absence of antibiotic selective 
pressure. However, unlike p107Apar, this system has an additional parS site (parS2) located 
downstream of the parB gene. Interestingly, plasmid pJEG033, which contains both 
pJEG029par and parS2, is less stable in comparison to pJEG032, which only contains 
pJEG029par. In the context of these mini-replicon plasmids and the absence of other regulatory 
mechanisms that may be present on the wild-type plasmid pJEG029, the predicted parS2 site 
may sequester ParB molecules from parS1 and thus complicate functional interaction with 
ParA and transcriptional repression of the par operon. As parS2 is located across the predicted 
promoter for the repA gene, its primary role may be in transcriptional regulation of plasmid 
replication, rather than partition function. As such, the potential regulatory role of ParB, in the 
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Based on previous studies that predominantly used rod-shaped Gram-negative organisms, the 
ParB protein of Type Ib plasmid partitioning systems is a DNA-binding protein that possesses 
a ribbon-helix-helix (RHH) domain fold. These proteins mechanistically bind to arrays of 
direct/inverted repeats (parS site) and mediate both transcriptional regulation of the par operon 
and attachment of ParA to the ParB-plasmid complex (Havey et al., 2012). Therefore, the aim 
of this chapter was to explore the role of ParB with respect to transcriptional regulation of the 
putative p107Apar and pJEG029par promoters (herein referred to as Ppar and Ppar-parS1, 
respectively), and in the case of pJEG029, the putative repA promoter via parS2 (herein 
referred to as Prep-parS2). Specifically, ParB binding to these promoters was explored through 
DNA-binding studies and promoter activity reporter assays. 
4.2 Transcriptional regulation of the staphylococcal p107A Type Ib 
partitioning system 
4.2.1 ParB DNA-binding studies 
4.2.1.1 Construction of ParB overexpression plasmids 
 
In order to produce purified ParB protein to examine binding to the predicted parS site, the parB 
gene was cloned into E. coli over-expression vectors that facilitate incorporation of a histidine 
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tag (His-tag). Tags were separately added to both N- and C-terminal ends of the encoded protein 
in case of instability or misfolding. 
 
In the case of adding an N-terminal His-tag, a 0.3 kb fragment containing the p107A parB gene 
was PCR amplified with primers GM15 and GM16 (Table 2.6), which contain BamHI and 
KpnI restriction sites, respectively. The amplicon was purified (Section 2.3.5) and then digested 
with BamHI and KpnI (Section 2.3.7), before being purified again and ligated (Section 2.3.9) 
with the similarly digested overexpression vector pQE30 (Table 2.2), which facilitates 
incorporation of an N-terminal hexahistidine (H6) tag. The ligations were used to transform E. 
coli NEB5α cells harbouring the pREP4 plasmid, to ampicillin resistance (Section 2.4.2). 
pREP4 is required as it encodes the repressor protein (LacI) of the pQE30 T5 promoter/lac 
operator element. Plasmid DNA was subsequently isolated from randomly selected 
transformants (Section 2.3.1), and presence of the insert was confirmed by restriction digestion 
with BamHI and KpnI (Section 2.3.7) combined with agarose gel electrophoresis. A single 
recombinant plasmid was sequenced (Section 2.3.10) using primers GM15 and GM16 and 
named pJEG019 (Table 2.2; Figure 4.1A). 
 
 
In the case of adding a C-terminal His-tag, a similarly sized fragment containing the p107A 
parB gene was PCR amplified with primers GM17 and GM18 (Table 2.6), which contain 
EcoRI and PstI restriction sites, respectively. The amplicon was purified (Section 2.3.5) and 
then digested with EcoRI and PstI (Section 2.3.7), before being purified again and ligated 
(Section 2.3.9) with the similarly digested overexpression vector pTTQ18-RGSH6, which 
facilitates incorporation of a C-terminal RGS-hexahistidine (RGSH6) tag. The ligations were 
used to transform E. coli NEB5α cells to ampicillin resistance (Section 2.4.2). Plasmid DNA 
was subsequently isolated from randomly selected transformants (Section 2.3.1) and presence 
of the insert was confirmed by restriction digestion with BamHI and KpnI (Section 2.3.7) 
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combined with agarose gel electrophoresis. A single recombinant plasmid was sequenced 
(Section 2.3.10) using primers GM17 and GM18 and named pJEG018 (Table 2.2; Figure 4.1B). 
4.2.1.2 Overexpression and detection of ParB His-tag fusion proteins 
 
To determine if N- or C-terminal His-tag ParB proteins were expressed upon IPTG induction, 
Western blotting was performed using whole cell lysates derived from E. coli NEB5α cells 
harbouring pJEG019 (H6-ParB) or pJEG018 (ParB-RGSH6), respectively. Small-scale protein 
overexpression experiments were performed as described in Section 2.5.1, using induction 
conditions of 1 mM IPTG at 37°C for 3 h. Equal amounts of total protein (normalised based on 
OD600 of induced cultures; Section 2.5.6) were loaded onto duplicate SDS-PAGE gels and 
proteins were fractionated by electrophoresis (Section 2.5.7). One replicate SDS-PAGE gel 
was analysed using Coomassie Brilliant Blue staining (Section 2.5.8; data not shown) so that 
band intensities could be compared to verify equal protein loading. Subsequently, proteins on 
the second replicate SDS-PAGE gel were transferred to a membrane for Western blotting 
(Section 2.6). Mouse-anti-His monoclonal antibodies were initially used to detect the presence 
of His-tagged ParB proteins as shown in Figure 4.2A. These results show that upon IPTG 
induction, ParB-RGSH6 (encoded by pJEG018) appears to be expressed at low-levels, which 
may indicate misfolding/instability of the fusion protein as a consequence of the C-terminal 
His-tag. In comparison, H6-ParB (encoded by pJEG019) appears to be more stably expressed 
with a protein band of approximately 10 kDa, which is the expected size. 
 
 
Subsequent to the above experiments, rabbit polyclonal ParB antibodies were generated by 
Mimotopes Pty Ltd (Victoria, Australia) using a synthesised p107A ParB peptide (sequence 
shown in Table 2.7). This was done in order to facilitate future detection of ParB expression 
more generally (i.e., in the absence of a tag). Small-scale protein overexpression, SDS-PAGE 
and Western blotting was again performed using cells containing pJEG019, and the newly 
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synthesised ParB antibodies were used for detection. Results are shown in Figure 4.2B and 
confirm the successful expression of H6-ParB and generation of polyclonal antibodies. 
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Figure 4.1: Construction of p107A ParB His-tag overexpression plasmids for use in E. 
coli 
A schematic representation of the construction of pJEG019 and pJEG018, which were used for 
p107A ParB overexpression. A. A BamHI/KpnI fragment containing the p107A parB gene was 
cloned into the multi-cloning site of the overexpression vector pQE30, resulting in an N- 
terminal fusion to the hexahistidine tag. This construct was named pJEG019 and utilised for 
overexpression studies in E. coli NEB5α cells harbouring the pREP4 plasmid. B. An 
EcoRI/PstI fragment containing the p107A parB gene was cloned into the multi-cloning site of 
the overexpression vector pTTQ18-RGSH, resulting in a C-terminal fusion to the RGS- 
hexahistidine tag; this construct was named pJEG018. Abbreviations: bla, ampicillin resistance 
gene; CoI EI ori, CoI EI origin of replication; lacIq, lac operon repressor; MCS, multi-cloning 
site; pBR322 ori, pBR322 origin of replication; Ptac, tac promoter; RGSH6, RGS- hexahistidine 




















































Figure 4.2: Small-scale overexpression and detection of p107A His-tagged ParB proteins 
in E. coli 
Immunodetection of overexpressed p107A ParB in E.coli NEB5α cells by Western blotting. 
H6-ParB and ParB-RGSH6 overexpression was induced with 1 mM IPTG for 3 h as described 
in Section 2.5.1. Whole-cell lysates were fractionated by SDS-PAGE (Section 2.5.7) and 
analysed by Western blotting (Section 2.7). A. Overexpression of p107A ParB with N-terminal 
and C-terminal His-tags via pJEG019 and pJEG018, respectively. Western blotting using anti- 
His monoclonal antibodies showed that H6-ParB (via pJEG019) appears to be more stably 
expressed in comparison to ParB-RGSH6 (via pJEG018). B. Overexpression of H6-ParB via 
IPTG induction was also analysed using rabbit ParB antibodies that were generated by 
Mimotopes Pty Ltd (Victoria, Australia) using a synthesised p107A ParB peptide. Lane L 
contains prestained protein markers, with marker sizes indicated in kDa. Positions of 
overexpressed ParB proteins and their approximate sizes are indicated by the black arrowheads. 
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4.2.1.3 Purification of the H6-ParB fusion protein encoded by pJEG019 
 
As an extension of the above experiments, large-scale overexpression of the H6-ParB fusion 
protein was performed using E. coli NEB5α cells containing the plasmids pJEG019 and pREP4 
(Section 2.5.1) (Table 2.2). Extracts from IPTG-induced cells were harvested and subjected to 
Ni2+-NTA metal affinity chromatography (Section 2.5.2). Samples of each successive wash 
and elution fraction were collected during the purification process and analysed by SDS-PAGE 
(Section 2.5.7) and Coomassie Brilliant Blue staining (Section 2.5.8), as shown in Figure 4.3A. 
Subsequently, as H6-ParB appeared to be purified to a sufficient level for DNA-binding studies, 
protein elutions were buffer exchanged with EMSA buffer (Table 2.5) using PD-10 Sephadex™ 
G-25 M columns (Section 2.5.3). The concentrations of the four collected fractions (of re- 
buffered elution samples) were then determined in conjunction with visualisation via SDS- 
PAGE and Coomassie Brilliant Blue staining, as shown in Figure 4.3B. Each fraction (F1-F4) 
again showed sufficient purity of H6-ParB (approximately 10 kDa) and the concentrations were 
as follows: 351 µg/mL, 1438 µg/mL, 2113 µg/mL and 1160 µg/mL. Note that F4 was used for 
subsequent electrophoretic mobility shift assays. 
4.2.1.4 Electrophoretic mobility shift assays: DNA-binding activity of ParB 
 
To examine potential interactions between the p107A ParB protein and parS site, 
electrophoretic mobility shift assays (EMSAs) (Section 2.9) were performed; EMSAs are based 
on the migration of complexes through a gel matrix, where protein-bound DNA migrates 
slower than unbound DNA. 
 
 
Initially, PCR amplification (Section 2.3.3) was performed using pJEG001 DNA (Table 2) and 
the primers GM19 and GM20 to obtain a DNA fragment that contains the parS site. EMSAs 
were then performed as described (Section 2.9), using purified H6-ParB (Section 4.2.1.3) at 
concentrations ranging from 0 to 1 µg. A non-specific DNA fragment of similar size to parS 
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was used as a negative control, and the resulting EMSA gels are shown in Figure 4.4; note that 
due to its size, competitor DNA (2 µg) cannot migrate into the gels and is therefore retained in 
the wells (Figure 4.4). In any case, as expected, there was no shift observed for non-specific 
DNA (Figure 4.4A) at all ParB concentrations. In contrast, an interaction was observed with 
parS, denoted by a shift in band migration at 160 ng of ParB, followed by a complete shift at 
320 ng (Figure 4.4B). This in vitro result indicates that the p107A ParB protein specifically 
binds to the predicted parS site. 
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Figure 4.3: Purification of overexpressed p107A H6-ParB 
Coomassie-stained 15% (w/v) SDS-polyacrylamide gels showing the stages of p107A H6-ParB 
purification. A. ParB protein was overexpressed in E. coli NEB5α cells with 1 mM IPTG 
induction for 3 h (Section 2.5.1) and purified using Ni2+-NTA resin (Section 2.5.2). Protein 
fractions were collected at each stage of the purification process and analysed via SDS-PAGE 
and Coomassie Brilliant Blue staining. S: Supernatant fraction of unbound protein following 
incubation of cleared lysate with Ni2+-NTA resin; W1: fraction obtained after first wash with 
Wash Buffer 1; W2: fraction obtained after second wash with Wash Buffer 2; E1: fraction 
obtained after first elution with Elution Buffer; E2: fraction obtained after second elution with 
Elution Buffer; R: sample of protein bound to Ni2+-NTA resin after elution process; M: 
resuspension of cell pellet from lysed E. coli cells. Lane L contains the prestained protein 
markers Precision Plus Protein Dual Xtra, with sizes indicated in kDa on the left of each gel; 
for clarity, some marker sizes are omitted. The position of the H6-ParB protein and its 
approximate size is indicated by a black arrowhead. B. Re-buffered elution fractions (F1 – F4) 
of p107A H6-ParB protein with EMSA Buffer following protein overexpression and 
purification. Note that all soluble fractions are only partially purified (non-specific higher 
molecular weight proteins are also present), however, H6-ParB (indicated by the black 
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Figure 4.4: EMSAs showing DNA-binding activity of p107A H6-ParB 
Electrophoretic mobility shift assays (EMSAs) showing p107A ParB specifically binding to 
the predicted parS site of the Type Ib system. The parS site was incubated with increasing 
concentrations of purified H6-ParB protein as described in Section 4.1.2. EMSAs were analysed 
via PAGE and visualised using ethidium bromide staining. A. EMSA performed using a non- 
specific DNA fragment of similar size to the parS site with varying concentrations of H6-ParB; 
no protein-DNA complexes are apparent at all concentrations tested. B. EMSA performed 
using the parS site with increasing concentrations of H6-ParB. Protein-DNA complexes appear 
with protein concentrations of 160 ng and above, as indicated by the black right bracket; a 
complete shift occurs with 320 ng of protein. Unbound DNA and competitor DNA are indicated 
by black arrowheads. Black asterisk (*) indicates additional PCR products that amplified with 
the parS site due to primer binding within a repeated region of the ParB binding site of parS, 
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4.2.2 Ppar activity reporter assays 
4.2.2.1 Construction of a Ppar-reporter gene fusion plasmid and a ParB 
expression plasmid 
In the previous section, EMSA experiments revealed that ParB specifically binds to the 
predicted parS site. As this site is located directly downstream of the par promoter it is 
predicted that ParB acts as a transcriptional repressor of the par operon. In order to explore 
this, the promoter reporter vector pSK5483 (Table 2.2), which contains a promoterless 
chloramphenicol acetyltransferase (cat) reporter gene, was utilised. Initially, a fragment 
containing the putative Ppar-parS region from p107A (Table 2.2) was PCR amplified with 
primers GM21 and GM22 (Table 2.6), which contain BamHI and HindIII restriction sites, 
respectively. The amplicon was purified (Section 2.3.5) and then digested with BamHI and 
HindIII (Section 2.3.7), before being purified again and ligated (Section 2.3.9) with the 
similarly digested reporter gene vector pSK5483 (Table 2.2). The ligations were used to 
transform E. coli DH5α cells to ampicillin resistance (Section 2.4.2). Plasmid DNA was 
subsequently isolated from randomly selected transformants (Section 2.3.1), and presence of 
the insert was confirmed by restriction digestion with BamHI and HindIII (Section 2.3.7) 
combined with agarose gel electrophoresis. A single recombinant plasmid was sequenced 
(Section 2.3.10) using primers GM21 and GM22 (Table 2.6) and named pJEG030 (Table 2.2; 
Figure 4.5A). Note that in this construct Ppar controls transcription of the cat reporter gene. 
 
 
Subsequently, a fragment containing the parB gene from p107A was PCR amplified with 
primers GM23 and GM24 (Table 2.6), which contain SalI and BamHI restriction sites, 
respectively. These sites were incorporated to facilitate cloning into the shuttle vector pJEG015 
(Table 2.2), which contains the IPTG-inducible promoter Pspac located directly upstream of a 
multi-cloning site. As above, the purified amplicon and vector were digested, ligated and used 
to transform E. coli DH5α cells to ampicillin resistance. Plasmid DNA was again isolated from 
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randomly selected transformants (Section 2.3.1), and presence of the insert was confirmed by 
restriction digestion with SalI and BamHI (Section 2.3.7) combined with agarose gel 
electrophoresis. A single recombinant plasmid was sequenced (Section 2.3.10) using primers 
GM23 and GM24 (Table 2.6) and named pJEG031 (Table 2.2; Figure 4.5B). 
Prior to determining Ppar-parS activity (via assaying for CAT) in the presence of ParB, the 
following plasmid/vector combinations were introduced into S. aureus RN4220 cells: pSK5483 
+ pJEG015 (for determining background CAT activity), pJEG030 + pJEG015 (for determining 
CAT activity in the absence of ParB) and pJEG030 + pJEG031 (for determining CAT activity 
in the presence of ParB). 
4.2.2.2 CAT Assays: Impact of ParB binding to parS on Ppar activity 
 
In order to determine if ParB acts as a transcriptional repressor of the par operon, CAT assays 
were performed using S. aureus RN4220 cells containing the co-resident plasmid/vector 
combinations described above. 
 
 
Specifically, cells were harvested from overnight cultures containing IPTG of strains 
harbouring pSK5483 and pJEG015, pJEG030 and pJEG015, and, pJEG030 and pJEG031 
(Table 2.2). Soluble cellular lysates were then extracted from these cells (Section 2.5.4) and 
CAT assays were conducted as described in Section 2.8. The total protein concentration of each 
cellular lysate was also determined using the BCA assay method (Section 2.5.5). Note that 
assays were performed in triplicate on three separate occasions and CAT activity is expressed 
as nmol of Cm acetylated per mg of soluble cellular protein per minute. Furthermore, 
background CAT activity, as determined using the strain containing pSK5483 (promoterless 
cat gene) and pJEG015, was subtracted from the activities obtained for test strains. 
The results of the CAT assays are presented graphically in Figure 4.6 with mean values +/- 
standard deviation shown. Consistent with the prediction that ParB is a repressor of par 
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transcription, through binding to the parS site, there was a significant difference in CAT activity 
measured for Ppar (via pJEG030) in the absence (pJEG015) and presence (pJEG031) of ParB. In 
combination, these results indicate that the predicted par promoter is functional and that binding of 




Figure 4.5: Construction of a p107A Ppar-reporter gene fusion plasmid and a ParB 
expression plasmid 
A schematic representation of the construction of pJEG030 and pJEG031, which were used for 
chloramphenicol acetyl transferase assays. A. A BamHI/HindIII fragment containing the p107A 
Ppar-parS region was cloned into the multi-cloning site (MCS) of the similarly digested reporter 
vector pSK5483, upstream of a promoterless chloramphenicol resistance gene (CmR); this 
construct was named pJEG030. B. A SalI/BamHI fragment containing the p107A parB gene was 
cloned into the MCS of the similarly digested expression vector pJEG015 to create plasmid 
pJEG031. Abbreviations: blaM, β-lactamase resistance gene; cat, chloramphenicol resistance 
gene; gfp, green fluorescent protein gene; lacI, lac operon repressor; MCS, multi-cloning site; 
NmR, neomycin resistance gene; pGEM53f ori, pGEM53f origin of replication; pMB1 ori, pMB1 
origin of replication; pSK1 ori, pSK1 origin of replication; pSK41 ori, pSK41 origin of 
replication; Pspac, IPTG-inducible promoter/lac operator; To, transcriptional terminator zero; T1, 






































































































































Figure 4.6: CAT activity of the p107A Ppar-reporter gene fusion plasmid in the 
absence/presence of ParB 
A graphical representation of the CAT (chloramphenicol acetyl transferase) activity 
measured using the Ppar-reporter fusion plasmid pJEG030. The assay was performed as 
described in Section 4.1.4 in triplicate on three separate occasions. The CAT activity of 
pJEG030 was measured when co-resident with either pJEG015 (empty vector, coloured 
blue) or pJEG031 (pJEG015 + ParB, coloured red). The mean activities are shown, and error 
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4.3 Transcriptional regulation of the enterococcal pJEG029 Type Ib 
partitioning system 
4.3.1 ParB DNA-binding studies 
4.3.1.1 Construction of ParB overexpression plasmid 
 
In order to produce purified ParB protein to examine binding to the predicted parS site, the 
parB gene was cloned into an E. coli over-expression vector that facilitates incorporation of a 




In the case of adding a C-terminal His-tag, a 0.3 kb fragment containing the pJEG029 parB 
gene was PCR amplified with primers GM25 and GM26 (Table 2.6), which contain EcoRI and 
SalI restriction sites, respectively. The amplicon was purified (Section 2.3.5) and then digested 
with EcoRI and SalI (Section 2.3.7), before being purified again and ligated (Section 2.3.9) 
with the similarly digested overexpression vector pTTQ18-RGSH6, which facilitates 
incorporation of a C-terminal RGS-hexahistidine (RGSH6) tag. The ligations were used to 
transform E. coli NEB5α cells to ampicillin resistance (Section 2.4.2). Plasmid DNA was 
subsequently isolated from randomly selected transformants (Section 2.3.1), and presence of 
the insert was confirmed by restriction digestion with EcoRI and SalI (Section 2.3.7) combined 
with agarose gel electrophoresis. A single recombinant plasmid was sequenced (Section 2.3.10) 
using primers GM25 and GM26 and named pJEG039 (Table 2.2; Figure 4.7). 
4.3.1.2 Overexpression and detection of ParB His-tag fusion protein 
 
To determine if the C-terminal His-tag ParB protein was expressed upon IPTG induction, 
Western blotting was performed using whole cell lysates derived from E. coli NEB5α cells 
harbouring pJEG039 (ParB-RGSH6). Small-scale protein overexpression experiments were 
performed as described in Section 2.5.1, using induction conditions of 1 mM IPTG at 37°C for 
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3 h. Equal amounts of total protein (normalised based on OD600 of induced cultures; Section 
2.5.6) were loaded onto duplicate SDS-PAGE gels and proteins were fractionated by 
electrophoresis (Section 2.5.7). One replicate SDS-PAGE gel was analysed using Coomassie 
Brilliant Blue staining (Section 2.5.8; data not shown) so that band intensities could be 
compared to verify equal protein loading. Subsequently, proteins on the second replicate SDS- 
PAGE gel were transferred to a membrane for Western blotting (Section 2.6). Rabbit 
polyclonal ParB antibodies were generated by Mimotopes Pty Ltd (Victoria, Australia) using 
a synthesised pJEG040-derived ParB peptide (sequence shown in Table 2.7). This was done in 
order to facilitate future detection of ParB expression more generally (i.e., in the absence of a 
tag). Small-scale protein overexpression, SDS-PAGE and Western blotting was again 
performed using cells containing pJEG039, and the newly synthesised ParB antibodies were 
used for detection. Results are shown in Figure 4.8 and confirm the successful expression of 
ParB-RGSH6 and generation of polyclonal antibodies. 
4.3.1.3 Purification of the ParB-H6 fusion protein encoded by pJEG039 
 
As an extension of the above experiments, large-scale overexpression of the ParB-RGSH6 
fusion protein was performed using E. coli NEB5α cells containing the plasmid pJEG039 
(Section 2.5.1) (Table 2.2). Extracts from IPTG-induced cells were harvested and subjected to 
Ni2+-NTA metal affinity chromatography (Section 2.5.2). Samples of each successive wash 
and elution fraction were collected during the purification process and analysed by SDS-PAGE 
(Section 2.5.7) and Coomassie Brilliant Blue staining (Section 2.5.8), as shown in Figure 4.9A. 
Subsequently, as ParB-RGSH6 appeared to be purified to a sufficient level for DNA-binding 
studies, protein elutions were buffer exchanged with EMSA buffer (Table 2.5) using PD-10 
Sephadex™ G-25 M columns (Section 2.5.3). The concentrations of the four collected fractions 
(of re-buffered elution samples) were then determined in conjunction with visualisation via 
SDS-PAGE and Coomassie Brilliant Blue staining, as shown in Figure 4.9B. Each fraction 
120  
(F1-F4) again showed sufficient purity of ParB-RGSH6 (approximately 12 kDa) and the 
concentrations were as follows: 347 µg/mL, 751 µg/mL, 748 µg/mL and 245 µg/mL. Note that 
F2 was used for subsequent electrophoretic mobility shift assays. 
4.3.1.4 Electrophoretic mobility shift assays: DNA-binding activity of ParB 
 
To examine potential interactions between the pJEG029 ParB protein and promoters Ppar-parS1 
and Prep-parS2, electrophoretic mobility shift assays (EMSAs) (Section 2.9) were performed; 
EMSAs are based on the migration of complexes through a gel matrix, where protein-bound 
DNA migrates slower than unbound DNA. 
 
 
Initially, PCR amplification (Section 2.3.3) was performed using pJEG029 DNA (Table 2.2) 
and the primers GM27/GM28 and GM29/GM30 to obtain DNA fragments that contain the Ppar- 
parS1 and Prep-parS2 sites, respectively. EMSAs were then performed as described (Section 2.9), 
using purified ParB-H6 (Section 4.3.1.3) at concentrations ranging from 0 - 1 µg. A non- 
specific DNA fragment of similar size to promoter sites was used as a negative control, and the 
resulting EMSA gels are shown in Figure 4.10; note that due to its size, competitor DNA (2 
µg) cannot migrate into the gels and is therefore retained in the wells (Figure 4.10). In any case, 
as expected, there was no shift observed for non-specific DNA (Figure 4.10A) at all ParB 
concentrations. In contrast, an interaction was observed with Ppar-parS1, denoted by a shift in 
band migration at 1 µg (of ParB) (Figure 4.10B). Similarly, an interaction was also observed 
with Prep-parS2, denoted by a shift in band migration at 320 ng (of ParB), followed by a complete 
shift at 1 µg (Figure 4.10C). This in vitro result indicates that the pJEG029 ParB protein 
specifically binds to the predicted Ppar-parS1  site, as well as the Prep-parS2 site. 
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Figure 4.7: Construction of a pJEG029 ParB His-tag overexpression plasmid for use in 
E. coli 
A schematic representation of the construction of pJEG039, which was used for pJEG029 ParB 
overexpression. An EcoRI/SalI fragment containing the pJEG029 parB gene was cloned into 
the overexpression vector pTTQ18-RGSH, resulting in a C-terminal fusion to the RGS- 
hexahistidine tag. This construct was named pJEG039 and utilised for overexpression studies 
in E. coli NEB5α cells. Abbreviations: bla, ampicillin resistance gene; lacIq, lac operon 
repressor; MCS, multi-cloning site; pBR322 ori, pBR322 origin of replication; Ptac, tac 



























Figure 4.8: Small-scale overexpression and detection of the pJEG029 His-tagged ParB 
protein in E. coli 
Immunodetection of overexpressed pJEG029 ParB in E. coli DH5α cells by Western 
blotting. ParB-RGSH6 was induced with 1 mM IPTG for 3 h as described in Section 2.5.1. 
Whole-cell lysates were fractionated via SDS-PAGE (Section 2.5.7) and analysed by 
Western blotting (Section 2.7). Overexpression of ParB-RGSH6 (via pJEG039) in the 
absence/presence of IPTG was detected using rabbit ParB antibodies that were generated by 
Mimotopes Pty Ltd (Victoria, Australia) using a synthesised pJEG040-derived ParB 
peptide. Lane L contains prestained protein marker, with marker sizes indicated on the left 
in kDa; for clarity, some marker sizes are omitted (Marker sizes from top to bottom: 250, 
150, 100, 75, 50, 37, 25, 20, 15, 10 kDa). The position of overexpressed ParB protein and 



















Figure 4.9: Purification of overexpressed pJEG029 ParB-RGSH6 
Coomassie-stained 15% (w/v) SDS-polyacrylamide gels showing the stages of pJEG029 ParB- 
RGSH6 purification. A. ParB protein was overproduced in E. coli NEB5α cells with 1 mM 
IPTG induction for 3 h (Section 2.5.1) and purified using Ni2+-NTA resin (Section 2.5.2). 
Protein fractions were collected at each stage of the purification process and analysed via SDS- 
PAGE and Coomassie Brilliant Blue staining. S: Supernatant fraction of unbound protein 
following incubation of cleared lysate with Ni2+-NTA resin; W1: fraction obtained after first 
wash with Wash Buffer 1; W2: fraction obtained after second wash with Wash Buffer 2; E1: 
fraction obtained after first elution with Elution Buffer; E2: fraction obtained after second 
elution with Elution Buffer; R: sample of protein bound to Ni2+-NTA resin after elution 
process; M: resuspension of cell pellet from lysed E. coli cells. Lane L contains the prestained 
protein markers Precision Plus Protein Dual Xtra, with sizes indicated in kDa on the left of 
each gel; for clarity, some marker sizes are omitted. The position of the ParB-RGSH6 protein 
and its approximate size is indicated by a black arrowhead. B. Re-buffered elution fractions 
(F1 – F4) of pJEG029 ParB-RGSH6 protein with EMSA Buffer following protein 
overexpression and purification. Note that all soluble fractions are only partially purified (non- 
specific higher molecular weight proteins are also present), however, ParB-RGSH6 (indicated 

























































Figure 4.10: EMSAs showing DNA-binding activity of pJEG029 ParB-RGSH6 
Electrophoretic mobility shift assays (EMSAs) showing pJEG029 ParB specifically binding to 
the Ppar-parS1 and Prep-parS2 regions of the Type Ib system. Both DNA regions were incubated 
with increasing concentrations of purified ParB-RGSH6 protein as described in Section 4.2.2. 
EMSAs were analysed via PAGE and visualised using ethidium bromide staining. A. EMSA 
performed using a non-specific DNA fragment of similar size to the Ppar-parS1 and Prep-parS2 DNA 
regions with varying concentrations of ParB-RGSH6; some protein-DNA complexes were 
apparent at the higher concentrations tested, however a complete shift was not observed. B. 
EMSA performed using the Ppar-parS1 region with increasing concentrations of ParB-RGSH6. 
Protein-DNA complexes appear with protein concentrations of 160 ng and above, as indicated 
by the black right bracket; a complete shift occurs with 1 µg of protein. C. EMSA performed 
using the Prep-parS2 region with increasing concentrations of ParB-RGSH6. Protein-DNA 
complexes again appear with protein concentrations of 160 ng and above, as indicated by the 
black right bracket; a complete shift also occurs with 1 µg of protein. Unbound DNA and 



























































































4.3.2 Prep activity reporter assays 
4.3.2.1 Construction of a Prep-reporter gene fusion plasmid and a ParB 
expression plasmid 
In the previous section, EMSA experiments revealed that ParB specifically binds to both Ppar- 
parS1 and Prep-parS2 predicted sites. As these sites are located within the par and rep promoters, 
respectively, it is predicted that ParB acts as a transcriptional repressor of both the par and rep 
operon. In order to explore this, the promoter reporter vector pSK5483 (Table 2.2), which 
contains a promoterless chloramphenicol acetyltransferase (cat) reporter gene, was utilised. 
Initially, fragments containing the putative Ppar-parS1 and Prep-parS2 regions from pJEG029 
(Table 2.2) were PCR amplified individually with primers GM31/GM32 and primers 
GM33/GM34 (Table 2.6), respectively. Both forward and reverse primers contained BamHI 
and HindIII restriction sites, respectively. The amplicons were purified (Section 2.3.5) and then 
digested with BamHI and HindIII (Section 2.3.7), before being purified again and ligated 
(Section 2.3.9) with the similarly digested reporter gene vector pSK5483 (Table 2.2). The 
ligations were used to transform E. coli DH5α cells to ampicillin resistance (Section 2.4.2). 
Plasmid DNA was subsequently isolated from randomly selected transformants (Section 2.3.1), 
and presence of both inserts were confirmed by restriction digestion with BamHI and HindIII 
(Section 2.3.7) combined with agarose gel electrophoresis. A single recombinant plasmid from 
each reaction was sequenced (Section 2.3.10) using primers GM31/GM32 and primers 
GM33/GM34 (Table 2.6), and named pJEG035 (Table 2.2; Figure 4.11A) and pJEG036 (Table 
2.2; Figure 4.11B), respectively. Note that in these constructs Ppar-parS1 and Prep-parS2 separately 
control transcription of the cat reporter gene. 
 
 
Subsequently, a fragment containing the parB gene from pJEG029 was PCR amplified with 
primers GM35 and GM36 (Table 2.6), which contain SalI and BamHI restriction sites, 
respectively. These sites were incorporated to facilitate cloning into the shuttle vector pJEG015 
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(Table 2.2), which contains the IPTG-inducible promoter Pspac located directly upstream of a 
multi-cloning site. As above, the purified amplicon and vector were digested, ligated and used to 
transform E. coli DH5α cells to ampicillin resistance. Plasmid DNA was again isolated from 
randomly selected transformants (Section 2.3.1), and presence of the insert was confirmed by 
restriction digestion with SalI and BamHI (Section 2.3.7) combined with agarose gel 
electrophoresis. A single recombinant plasmid was sequenced (Section 2.3.10) using primers 
GM35 and GM36 (Table 2.6) and named pJEG034 (Table 2.2; Figure 4.11C). 
 
 
Prior to determining Ppar-parS1 and Prep-parS2 activity (via assaying for CAT) in the presence of 
ParB, the following plasmid/vector combinations were introduced into S. aureus RN4220 cells: 
pSK5483 + pJEG015 (for determining background CAT activity), pJEG035 + pJEG015 and 
pJEG036 + pJEG015 (for determining CAT activity in the absence of ParB) and pJEG035 
+ pJEG034 and pJEG036 + pJEG034 (for determining CAT activity in the presence of ParB). 
 
4.3.2.2 CAT Assays: Impact of ParB binding (to parS1 and parS2) on Ppar and 
Prep activity 
In order to determine if ParB acts as a transcriptional repressor of the par and rep operon, CAT 
assays were performed using S. aureus RN4220 cells containing the co-resident plasmid/vector 
combinations described above. 
 
 
Specifically, cells were harvested from overnight cultures (containing IPTG) of strains harbouring 
pSK5483 and pJEG015, pJEG035 and pJEG015, pJEG036 and pJEG015, pJEG035 and pJEG034 
and pJEG036 and pJEG034 (Table 2.2). Soluble cellular lysates were then extracted from these 
cells (Section 2.5.4) and CAT assays were conducted as described in Section 2.8. The total protein 
concentration of each cellular lysate was also determined using the BCA assay method (Section 
2.5.5). Note that assays were performed in triplicate on three separate occasions and CAT activity 
is expressed as nmol of Cm acetylated per mg of soluble cellular protein per minute. Furthermore, 
background CAT activity, as determined using the strain containing pSK5483 (promoterless cat 
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gene) and pJEG015, was subtracted from the activities obtained for test strains. 
 
 
The results of the CAT assays are presented graphically in Figure 4.12 with mean values +/- 
standard deviation shown. Consistent with the prediction that ParB is a repressor of par 
transcription, through binding to the parS1 site, there was a significant difference in CAT activity 
measured for Ppar (via pJEG035) in the absence (pJEG015) and presence (pJEG034) of ParB. CAT 
activity measured for Prep (via pJEG036) also showed a significant difference in the absence and 
presence of ParB, which is also consistent with the prediction that ParB is a repressor of rep 
transcription. In combination, these results indicate that the predicted par promoter is functional 




Figure 4.11: Construction of pJEG029 Ppar- and Prep-reporter gene fusion plasmids and a 
ParB expression plasmid 
A schematic representation of the construction of pJEG035, pJEG036 and pJEG034, which were 
used for chloramphenicol acetyl transferase assays. The reporter vector pSK5483 was digested 
with BamHI and HindIII and used to clone similarly digested fragments of Ppar-parS1 and Prep-parS2 
upstream of a promoterless chloramphenicol resistance gene, to create plasmids pJEG035 (A) and 
pJEG036 (B), respectively. C. A SalI/BamHI fragment containing the pJEG029 parB gene was 
cloned into the MCS of the similarly digested expression vector pJEG015 to create plasmid 
pJEG034. Abbreviations: ApR/blaM, ampicillin resistance gene; cat, chloramphenicol resistance 
gene; gfp, green fluorescent protein gene; lacI, lac operon repressor; MCS, multi-cloning site; 
NmR, neomycin resistance gene; pGEM53f ori, pGEM53f origin of replication; pMB1 ori, pMB1 
origin of replication; pSK1 ori, pSK1 origin of replication; pSK41 ori, pSK41 origin of 
replication; Pspac, IPTG-inducible promoter/lac operator; To, transcriptional terminator zero; T1, 















































































































































































































































































Figure 4.12: CAT activity of the pJEG029 Ppar-parS1- and Prep-parS2-reporter gene fusion 
plasmids in the absence/presence of ParB 
A graphical representation of the CAT (chloramphenicol acetyl transferase) activity measured 
using the Ppar-parS1- and Prep-parS2-reporter fusion plasmids pJEG035 and pJEG036. The assays were 
performed as described in Section 4.1.4 in triplicate on three separate occasions. CAT activities 
of pJEG035 and pJEG036 were measured when co-resident with either pJEG015 (empty vector, 
coloured blue) or pJEG034 (pJEG015 + ParB, coloured red). The mean activities are shown, and 




























92 ± 4.8 
- ParB 
+ ParB 
54 ± 2.9 






















4.4.1 Transcriptional regulation of p107Apar 
Preliminary p107A ParB overexpression studies in E. coli revealed that the His6-ParB fusion 
protein (encoded by pJEG019) was more stably expressed, upon IPTG induction, in 
comparison to ParB-RGSHis6 (encoded by pJEG018). The reason for this is ultimately 
unknown but it may be due to the C-terminal tag sterically hindering ParB protein folding, as 
discussed above. In any case, His6-ParB was overexpressed and purified as described in Section 
4.2.1.3, in order to facilitate DNA binding studies. Note that while His6-ParB was not the only 
protein present in the final elution (Figure 4.3), the purity was sufficient for use in 
electrophoretic mobility shift assays (EMSAs); methods to improve purity in the future will be 
discussed in Chapter 6. 
 
 
Subsequently, EMSAs were performed using increasing concentrations of His6-ParB in order 
to examine binding to the putative parS region (Figure 4.4). In this regard, parS DNA 
complexes were evident with 80 - 160 ng of His6-ParB and complete binding was observed 
with 320 ng. In comparison, no complexes were observed with the non-specific DNA, thus 
confirming that ParB specifically binds to the predicted parS region. Not surprisingly, and 
consistent with the EMSA results, the CAT assays performed using the promoter-reporter 
fusion plasmids pJEG030 and pJEG031 revealed that ParB regulates the Ppar-parS promoter 
region (Figure 4.6). In combination, these results reflect what has been observed for the 
transcriptional regulation of Type Ib partitioning systems from other bacteria. 
4.4.2 Transcriptional regulation of pJEG029par 
In the case of the enterococcal system (pJEG029par), only a ParB-RGSH6 fusion protein 
construct could be made (pJEG039). Multiple attempts to make an N-terminal His-tag fusion 
protein were unsuccessful which could not be explained, but most likely due to a cloning 
problem. However, unlike in the case of p107A ParB, the pJEG029 ParB C-terminal His-tag 
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fusion protein was stably expressed upon IPTG induction and thus was subjected to 
purification, as described in Section 4.2.1.3, for use in EMSAs. Note that similar to the above 
section (4.4.1) ParB-RGSH6 was not the only protein present in the final elution (Figure 4.9), 
but again the purity was sufficient for EMSAs, which were performed using increasing 
concentrations of ParB-RGSH6 in order to examine binding to the putative parS regions located 
across both Ppar and Prep. In the case of both promoters, parS DNA complexes were evident 
with 160 ng of ParB-RGSH6 and complete binding was observed with 1 g. In comparison, 
while a single complex was observed with the non-specific DNA (160 ng - 1 g), no complete 
shift occurred, thus indicating that ParB specifically binds to the predicted parS regions. In 
support of these results, the CAT assays performed using the promoter-reporter fusion plasmids 
pJEG034, pJEG035 and pJEG036 revealed that ParB regulates both the Ppar- parS1 and Prep-parS2 
promoter regions (Figure 4.12). In combination, these results represent the first report of a ParB 
protein transcriptionally regulating a Type Ib partitioning system and its cognate replication 











Cytological studies have provided significant insights into the partitioning mechanisms of 
plasmids from rod-shaped bacteria, such as E.coli, but information about how partitioning 
occurs in cocci is currently very limited and not available for Type Ib systems. In this regard, 
very few research teams in the world are applying high-resolution fluorescence imaging to 
study cellular processes in coccoid organisms, which are complicated by their small size (1 μm 
diameter), spherical shape and, (in the case of S. aureus) alternating planes of division. 
 
 
In the experiments described below, green fluorescent protein (GFP)-fusion constructs were 
made using the E. coli-S. aureus shuttle vector pLOW-GFP in conjunction with the p107A par 
system; both parA (pJEG016; Table 2.2) and parB (pJEG024; Table 2.2) fusions were made in 
order to facilitate their visualisation in S. aureus cells. Subsequently, fluorescence microscopy 
via live cell imaging was used to determine if the GFP-Par fusion proteins exhibited dynamic 
in vivo movement and localisation towards the bacterial nucleoid, as what has been observed 
for rod-shaped organisms. In this regard, we also explored the functionality of this system in 
E. coli as an adjunct to our staphylococcal studies, as its rod shape and larger size, established 




5.2 Generation of constructs for fluorescence imaging 
 
5.2.1 Introduction 
For viewing cellular localisation patterns of ParA and ParB, with respect to the p107A Type Ib 
partitioning system, the approach was to introduce parA-gfp and parB-gfp constructs into cells 
that already contain a compatible plasmid that encodes the complete Type Ib par system. 
Without the wild-type ParA and ParB proteins present, polymerisation of a GFP-fusion protein, 
such as occurs for par system motor proteins, could be disrupted due to steric hindrance 
associated with the GFP tag. In this regard, note that co-resident plasmids encoding the Type 
Ib system or a Par protein fusion, must be compatible with respect to both the plasmid replicon 
and antibiotic selection marker. 
5.2.2 Generation of GFP-fusion constructs for visualising ParA localisation 
5.2.2.1 Construction of a parA-gfp plasmid for use in E. coli 
 
A fragment containing the parA gene from p107A was PCR amplified using primers GM37 
and GM38 (Table 2.6), which contain SalI and BamHI restriction sites, respectively, in order 
to facilitate C-terminal transcriptional fusion to the gfp gene. The amplicon was purified 
(Section 2.3.5) and then digested with SalI and BamHI (Section 2.3.7), before being purified 
again and ligated (Section 2.3.9) with the similarly digested E. coli-S. aureus shuttle plasmid 
pLOW-GFP (Table). The ligation was used to transform E. coli NEB5α cells to ampicillin 
resistance (Section 2.4.2) and selected transformants were initially screened by PCR using the 
same primers. Plasmid DNA was subsequently isolated from positive clones and presence of 
the insert confirmed by restriction digestion with SalI and BamHI (Section 2.3.7) and 
subsequent agarose gel electrophoresis. A single recombinant plasmid was sequenced (Section 
2.3.10) using primers GM37 and GM38 and named pJEG016 (Table 2.2; Figure 5.1). 
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Figure 5.1: Construction of a parA-gfp fusion plasmid for use in E. coli 
A schematic representation of the construction of pJEG016, which was used for cellular 
localisation studies in E. coli. A SalI/BamHI fragment containing the parA gene from p107A 
was cloned into the similarly digested shuttle vector pLOW-GFP, resulting in a transcriptional 
fusion to the gfp gene. Abbreviations: blaM, ampicillin resistance gene; ermC, erythromycin 
resistance gene; gfp, green fluorescent protein gene; lacI, lac operon repressor; pMB1 ori, 
pMB1 origin of replication; pSK41 ori, pSK41 origin of replication; Pspac, IPTG-inducible 































5.2.2.2 Live cell imaging of ParA-GFP in E. coli 
 
Prior to viewing the localisation of ParA in E. coli, the approach was to introduce pJEG016 
(Section 5.2.2.1) into cells that already harbour the compatible plasmid pJEG014, which 
contains the entire Type Ib par system (Section 3.2.1). However, prior to this, the viability of 
cells expressing ParA-GFP (via pJEG016 in isolation) was first examined. In this regard, it 
should be noted that the pJEG016 Pspac promoter controlling parA-gfp is constitutively 
expressed in E. coli. 
 
 
In any case, E. coli NEB5α cells containing pJEG016 were grown to mid-exponential phase at 
37°C and imaged using fluorescence microscopy (Section 2.10; Figure 5.2). As shown in 
Figure 5.2, it is clear that constitutive expression of ParA-GFP (via the Pspac promoter) in E. 
coli results in variable fluorescence patterns and a partial cell division defect, as indicated by 
elongated/filamentous cells. As a result of these findings, a construct that allows inducible 
expression of ParA-GFP in E. coli is required in order to appropriately assess the viability of 
such studies in a heterologous host, however this was not further pursued due to time 
constraints. 
5.2.2.3 Construction of a parA-gfp plasmid for use in S. aureus 
 
As described in Section 5.2.2.1, the parA gene from p107A was PCR amplified with primers 
GM37 and GM38 (Table 2.6), which contain SalI and BamHI restriction sites, respectively. 
These endonucleases were used to facilitate cloning into the similarly digested shuttle plasmid 
pJEG015 (Table 2.2), where a transcriptional fusion to the gfp tag was created at the C-terminal 
end of parA. Ligations containing the digested amplicon and vector plasmid were subsequently 
used to transform E. coli NEB5α cells to ampicillin resistance. Clones carrying recombinant 
plasmid DNA were confirmed by restriction digestion with SalI and BamHI and a single 
positive clone was sequenced with primers GM37 and GM38 (Table 2.6) and named pJEG017 
(Table 2.2; Figure 5.3). 
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Figure 5.2: Live cell imaging of constitutively expressed ParA-GFP in E. coli 
E. coli NEB5α cells carrying pJEG016, which encodes the parA-gfp fusion, were grown to 
mid-exponential phase (without IPTG induction) and imaged using fluorescence light 
microscopy. Fluorescence (top) and corresponding phase (bottom) images are shown. 
Constitutive expression of ParA-GFP results in a partial cell division defect as indicated by 







Figure 5.3: Construction of parA-gfp fusion plasmid for use in S. aureus 
A schematic representation of the construction of pJEG017, which was used for cellular 
localisation studies in S. aureus. A SalI/BamHI fragment containing the parA gene from p107A 
was cloned into the similarly digested shuttle vector pJEG015, resulting in a transcriptional 
fusion to the gfp gene. Abbreviations: blaM, ampicillin resistance gene; EmR, erythromycin 
resistance gene; gfp, green fluorescent protein gene; lacI, lac operon repressor; pMB1 ori, 
pMB1 origin of replication; pSK41 ori, pSK41 origin of replication; Pspac, IPTG-inducible 































5.2.2.4 Live cell imaging of ParA-GFP in S. aureus 
 
Based on the strategy described in Section 5.2 for examining ParA localisation in S. aureus, 
pJEG017 (parA-gfp) and pJEG015 (gfp; control plasmid) were used to separately transform S. 
aureus RN4220 cells containing pJEG001 (entire p107Apar region) by electroporation 
(Section 2.4.4). Subsequently, cells harbouring co-resident plasmids were grown at 37°C to 
mid-exponential phase with varying levels of IPTG induction (0, 0.1 and 1 mM) and imaged 
using fluorescence microscopy (Section 2.10; Figure 5.4). As shown in Figure 5.4, maximal 
induction of cells containing pJEG001 and pJEG015, via growth with 1 mM IPTG, resulted in 
low-level background fluorescence, as expected. In contrast, induction of cells containing 
pJEG001 and pJEG017 using 0.1 or 1 mM IPTG, resulted in observable localisation, most 
likely in association with the bacterial nucleoid. Although nucleoid staining was not performed 
on these cells, the fluorescent images are consistent with nucleoid position/shape and thus what 
has been observed for Type I ParA proteins in Gram-negative organisms i.e., localisation to the 
nucleoid. 
5.2.2.5 Effect of IPTG induction on ParA-GFP expression in S. aureus 
 
In order to determine if ParA-GFP expression impacts on p107Apar system functionality, the 
segregational stability of pJEG001 was examined in S. aureus RN4220 cells containing both 
pJEG001 and pJEG017. Plasmid segregational stability assays were performed on cells 
containing these plasmids (Section 2.7) grown in the presence of varying levels of IPTG 
induction (of ParA-GFP), and tetracycline selection for pJEG017. 
 
 
The stability assay results shown in Figure 5.5 indicate that expression of ParA-GFP had no 
impact on p107Apar stability (via pJEG001), as the percentage of cells retaining pJEG001 after 
30 generations was comparable at all levels of IPTG induction. The level of pJEG001 stability 
observed in Section 3.3.2, was also comparable to this result; data shown as dashed red lines 
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in Figure 5.5. It should be noted that while these results show ParA-GFP expression does not 
affect pJEG001 stability, they do not definitively demonstrate that ParA-GFP is directly 
mediating the partitioning process via interaction with the wild-type ParA and ParB proteins. 
In any case, the imaging performed in Section 5.2.2.4 in combination with these stability assay 
results confirmed the optimal level of IPTG induction to be 1 mM, and thus this level of 
induction was used for further microscopy analysis. 
5.2.3 Generation of GFP-fusion constructs for visualising ParB localisation 
5.2.3.1 Construction of a parB-gfp plasmid for use in S. aureus 
 
A fragment containing the parB gene from p107A was PCR amplified using primers GM39 
and GM40 (Table 2.6), which contain SalI and BamHI restriction sites, respectively, in order 
to facilitate C-terminal transcriptional fusion to the gfp gene (of pJEG015). The amplicon was 
purified (Section 2.3.5) and then digested with SalI and BamHI (Section 2.3.7), before being 
purified again and ligated (Section 2.3.9) with the similarly digested plasmid pJEG015 (Table 
2.2). The ligation was used to transform E. coli NEB5α cells to ampicillin resistance (Section 
2.4.2) and selected transformants were initially screened by PCR using the same primers. 
Plasmid DNA was subsequently isolated from positive clones and presence of the insert 
confirmed by restriction digestion with SalI and BamHI (Section 2.3.7) and subsequent agarose 
gel electrophoresis. A single recombinant plasmid was sequenced (Section 2.3.10) using 
primers GM39 and GM40 and named pJEG024 (Table 2.2; Figure 5.6). 
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Figure 5.4: Live cell imaging of ParA-GFP in S. aureus 
S. aureus RN4220 cells carrying pJEG001 with and without parA-gfp (pJEG017 and pJEG015, 
respectively), were grown to mid-exponential phase with 0, 0.1 and 1 mM IPTG induction and 
imaged using fluorescence light microscopy. Cells grown with 0.1 and 1 mM IPTG display 
observable ParA-GFP localisation, most likely associated with the nucleoid. A. Fluorescence 
images of cells at varying levels of IPTG induction. B. Corresponding phase images. Scale bars 
represent 1 µm. 
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Figure 5.5: Effect of ParA-GFP expression on pJEG001 segregational stability in S. 
aureus 
Segregational stability of pJEG001 in S. aureus RN4220 cells containing both pJEG001 and 
pJEG017. The stability of pJEG001 when ParA-GFP expression was induced with 0 mM (▲), 
0.1 mM (●) and 1 mM (×) IPTG was determined as described in Section 2.7. Data was 
normalised to 100% plasmid retention at generation 0. Percentage of cells retaining the plasmid 
was measured at 0, 12, 22 and 31 generations. Approximately 45% of cells retained pJEG001 
at all levels of IPTG induction after 30 generations and this was comparable to the level of 
pJEG001 stability observed in Section 3.3.2 (shown as dashed line; ■). pSK4833 (empty 
vector, dashed line; ♦) is also shown for comparison. Note that repeat assays were not 


























0 mM IPTG 
0.1 mM IPTG 
1 mM IPTG 

































Figure 5.6: Construction of parB-gfp fusion plasmid for use in S. aureus 
A schematic representation of the construction of pJEG024, which was used for cellular 
localisation studies in S. aureus. A SalI/BamHI fragment containing the parB gene from p107A 
was cloned into multi-cloning site of the similarly digested shuttle vector pJEG015, resulting 
in a transcriptional fusion to the gfp gene. Abbreviations: blaM, ampicillin resistance gene; gfp, 
green fluorescent protein gene; lacI, lac operon repressor; pMB1 ori, pMB1 origin of 
replication; pSK41 ori, pSK41 origin of replication; Pspac, IPTG-inducible promoter/lac 
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5.2.3.2 Live cell imaging of ParB-GFP in S. aureus 
 
To determine if ParB-GFP and any bound plasmid via parS sites also localises to the bacterial 
nucleoid, plasmid pJEG024 (parB-gfp) was used to transform S. aureus RN4220 cells 
harbouring either pJEG001 (entire p107Apar region) or pJEG006 (parB mutant) by 
electroporation (Section 2.4.4). Cells containing these plasmid combinations were 
subsequently grown at 37°C to mid-exponential phase with 1 mM IPTG induction and imaged 
using fluorescence microscopy (Section 2.10; Figure 5.7). As shown in Figure 5.7A, maximal 
induction of cells containing pJEG001 and pJEG024, via growth with 1 mM IPTG, resulted in 
observable localisation to the bacterial nucleoid, which reflects a similar association to that of 
ParA-GFP and the nucleoid (Section 5.2.2.4). Similarly, cells containing plasmids pJEG006 
and pJEG024 also exhibited observable localisation towards the bacterial nucleoid with 1 mM 
IPTG induction (Figure 5.7B). As such, these results suggest that even in the absence of wild- 
type ParB, ParB-GFP is able to bind to ParA and co-localise to the nucleoid. 
5.2.3.3 Effect of IPTG induction on ParB-GFP expression in S. aureus 
 
In order to determine if ParB-GFP expression impacts on functionality of the p107Apar system, 
the segregational stability of pJEG001 was examined in S. aureus RN4220 cells containing 
both pJEG001 and pJEG024. Plasmid segregational stability assays were performed on cells 
containing these plasmids (Section 2.7) grown in the presence of varying levels of IPTG 
induction (of ParB-GFP), and tetracycline selection for pJEG024. 
 
 
The stability assay results shown in Figure 5.8 indicate that expression of ParB-GFP in the 
presence of varying levels of IPTG induction (0.1, 0.5 and 1 mM) negatively impacted 
p107Apar stability (of pJEG001), as the percentage of cells retaining pJEG001 at 20 
generations was comparable to cells containing the empty vector control (pSK4833 – data 
shown as dashed blue line; Figure 5.8). It is interesting to note that although clear nucleoid 
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localisation of ParB-GFP was observed with 1 mM IPTG induction, which is reflective of 
ParB-ParA interaction, functionality was significantly impacted indicating that the C-terminal 
GFP tag either disrupts parS binding, ParA hydrolysis of ATP, or ParA-ParA interaction. It 
should also be noted that due to the observed plasmid loss no repeat assays were performed. 
5.2.4 Generation of a TetR-GFP/tetO array system for visualising plasmid localisation 
5.2.4.1 Construction of a tetO plasmid for use in S. aureus 
 
The tetracycline operator (tetO) array from pLAU44 is a ~ 9 kb region containing two tetO 
arrays (Lau et al., 2003). In order to minimise the size of DNA fragment being introduced into 
the vector, the fragment containing a tetracycline operator (tetO) array from pLAU44 (Table 
2.2) was PCR amplified using primers GM41 and GM42 (Table 2.6). The amplicon was 
purified (Section 2.3.5) and electrophoresed on an agarose gel (Section 2.3.2) revealing a 4.0 
kb fragment, which contained one array of tetO operators. This fragment was subsequently gel- 
purified (Section 2.3.5) and then digested with KasI (Section 2.3.7), to further reduce the tetO 
array size to approximately 2 kb.  Following agarose gel electrophoresis of this digestion, the 
2 kb fragment was purified and ligated (Section 2.3.9) to the KasI-digested and 
dephosphorylated (Section 2.3.8) ends of pJEG001 (Table 2.2). The ligation reaction was then 
used to transform E. coli DH5α cells to ampicillin resistance (Section 2.4.2) and plasmid DNA 
was isolated from selected transformants (Section 2.3.1). Clones carrying recombinant plasmid 
DNA were confirmed by restriction digestion with KasI (Section 2.3.7) and agarose gel 
electrophoresis. Based on the presence of a 2 kb insert, a single recombinant plasmid was 
named pJEG037 (Table 2.2; Figure 5.9). 
162  
Figure 5.7: Live cell imaging of ParB-GFP in S. aureus 
S. aureus RN4220 cells carrying pJEG024 with pJEG001 or pJEG006 (wild-type p107Apar 
and parB mutant derivative, respectively), were grown to mid-exponential phase with 1 mM 
IPTG induction and imaged using fluorescence confocal microscopy; note that nucleoids are 
stained with DAPI. Ai-ii. Fluorescence images of cells containing pJEG001 and pJEG024 that 
show observable localisation of ParB-GFP, in the presence of wild-type ParB (via pJEG001), 
towards the bacterial nucleoid. Bi-ii. Fluorescence images of cells containing pJEG006 and 
pJEG024 that show similar localisation of ParB-GFP in the presence of truncated ParB (ParB- 
S53fsX57; encoded by pJEG006). Cells shown in (i-ii) for each of (A) and (B) represent 
biological replicates. From left to right: Nucleoid; ParB-GFP; overlay of both. Scale bars 




























































Figure 5.8: Effect of ParB-GFP expression on pJEG001 segregational stability in S. 
aureus 
Segregational stability of pJEG001 in S. aureus RN4220 cells containing both pJEG001 
and pJEG024. The stability of pJEG001 when ParB-GFP expression was induced with 0 
mM (▲), 0.1 mM (●), 0.5 mM (■) and 1 mM (×) IPTG was determined as described in 
Section 2.7. Data was normalised to 100% plasmid retention at generation 0. Percentage of 
cells retaining the plasmid was measured at 10 and 20 generations. Approximately 20% of 
cells retained pJEG001 with 0.1 mM IPTG induction, while plasmid retention was 
completely lost with 0.5 mM and 1 mM IPTG and comparable to the empty vector control 
pSK4833 (blue dashed line). In contrast, approximately 60% of cells retained pJEG001 in 
the absence of IPTG induction. Note that repeat assays were not performed due to the 
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Figure 5.9: Construction of a tetO array plasmid using pJEG001 
A schematic representation of the construction of pJEG037, which was used for cellular 
localisation studies in S. aureus. A KasI-digested fragment containing a tetO array was cloned 
into the similarly digested vector pJEG001, to create plasmid pJEG037. Abbreviations: bla, 
ampicillin resistance gene; ermC, erythromycin resistance gene; MCS, multi-cloning site; pSK1 


































5.2.4.2 Live cell imaging of TetR-GFP in S. aureus 
 
The tetO array in pJEG037 provides multiple binding sites for the fluorescently-tagged 
repressor protein TetR, and together they form a fluorescent repressor-operator system (FROS) 
(Robinett et al., 1996) that can be used for studying plasmid localisation in live S. aureus cells. 
As such, the plasmid pSK9142 (containing tetR-gfp; Table 2.2) was used to transform S. aureus 
RN4220 cells harbouring pJEG037 (Section 5.2.4.1) by electroporation (Section 2.4.4). 
Tagging of a plasmid in this way facilitates tracking of movement over time and has been 




Cells containing the co-resident plasmids were grown at 37°C to mid-exponential phase with 
1 mM IPTG induction and imaged using fluorescence microscopy (Section 2.10; Figure 5.10). 
As shown in Figure 5.10A, induction of cells containing pJEG037 and pSK9142 using 1 mM 
IPTG resulted in observable plasmid localisation, compared to cells without IPTG induction. 
These preliminary images show single foci in most cells and in some instances two foci within 
a cell, which is indicative that this tagging system may be an appropriate way of studying 
plasmid localisation in context of p107Apar functionality. Note that initial time-lapse imaging 
was also performed, and this clearly showed that foci were not static and displayed movement 
within a cell (Figure 5.10B). 
5.2.4.3 Effect of TetR-GFP expression on p107Apar functionality in S. aureus 
 
In order to determine if TetR-GFP expression impacts on p107Apar functionality, the 
segregational stability of pJEG037 was examined in S. aureus RN4220 cells containing both 
pJEG037 and pSK9142. Initially, plasmid segregational stability assays were performed on 
cells containing these plasmids (Section 2.7) grown in the presence of 1 mM IPTG induction 
(of TetR-GFP), and  neomycin  selection  for pSK9142 (data not  shown).  Unfortunately, the 
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stability assay results showed that pJEG037 was significantly destabilised under these 
conditions, as the plasmid was lost from the cell population after 10 generations. Thus, the 
maximal level of IPTG induction severely impacts p107Apar functionality despite cells 
displaying distinct plasmid localisation foci (Section 5.2.4.2). 
 
 
Therefore, the next approach was to determine a level of induction where functionality was not 
affected prior to exploring plasmid localisation via microscopy. In this regard, stability assays 
were then performed on RN4220 cells containing pJEG037 and pSK9142 in the presence of 
varying levels of IPTG induction (0, 0.1, 0.5 and 1 mM IPTG), and neomycin selection for 
pSK9142 (Figure 5.11). This time, the stability assay results shown in Figure 5.11 indicate that 
expression of TetR-GFP at all levels of IPTG induction negatively impacts p107Apar function. 
Therefore, the use of this tagging system, under the conditions tested, is not a viable option for 
studying/visualising how p107Apar increases plasmid stability. 
5.3 Cellular localisation studies of ParA-GFP fusions in S. aureus 
 
5.3.1 Introduction 
As described above in Section 5.2, constructs generated for cellular localisation studies 
involving expression of ParB-GFP or TetR-GFP (as part of a FROS) significantly impaired 
p107Apar functionality despite showing promise based on initial imaging experiments. In 
comparison, initial studies exploring ParA-GFP expression/functionality in S. aureus revealed 
a viable option for additional imaging experiments that explore the mechanism employed by 
Type Ib systems to segregate plasmids in coccoid cells. Therefore, in the below sections, 
fluorescence imaging via confocal microscopy was used to further investigate ParA-GFP 
localisation under a variety of conditions. 
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5.3.2 Plasmid combinations for studying ParA-GFP cellular localisation 
Prior to conducting investigations using our ParA-GFP construct (pJEG017), various plasmid 
combinations were introduced into S. aureus RN4220 cells as described in Table 5. These 
plasmids comprised control vectors and existing mutant derivatives of pJEG001. 
 
 
Table 5: Plasmid combinations used for localisation studies in S. aureus 
 
Plasmid Combination Relevant Genotype 
 
pSK4833 + pJEG017 
 
parA-gfp 
pJEG001 + pJEG015 p107AparIb + gfp 
pJEG005 + pJEG015 p107AparIb-parAK15T + gfp 
pJEG001 + pJEG017 p107AparIb + parA-gfp 
pJEG005 + pJEG017 p107AparIb-parAK15T + parA-gfp 
pJEG006 + pJEG017 p107AparIb-parBL53fsx57 + parA-gfp 
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Figure 5.10: Live cell imaging of TetR-GFP in S. aureus 
S. aureus RN4220 cells carrying pJEG037 (pJEG001 + tetO array) and pSK9142 (tetR-gfp), 
were grown to mid-exponential phase in the absence and presence of 1 mM IPTG and imaged 
using fluorescence light microscopy. A. Cells with maximal IPTG induction show plasmid 
localisation, where foci can be observed within individual coccoid cells. White arrows 
indicate single foci within a cell and white arrowheads indicate cells with two plasmid foci. 
B. Time- lapse phase/fluorescence images of cells containing pJEG037 and pSK9142 with 
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Figure 5.11: Effect of TetR-GFP expression on pJEG037 segregational stability in S. 
aureus 
Segregational stability of pJEG037 in S. aureus RN4220 cells containing both pJEG037 and 
pSK9142. The stability of pJEG037 when TetR-GFP expression was induced with 0 mM 
(▲), 
0.1 mM (●), 0.5 mM (■) and 1 mM (×) IPTG was determined as described in Section 2.7. 
Data was normalised to 100% plasmid retention at generation 0. Percentage of cells retaining 
the plasmid was measured at 8, 18 and 28 generations. Approximately 35% of cells retained 
pJEG037 in the absence of IPTG induction, while plasmid retention was completely lost 
with all levels of IPTG induction (0.1 mM, 0.5 mM and 1 mM IPTG). In contrast, 
approximately 45% of cells retained pJEG037 (dashed line; ●) in the absence of IPTG 
induction and TetR- GFP. Note that repeat assays were not performed due to the observed 




















































5.3.3 Live cell fluorescence imaging of ParA-GFP using confocal microscopy 
Cells harbouring the plasmid combinations described in Table 5 were grown at 37°C to mid- 
exponential phase with 1 mM IPTG and imaged using fluorescence confocal microscopy 
(Section 2.10; Figure 5.12); note that nucleoids were also visualised via DAPI staining. As 
originally observed in Figure 5.4, ParA-GFP, in the presence of wild-type p107Apar 
(pJEG001), appears to localise to the nucleoid and this is supported by the staining of 
chromosomal DNA with DAPI (Figure 5.12C). Not surprisingly, as ParA is predicted to non- 
specifically bind DNA (Bouet et al., 2007), ParA-GFP also localises to the nucleoid (at least to 
some extent) in the absence of the complete system (Figure 5.12B). In contrast, the GFP tag 
(when not fused to ParA), displays diffuse fluorescence even in the presence of p107Apar 
(pJEG001). In this regard, GFP appears most concentrated in the space between nucleoids 
(Figure 5.12A). Also, in the context of mutant ParA (ParAK15T) and ParB (ParBS53fsX57) 
proteins, supplied in trans via the pJEG001 mutant derivative plasmids pJEG005 and pJEG006, 
respectively, ParA-GFP still displayed localisation towards the nucleoid (Figure 5.12D-E). 
This is again not surprising as ParA is predicted to non-specifically bind DNA (in the absence 
of other proteins) and overall the observed localisation behaviour is consistent with what has 
been revealed for Type I plasmid partitioning systems in rod-shaped organisms (Vecchiarelli 
et al., 2010). Note that attempts to introduce the K15T mutation into the GFP tagged version 
of ParA were unsuccessful. 
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Figure 5.12: Live cell imaging of ParA-GFP in S. aureus with varying p107Apar genotypes 
S. aureus RN4220 cells expressing ParA-GFP via pJEG017 with plasmids containing 
p107Apar or mutant derivatives, were grown to mid-exponential phase with 1 mM IPTG 
induction and imaged using fluorescence confocal microscopy. Ai-iii. Cells containing 
pJEG001 (p107Apar wild-type) and pJEG015 (no parA-gfp); shows no localisation of GFP 
towards the bacterial nucleoid. Bi-iii. Cells containing pSK4833 (no p107Apar) and pJEG017 
(parA-gfp); shows localisation (at least to some extent) of ParA-GFP towards the bacterial 
nucleoid. Ci-iii. Cells containing pJEG001 and pJEG017 showing clear association of ParA- 
GFP with the bacterial nucleoid; similar results are also shown in D and E. Di-iii. Cells 
containing pJEG005 (parA-K15T) and pJEG017. Ei-iii. Cells containing pJEG006 (parB- 
S53fsX57) and pJEG017. Cells shown in i-iii for each of (A), (B), (C), (D) and (E) represent 
biological replicates. From left to right: Nucleoid; GFP/ParA-GFP; overlay of both. Scale bars 
represent 1 µm. 
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E. p107Apar-ParBS53FSX57 + ParA-GFP 
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Nucleoid ParA-GFP Overlay 
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5.3.4 Effect of ParA-GFP expression on pJEG005 stability in S. aureus 
In order to determine if ParA-GFP expression rescues functionality of the p107Apar system in 
the absence of wild type ParA, the segregational stability of pJEG005 was examined in S. 
aureus RN4220 cells containing both pJEG005 and pJEG017. Plasmid segregational stability 
assays were therefore performed on cells containing these plasmids (Section 2.7) grown in the 




The stability assay results shown in Figure 5.13 indicate that expression of ParA-GFP partially 
rescues pJEG005 stability, as the percentage of cells retaining pJEG005 after 30 generations 
was 30%, compared to 60% for pJEG001 (wild type ParA) in the presence/absence of ParA- 
GFP (dashed lines, Figure 5.13). In contrast, pJEG005 is lost from the cell population after 30 
generations in the absence of ParA-GFP (green triangle; Figure 5.13). In context of the 
observed partial rescue, it is conceivable that functionality of ParA-GFP is impaired due to 
interaction with ParAK15T (encoded by pJEG005), which is likely unable to bind and hydolyse 
ATP. In the future, a ParA truncation/deletion mutant could be generated to overcome this 
potential issue. 
5.3.5 Time-lapse fluorescence imaging of ParA-GFP 
To determine if ParA displays dynamic in vivo movement when associated with the bacterial 
nucleoid, time-lapse fluorescence confocal microscopy was performed using S. aureus cells 
harbouring pJEG017 (parA-gfp) with either pJEG001 (p107Apar) or pSK4833 (empty vector 
control). Cells were prepared as described in Section 2.10 and ParA-GFP expression was 
visualised (via induction with 1 mM IPTG) and imaged at 14 second intervals for up to two – 
three minutes (Figure 5.14). 
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The series of micrographs presented in Figure 5.14A depicts localisation of ParA-GFP in the 
presence of wild-type p107Apar (via pJEG001) and movement of fluorescent foci is indicated 
by the white arrows. Based on these images, it is clear that ParA-GFP displays dynamic 
movement over the timecourse of 126 seconds. In contrast, while cells expressing ParA-GFP 
in the absence of wild-type p107Apar revealed observable localisation to the nucleoid, little to 
no dynamism was evident over the longer timecourse of 196 seconds (Figure 5.14B). In the 
context of Type I partitioning systems, ParB binding to ParA has been shown to enhance ATP 
hydrolysis and thus ParA movement (Vecchiarelli et al., 2010). With no ParB present to 
enhance the polymerisation of ParA, white arrows shown at 56 s, 126 s, and 196 s result in no 
movement of plasmid foci or GFP fluorescence. This result further confirms that ParA displays 
dynamic movement within the cell when in the presence of the p107Apar components for full 
functionality. 
5.3.6 ParA-GFP fluorescence recovery after photobleaching (FRAP) 
As described in the above section (5.3.5), ParA-GFP exhibited dynamic movement in the 
presence of p107Apar. To determine if the observed nucleoid associated dynamism involves 
rapid exchange of ParA molecules (potentially with a cytoplasmic pool), S. aureus cells 
harbouring pJEG001 and pJEG017 were again grown to mid-exponential phase with 1 mM 
IPTG and imaged using time-lapse fluorescence confocal microscopy (Section 2.10; Figure 
5.15). Subsequently, cells within a region of interest (ROI) were photobleached using a 488 
nm laser at high power for one iteration; photobleaching occurred at 48 seconds and recovery 
of fluorescence within the ROI was monitored by imaging every 16 seconds for eight minutes. 
As shown in Figure 5.15, ParA-GFP fluorescence recovered quickly, with new fluorescent foci 
visible within 16 seconds post bleaching. During the remainder of the timecourse experiment 
these foci increased in numbers and displayed rapid movement in association with the nucleoid 
(white arrows; Figure 5.15). 
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Figure 5.13: Effect of ParA-GFP expression on pJEG005 segregational stability in S. 
aureus 
Segregational stability of pJEG005 in S. aureus RN4220 cells containing both pJEG005 and 
pJEG017. The stability of pJEG005 when ParA-GFP expression was induced with 1 mM IPTG 
was determined as described in Section 2.7. Data was normalised to 100% plasmid retention at 
generation 0. Percentage of cells retaining the plasmid was measured at 10, 20 and 30 
generations. Approximately 30% of cells retained pJEG005 in the presence of ParA-GFP 
(pJEG017, ■) while plasmid retention was completely lost in its absence (pJEG015, ▲). In 
contrast, approximately 60% of cells retained pJEG001 in the presence (dashed line; ●) or 
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Figure 5.14: Time-lapse imaging of ParA-GFP in S. aureus 
S. aureus RN4220 cells carrying pJEG017 (ParA-GFP) with p107Apar (pJEG001; A) or 
without p107Apar (pSK4833; B) were grown to mid-exponential phase and imaged using 
fluorescence confocal microscopy. Expression of ParA-GFP was induced with 1 mM IPTG and 
cells were imaged every 14 seconds. (A) Cells expressing ParA-GFP resulting in observable 
localisation and dynamic movement of fluorescent foci (indicated by white arrows) in the 
presence of wild-type p107Apar; movement continued throughout the 126 s duration. 
(B) Cells expressing ParA-GFP resulting in observable localisation but no dynamic movement 
of fluorescent foci in the absence of wild-type p107Apar; white arrows at 56 s, 126 s and 196 
s indicate no movement within cells. Bottom frames from left to right: Nucleoid and overlay 
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Figure 5.15: Fluorescence recovery after photobleaching (FRAP) analysis of ParA-GFP 
in S. aureus 
S. aureus RN4220 cells carrying pJEG017 (ParA-GFP) and pJEG001 (p107Apar) were grown 
to mid-exponential phase with 1 mM IPTG and imaged (every 16 seconds) using fluorescence 
confocal microscopy. Selected cells expressing ParA-GFP were photobleached using a 488 nm 
laser line at high power for one iteration at 48 s. FRAP was subsequently monitored by imaging 
cells every 16 seconds for a duration of eight minutes and recovery was evident within 16 s 
(see 64 second timepoint). Arrows indicate fluorescent foci of ParA-GFP displaying dynamic 
movement after photobleaching. Bottom frames from left to right: Nucleoid and overlay (of 
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In this chapter the cell biology of the staphylococcal Type Ib partitioning system was largely 
examined using various Par-GFP fusion proteins, such as ParA-GFP and ParB-GFP, in 
conjunction with confocal laser scanning fluorescence microscopy. 
5.4.1 Localisation of ParA-GFP in E. coli 
The use of fluorescence imaging to study cellular processes in staphylococci is complicated by 
its small size (1 µm), spherical shape and alternating planes of division. Therefore, E. coli was 
trialled as an alternative host, as its rod shape and larger size make it a more amenable host for 
studying the localisation patterns of Par-GFP fusion proteins. 
 
 
The segregational stability assay results described in Chapter 3 (see Figure 3.1) indicated that 
p107Apar is in fact functional in E. coli, however, live cell imaging of ParA-GFP (via 
pJEG016) revealed irregular bright fluorescence in a limited number of cells (Figure 5.2). 
Many of the cells also appeared to be filamentous, indicating that maximal expression of the 
ParA-GFP fusion protein (via the Pspac promoter) results in a cell division defect. In E. coli, the 
Pspac promoter cannot be controlled, unlike in S. aureus, therefore the use of an inducible 
promoter, such as the Ptac  promoter, would better facilitate future studies in E. coli. 
5.4.2 Localisation of ParA-GFP in S. aureus 
In parallel to the E. coli experiments, ParA-GFP localisation in S. aureus cells was examined 
using varying levels of IPTG induction (Figure 5.4). In this regard, localisation reflected the 
bacterial nucleoid and this is consistent with what has been observed for Type I ParA proteins 
in Gram-negative organisms (i.e., localisation to the nucleoid). Segregational stability assays 
also confirmed that ParA-GFP expression (via pJEG017), at all levels of IPTG induction tested, 
did not affect the stability of a plasmid (pJEG001) containing wild-type p107Apar, thus 
pJEG017 represented a workable construct for further imaging of ParA-GFP. 
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As such, confocal laser scanning fluorescence microscopy techniques were performed using S. 
aureus cells containing pJEG017 and pJEG001 (or mutant derivatives thereof) in order to 
further examine the cellular localisation of ParA and determine if it exhibits dynamic 
movement. Firstly, live cell static imaging of ParA-GFP revealed observable localisation to the 
bacterial nucleoid, similar to related proteins in Gram-negative rod-shaped bacteria (Bouet et 
al., 2007). Likewise, with the pJEG001 mutant derivatives (ParA-K15T or ParB-S53fsX57; as 
shown in Figure 5.12), ParA-GFP displayed a similar localisation pattern, which was expected 
as these mutant proteins should not affect its association with the nucleoid. 
 
 
Subsequently, time-lapse microscopy was performed on cells containing ParA-GFP (pJEG017) 
and wild-type p107Apar (pJEG001), and this revealed that ParA exhibits dynamic movement 
in association with the nucleoid (see Figure 5.14). Interestingly, in the absence of p107Apar, 
ParA-GFP did not display dynamic movement, as fluorescent foci remained relatively static. 
This suggests that ParA requires ParB for such movement to occur and this is consistent with 
previous reports stating that ParB enhances ParA ATP hydrolysis (Vecchiarelli et al., 2013), 
which drives its movement. Note that time-lapse imaging was not performed on cells 
containing ParA-GFP and ParB-S53fsX57 (via pJEG006), however this could be done in the 
future to confirm that ParB is required to enhance ParA ATP hydrolysis. 
 
 
Cells expressing ParA-GFP and p107Apar (pJEG001) were then subjected to photobleaching 
in order to confirm the observed ParA dynamism. This revealed that after one iteration of 
bleaching cells at high power, fluorescence recovered quickly indicating dynamic movement 
of ParA-GFP within cells (Figure 5.15). Similar studies using FRAP in E. coli have also shown 
dynamic movement of ParA-like proteins (Roberts et al., 2012). It should be noted that FRAP 
experiments were difficult to perform on S. aureus cells due to their small size (1 µm), 
particularly with respect to looking at sections within a cell. In any case, future work should 
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involve replicate experiments and imaging of ParA-GFP recovery in the absence of ParB. 
5.4.3 Localisation of ParB-GFP expression in S. aureus 
Cell imaging of ParB-GFP with maximal IPTG induction revealed observable localisation to 
the bacterial nucleoid in the presence of wild-type p107Apar, similar to that of ParA-GFP 
(Figure 5.7). However, as revealed by preliminary segregational stability assays, the fusion 
protein had a negative effect on par functionality at all levels of IPTG induction tested. This is 
most likely be due to the GFP tag at the C-terminal end disrupting ParB functionality, either by 
hindering protein folding, interaction with itself or ParA, or ATP hydrolysis; note that at least 
some interaction with ParA must occur as it co-localises to the nucleoid. These results are also 
consistent with the ParB overexpression studies (Chapter 4), where the ParB-His fusion protein 
was not stably expressed. In any case, no further cellular studies were performed using this 
fusion protein and future studies may require adding a fluorescent tag to the ParB N- terminal 
end. 
5.4.4 Localisation of TetR-GFP in S. aureus 
A different approach to studying the cell biology of the Type Ib system was to utilise FROS 
(fluorescent repressor-operator system) for plasmid localisation in S. aureus. In this case, a 
plasmid containing p107Apar and a tet operator, tetO (via pJEG037), was combined with 
pSK9142, which encodes the repressor counterpart, TetR, with a GFP tag. Fluorescence 
imaging of cells containing these co-resident constructs showed observable plasmid foci upon 
maximal IPTG induction as shown in Figure 5.10. Further time lapse imaging of these cells 
also confirmed this result, indicating FROS may be suitable for studying cellular localisation 
of the Type Ib system in S. aureus. However, similar to the case for ParB-GFP, segregational 
stability assays revealed that expression of TetR-GFP had a negative effect on par functionality 








Most naturally occurring low-copy multiresistance plasmids, including those from 
staphylococci and enterococci, utilise an active plasmid partitioning system (as part of a 
broader maintenance toolkit) to ensure that plasmid copies are efficiently segregated into 
daughter cells during bacterial cell division. Generally, these systems encode a centromere-like 
site, a DNA-binding protein and a motor protein (NTPase) (Schumacher, 2008). Currently, 
there are three characterised types of partitioning systems (Types I-III), which differ according 
to the type of NTPase and DNA-binding protein that they encode. 
 
 
Type Ib plasmid partitioning systems have been identified on a number of plasmids associated 
with Gram-negative bacteria and possess a Walker-type ATPase motor protein (ParA), a DNA- 
binding protein (ParB) with a RHH domain fold and a cis-acting centromere-like site (parS) to 
which ParB binds. Although Type Ib systems have been well characterised in such organisms, 
they have been studied to a much lesser extent in Gram-positive organisms, and in relation to 
staphylococcal and enterococcal plasmids, they have hardly been studied at all. 
 
 
In this chapter, results will be collectively discussed in the context of existing literature and 
understanding the Type Ib partitioning mechanisms that plasmids p107A and pJEG029 utilise. 
Understanding the mechanistic details illuminated by this research will potentially provide 
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opportunities for the development of targeted interventions aimed at disrupting plasmid 
carriage in these important hospital pathogens, which would ultimately impact the spread of 
antimicrobial resistance. 
6.2 Staphylococcal Type Ib plasmid partitioning systems 
As described above, there has been little to no exploration of Type Ib partitioning systems in 
Gram-positive organisms, and no studies have been conducted using staphylococci. In the 
context of the latter, imaging studies are complicated by their small size (1 μm diameter), 
spherical shape and alternating planes of division; successive division rounds are orthogonal 
(Stamsas et al., 2018). Therefore, this research addresses a serious gap in our understanding of 
how Type Ib partitioning systems function in coccoid shaped bacteria. 
6.2.1 Functional significance 
As investigated in Chapter 3, the putative p107A Type Ib plasmid partitioning system 
(p107Apar) increased plasmid stability as illustrated by the segregational stability assays 
shown in Figure 3.2. Additionally, the requirement of the individual proteins (ParA and ParB) 
for functionality was confirmed via the generation of mutant derivatives using SDM. The ParA 
protein is a member of the Walker-type ATPase family, and the lysine residue at codon 15 of 
parA was targeted as it has been previously shown to be essential for ATP binding (Vecchiarelli 
et al., 2013); it is highly conserved in the variant Walker A motif of other ATPase proteins 
such as ParF of the E. coli plasmid pTP228 (Barilla et al., 2005). In the case of ParB, the RHH 
fold is predicted to interact with parS DNA-binding sites, therefore to ensure functional 
disruption, as shown in Figure 3.2, a frameshift mutation was introduced at the N-terminal end. 
(Ringgaard et al., 2007) conducted similar mutational studies with truncated versions of ParB 
from plasmid pB171 and showed that the binding of ParB to parS DNA significantly enhanced 
the polymerisation of ParA. As such, these results support the conclusion that both Par proteins 
are required for efficient plasmid segregation. 
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In general, ParB proteins of Type I partitioning systems regulate their cognate par operons at 
the transcriptional level via binding to the upstream parS site. Such binding has been observed 
for SopB from the F plasmid (Type Ia; Schumacher, 2008) and ParG from plasmid pTP228 
(Type Ib; Golovanov et al., 2003), and also facilitates formation of the partition complex, which 
enhances ParA ATP hydrolysis. Therefore, ParB functionality was investigated for p107Apar. 
 
 
As described in Chapter 4, the ParB protein was more stably expressed with an N-terminal 
His6-fusion tag, and a possible explanation for this is that a tag at the C-terminal end causes 
steric hindrance and some degree of protein misfolding. Nevertheless, the N-terminal His tag 
fusion protein was used to facilitate DNA binding studies, where specific binding of ParB to 
parS DNA was observed via gel mobility shift assays (Section 4.2.1.2-4.2.1.3). Such binding 
of ParB to the predicted parS site is consistent with what has been previously observed for ParB 
homologs, such as ParG from pTP228 (Golovanov et al., 2003). Furthermore, chloramphenicol 
acetyltransferase (CAT) assays confirmed this specific binding through the use of promoter-
reporter fusion plasmids, revealing that ParB regulates the Ppar-parS promoter region (Section 




As mentioned in Section 4.4.1, the final elution of His6-ParB used for gel mobility shift assays 
did not contain the protein solely - the purity was adequate for use, revealing the specific 
binding of ParB to the parS region. Although these DNA-binding studies exhibit the role of 
ParB, methods to improve and further delineate the mechanistic role are essential to increase 
understanding of Type Ib partitioning systems. Rabbit polyclonal p107A ParB antibodies were 
synthesised and used to detect ParB overexpression (Section 4.2.1.2). To ensure that His6-
ParB alone binds to parS, purification of ParB via antibody affinity chromatography under both 
native and denaturing conditions using the synthesised antibodies, would ensure a pure protein 
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fraction for DNA-binding experiments such as DNase I footprinting. Additionally, gel mobility 
shift assays in this study were performed using ethidium bromide for detection, whereas the 
conventional method of radioactive labelling DNA fragments for protein binding detection is 
more common. Antibody-purified His6-ParB protein would be ideal for EMSA experiments 
using radiation as a means for detecting specific binding interactions. These combined 
experiments would confirm that ParB specifically binds to parS (as expected) and delineate the 




Furthermore, crystallization of Type Ib ParB proteins from both Gram-positive and Gram- 
negative bacteria has revealed the segresome structure and interactions with their ParA protein 
counterparts, as has previously been revealed for the Type II partitioning system of the 
staphylococcal plasmid pSK41 (Schumacher et al., 2007). The RHH domain has been 
identified in DNA-binding proteins of both Type Ib and Type II partitioning systems, however, 
a study by Huang et al. (2011) revealed the structural alignment of ParB is more similar to 
Type Ib DNA-binding proteins than to Type II. Crystallization of the p107A Type Ib ParB 
protein has not been attempted, and so obtaining the crystal structure of the ParB bound to parS 
DNA would increase a mechanistic understanding of the DNA-binding motif as a result of the 
dimeric RHH structure it possesses. As an adjunct to this study, ParB-ParA interactions could 
be further explored by trying to co-crystalize both proteins or use the yeast/bacterial two-hybrid 
system (Jensen and Gerdes, 1997). Once interacting amino acids have been identified, site- 
directed mutagenesis can then be performed on these targets and resultant functionality 
examined via segregational stability assays. 
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Although the mechanistic role of ParA in mediating plasmid partitioning via dynamic filament 
movement was explored, ATP hydrolysis was not investigated due to time restrictions. 
However, as the p107A ParA protein is a putative member of the Walker-type ATPase ParA 
superfamily, it would be very interesting to assess the ATPase activity of ParA in vitro by 
cloning the parA gene into the same E. coli overexpression plasmids (N-terminal and C- 
terminal His tags) as described in Chapter 4. Using purified ParA protein via the same methods 
for ParB purification, the ATPase activity of ParA can be determined using established ATPase 
assay systems. Studies by Bouet et al. (2007), observing the ATP hydrolytic activity of SopA 
of the F plasmid, have revealed that hydrolysis of SopA is stimulated by SopB bound with 
DNA at high concentrations, which in turn would increase depolymerisation. In contrast, with 
high local concentrations of SopB taking up free DNA, SopA can be stimulated on its own to 
polymerise and drive the partition reaction (Bouet et al., 2007). Likewise with observing the 
ATP hydrolysis of the ParA protein from the P1 plasmid, the ParA-ParB interactions provide 
a suitable explanation for proposing the diffusion-ratchet model of partitioning due to the 
oscillatory patterns observed in other partition systems (Vecchiarelli et al., 2010). Taking this 
into account, we would expect to observe similar results and resort to the same conclusions 
when exploring the role of the Type Ib ParA protein. 
6.2.2 Cell biology studies 
From a mechanistic perspective, the roles of ParA and ParB from p107A seem to correlate with 
what has been previously shown for other Type I systems in both Gram-positive and Gram- 
negative bacteria. The cell biology of the Type Ib partitioning system has been well studied in 
E. coli, however nothing is known about the cellular localisation of Type Ib ParA proteins in 
Gram-positive organisms. 
 
The findings from this study however, revealed the first cellular localisation data obtained of a 
plasmid partitioning protein in a Gram-positive coccus and mechanistically, it appears that they 
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behave similarly to their Gram-negative counterparts. Specifically, cells expressing ParA-GFP 
supplied in trans to the wild-type system (encoded on pJEG001) displayed observable 
localisation towards the bacterial nucleoid (Figure 5.12). Similarly, with pJEG001 mutant 
derivatives (ParA-K15T or ParB-S53fsX57; as shown in Figure 5.12), ParA-GFP displayed a 
similar localisation pattern, which was expected as these mutant proteins should not affect its 
association with the nucleoid (Ringgaard et al., 2009). Also consistent with these results was 
the functionality of the combined plasmid constructs via segregational stability assays (Figure 
5.3.4). As has been previously shown in this study through Figure 3.2 (Section 3.2.2), 
functionality of p107Apar is dependent on both Par proteins to increase segregational stability. 
Therefore, the ability for ParA-GFP to partially rescue functionality of ParAK15T (encoded by 
pJEG005), signifies that this fusion protein can bind and hydrolyse ATP, however interaction 
with ParAK15T may decrease overall functional rescue. A construct containing a 
truncation/deletion of ParA could potentially resolve this issue and show more wild-type 
results; note that other studies have observed that mutations of ParA rendered the protein 
defective for plasmid segregation or created “super-repressors”, which allowed ATP binding 
but not hydrolysis (Vecchiarelli et al., 2013). The attempt to view ParB-GFP expression in the 
presence of wild-type p107Apar was successful when localisation to the bacterial nucleoid was 
observed, however, functionality was significantly hindered. This is most likely due to the GFP 
tag at the C-terminal end of parB, as it is consistent with what has been described with 
overexpression (Section 6.2.1). Once crystal structures have been obtained for both ParB and 
ParA, exploring ParB expression in addition to ParA localisation would further establish the 
dynamic interaction. 
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Plasmids are actively driven apart during cell division using NTPase motor proteins via 
mechanisms such as the proposed diffusion-ratchet model for Type Ia partitioning systems 
(Vecchiarelli et al., 2010), unstable filaments being ‘pushed’ by an insertional polymersiation 
model for Type II partitioning systems (Moller-Jensen et al., 2003), and ‘tramming’ or 
treadmilling of tubulin-like filaments in Type III systems (Ni et al., 2010). Despite the various 
models for partition segregation, NTPase activity is essential in the segregation process for 
most plasmid partitioning systems described to date. For Type I ParA proteins, the segregation 
mechanisms have been recently characterised to suggest two models which share the common 
theme of using the nucleoid as a scaffold for ParB-DNA interaction and attachment: a nucleoid- 
associated ParA filament pulling plasmids to cell poles and the diffusion-ratchet model as 
previously described (McLeod et al., 2017). As described in Section 5.3.5, time-lapse 
fluorescence imaging of ParA-GFP localisation suggests that while ParA displays dynamic 
movement within the cell when in the presence of p107Apar, localisation to the nucleoid that 
is observed best represents the diffusion-ratchet model for segregation (Figure 5.14A). 
 
 
It was also interesting to observe the fluorescence recovery of cells expressing ParA-GFP after 
photobleaching, as described in Section 5.3.6 (Figure 5.15). New fluorescent foci were visible 
after a quick recovery, indicating dynamic ParA molecules rapidly exchange across the 
nucleoid. Plasmid foci increased in numbers for the remainder of the timecourse, continually 
displaying rapid movement in association with the nucleoid. FRAP analysis by Hwang et al. 
(2013) assessed the exchange times of the plasmid P1 ParA and the rate of ATP hydrolysis in 
the presence and absence of plasmid DNA and compared it when observing the Sop partition 
system of the F plasmid. With further FRAP experiments of both p107A ParA and ParB 




While studies observing mutant derivatives for such experiments are also required to elucidate 
this dynamic association, a complement to the studies described above would be to obtain 
super-resolution images of ParA and ParB and perform techniques such as 
immunofluorescence microscopy (IFM) and fluorescence in situ hybridization (FISH). 
Conducting these experiments would ultimately reveal the cellular processes of the p107A Par 
proteins and confirm that localisation of these fluorescent fusion proteins in fixed S. aureus 
cells is mechanistically accurate. 
 
 
Furthermore, in order to obtain higher resolution images of ParA or ParA-GFP localisation, 
cutting edge technology such as 3D-SIM super resolution microscopy, would enable 3D super 
resolution images to be obtained of any structures formed by ParA and ParB proteins (or 
protein-GFP fusions) in fixed S. aureus or E. coli cells. Using this methodology, observations 
of a 3D meshwork (through the nucleoid) for pTP228 ParF-mediated plasmid segregation by 
McLeod et al. (2017), have led to the proposal of a new model to characterise the mechanism 
of plasmid segregation by ParA proteins. This proposed ‘venus flytrap’ mechanism for plasmid 
capture, demonstrates that the ParF meshwork results in a self-association of polymer bundles 
protruding into the nucleoid (McLeod et al., 2017). Although the diffusion-ratchet model is the 
current mechanism for Type Ib plasmid segregation, performing these techniques on p107A 
ParA might provide some insight into the mechanism utilised by Walker-type ATPases, which 
may contribute to the distribution of efficient plasmid partitioning. 
 
 
As described in Section 5.1, the use of fluorescence imaging to study cellular processes in 
staphylococci is complicated by its small size (1 µm), spherical shape and alternating planes of 
division. Therefore, as an adjunct to the cytological studies discussed above, E. coli was trialled 
as an alternative host, as its rod shape and larger size, established genetic tools and better 
characterised cell cycle processes make it a significantly more amenable host for such studies. 
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The functionality of the p107A Type Ib partitioning system in E. coli was initially determined 
and confirmed that p107Apar via pJEG014 increased segregational stability (Figure 3.4). 
Although this was not fully explored, the ability for p107Apar to function in a heterologous 
host implies that this system functions independent to other host cell machinery. As such, the 
feasibility to study the cellular localisation of p107Apar in a larger host would shed further 
light on the mechanism of ParA movement and segregation. As previously described (Section 
5.2.2.2), the ParA-GFP fusion protein plasmid pJEG016 contains a Pspac promoter which only 
allows constitutive expression in E. coli. Therefore, initially examining the viability of cells 
expressing ParA-GFP in isolation was necessary as the genetic organisation of pJEG016 places 
parA-gfp directly downstream of the Pspac promoter, meaning any genes fused to gfp would be 
continually switched on. Genes transcribed in an ongoing manner like parA-gfp normally result 
in irregular fluorescence patterns and partial cell defects, which was what was observed in this 
study via pJEG016 in E. coli (Figure 5.2). The elongated, filamentous E. coli cells observed 
were indicative that constitutive expression of ParA-GFP via the Pspac promoter causes a cell 
division defect. As a result, plasmid constructs in future that allow for controlled protein 
expression in E.coli, via a Ptac promoter, for example, may allow functional interaction of wild- 
type ParA with ParA-GFP. This would in turn not only assist with performing functional 
assays, but also facilitate with evaluating the mechanistic model in which ParA segregates 
plasmids as part of the p107A Type Ib system. 
6.3 Enterococcal Type Ib plasmid partitioning systems 
In the context of enterococcal RepA_N plasmids, the partitioning genes of pRUM-like 
plasmids have not been studied and only share low-level homology with those of pheromone- 
responsive plasmids, such as pAD1. While the Type Ib system of pJEG029 shares a similar 
genetic arrangement to that of the pheromone-responsive plasmid pAD1 and the staphylococcal 
plasmid p107A (discussed above), it has an additional parS site (parS2) located downstream 
of the parB gene across the predicted promoter for the replication (rep) gene. As the repeats 
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identified in parS2 are similar to parS1 in which ParB is predicted to bind to, the work 
conducted as part of this study focused on determining the functionality of the Type Ib 
partitioning system and investigating the impact on regulation of both the par and rep regions. 
The functionality of pJEG029par (pJEG032) was investigated and confirmed in Chapter 3 of 
this study, where increased plasmid stability was observed (Figure 3.6). Interestingly, 
segregational stability assays of pJEG033, which contains the pJEG029par-parS2 region, 
showed that inclusion of the parS2 site resulted in a lower level of increased stability. This 
result indicates that ParB molecules are likely sequestered to the parS2 site where they do not 
contribute to stability function but rather transcriptional regulation of the rep promoter. Note 
that although potential mutants for both pJEG029 parA and parB were constructed, stability 
assays are still required to confirm their individual requirement for functionality. 
 
 
With regards to assessing the transcriptional regulation of pJEG029par and the repA gene, only 
a ParB C-terminal His-tag fusion protein construct could be made. However, unlike p107A 
ParB-RGSH6, this protein was stably expressed as described in Section 4.3.1.2. Similar to the 
p107A His6-ParB-DNA binding experiments, specific binding of ParB-RGSH6 to the putative 
parS sites located across both Ppar and Prep was observed. Combined with CAT reporter assays, 
these results are similar to what was observed for the p107A system, in that ParB regulates 
promoters that contain parS sites (Figure 4.12). It should be noted that these results represent 
the first report of a ParB protein transcriptionally regulating a Type Ib partitioning system and 
its cognate replication gene located in a separate operon. Interestingly, a concurrent study of a 
related pRUM-like plasmid pJEG040, which contains a par-rep region sharing 96% homology 
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(at the DNA level) with the pJEG029 par-rep region, has revealed similar results (Jensen and 
McCann, unpublished data). With respect to the role of ParB in pRUM-like plasmid replication, 
decreased transcriptional repression of Prep could serve as a rescue mechanism that prevents 
plasmid loss (by increasing copy number) in newly divided cells or other conditions that result 
in non-saturating concentrations of ParB. 
 
 
In any case, additional experiments that could be performed to support/extend the above 
observations include utilising purified ParB-RGSH6 for DNase I footprinting (to delimit the 
identified binding regions) and obtaining a crystal structure of ParB (apo-structure) and ParB- 
parS1/parS2 complexes. Continued studies of the pJEG029 partitioning and replication 
mechanisms will contribute more broadly to our understanding of such systems in other 
bacteria due to the ubiquitous nature of RepA_N plasmids. 
 
6.4 Concluding remarks 
It is abundantly clear that resistance plasmids from strains of S. aureus, CNS and VRE play a 
key role in the maintenance and spread of antibiotic resistance in healthcare settings and the 
broader environment. Even in the absence of antibiotic selection, carriage of these plasmids is 
maintained during cell division due to a number of plasmid-encoded maintenance systems. In 
this regard, Type I plasmid partitioning systems, mainly based on studies of Gram-negative 
rod-shaped bacteria, have been shown to actively segregate plasmid copies into daughter cells. 
In this study, we have provided (for the first time) fundamental mechanistic understanding of 
the putative Type Ib plasmid partitioning systems located on the staphylococcal and 
enterococcal plasmids p107A and pJEG029, respectively. As part of this study, we have 
obtained the first ever cellular localisation images of a plasmid partitioning protein in a Gram- 
positive coccus, where it mechanistically appears to behave similarly to its Gram-negative 
counterparts, i.e., Type I ParA proteins obtain spatial information by localising to the nucleoid. 
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Furthermore, we have identified a ParB protein that regulates both partitioning and replication 
at the transcriptional level and this represents the first report of such regulation where the rep 
gene is located in a separate operon. Nevertheless, there remain unanswered questions about 
the p107A and pJEG029 Type Ib par mechanisms, and further research is required in order to 
increase our understanding of these processes. 
 
 
In the long term, a detailed understanding of these mechanisms will provide opportunities for 
the development of novel strategies aimed at disrupting partitioning processes in both 
staphylococci and enterococci. In this way, disrupting the inheritance of multiresistance 
plasmids could ultimately promote resistance plasmid loss within healthcare facility. Antibiotic 
resistance is clearly one of the most important public health issues worldwide and such 
innovative strategies need to be explored, as they have the key advantage of maximising the 
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